Term,Overlap,P.value,Adjusted.P.value,Old.P.value,Old.Adjusted.P.value,Odds.Ratio,Combined.Score,Genes
linoleic acid metabolic process (GO:0043651),5/16,8.509919016251744e-4,1,0,0,6.25,44.18192466087702,CYP2J2;GSTP1;GSTA1;ALOX12B;ALOX12
signal transduction by p53 class mediator (GO:0072331),7/39,0.0028894498964380593,1,0,0,3.5897435897435894,20.988114869541434,HINT1;IFI16;SESN2;BCL3;MDM4;ZNF346;POU4F2
carboxylic acid metabolic process (GO:0019752),6/33,0.005343233658797252,1,0,0,3.6363636363636362,19.0251791098256,CYP2J2;PTGIS;SLC2A3;GLYAT;MIF;ACOT4
establishment of skin barrier (GO:0061436),4/16,0.006976160030101439,1,0,0,5,24.82628326271881,STMN1;ALOX12B;ALOX12;RPTN
regulation of water loss via skin (GO:0033561),4/16,0.006976160030101439,1,0,0,5,24.82628326271881,STMN1;ALOX12B;ALOX12;RPTN
epidermis development (GO:0008544),10/81,0.0070077818561398554,1,0,0,2.4691358024691357,12.248726058435684,ALDH3A2;CDSN;RBP2;DCT;CRABP2;GRHL3;ATP2C1;FOXN1;RPTN;ZNF750
maintenance of protein localization in endoplasmic reticulum (GO:0035437),3/9,0.008342411451160579,1,0,0,6.666666666666666,31.90935307720135,RER1;GPAA1;INSIG1
negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),3/9,0.008342411451160579,1,0,0,6.666666666666666,31.90935307720135,HHEX;MMRN2;EPN2
microtubule nucleation (GO:0007020),4/17,0.008766901403579476,1,0,0,4.705882352941176,22.2906910717708,TUBGCP2;NDE1;RANBP9;NDEL1
chaperone-mediated protein complex assembly (GO:0051131),4/17,0.008766901403579476,1,0,0,4.705882352941176,22.2906910717708,HSP90AB1;BBS12;LONP1;HSPD1
glutathione metabolic process (GO:0006749),7/49,0.010484599803003085,1,0,0,2.8571428571428568,13.02242223966532,GGCT;GSTA5;GSTP1;GDAP1L1;GSTA1;CTNS;SOD1
prostaglandin biosynthetic process (GO:0001516),4/18,0.010832993829611394,1,0,0,4.444444444444444,20.111816967158788,CBR1;PTGIS;EDN2;MIF
superoxide anion generation (GO:0042554),3/10,0.011479073193892965,1,0,0,5.999999999999999,26.803377741534163,DUOX1;ALOX12;CYBA
positive regulation of glucose import in response to insulin stimulus (GO:2001275),3/10,0.011479073193892965,1,0,0,5.999999999999999,26.803377741534163,OSBPL8;RARRES2;PIK3R1
regulation of adenylate cyclase activity (GO:0045761),5/28,0.011645740044549789,1,0,0,3.571428571428571,15.902910097331779,GRM3;CAP1;GABBR2;HRH4;NF1
arachidonic acid metabolic process (GO:0019369),7/51,0.012969880614376915,1,0,0,2.7450980392156863,11.927795450247627,CYP2J2;CBR1;PTGIS;AWAT1;ALOX12B;ALOX12;CYP2C18
regulation of transcription factor import into nucleus (GO:0042990),4/19,0.01318872540853091,1,0,0,4.2105263157894735,18.224812421427043,NFKBIA;BCL3;NF1;PIK3R1
superoxide metabolic process (GO:0006801),5/29,0.013506098212759996,1,0,0,3.4482758620689657,14.843496469201975,DUOX1;NCF1B;ALOX12;CYBA;SOD1
regulation of phosphorylation of RNA polymerase II C-terminal domain (GO:1901407),3/11,0.015204352818016067,1,0,0,5.454545454545454,22.833673759197463,CCNT2;CCNH;PPIL4
hydrogen peroxide metabolic process (GO:0042743),4/20,0.015846713681637082,1,0,0,4,16.579172555417852,DUOX1;PRDX5;CYBA;SOD1
long-chain fatty acid metabolic process (GO:0001676),7/55,0.019161191353647928,1,0,0,2.545454545454545,10.066937565142911,CYP2J2;AWAT1;GSTP1;GSTA1;ALOX12B;ALOX12;ACOT4
intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),6/43,0.01929988711082831,1,0,0,2.7906976744186043,11.016714508655674,HINT1;IFI16;BCL3;ZNF346;USP28;POU4F2
rRNA 3'-end processing (GO:0031125),3/12,0.01953037772410442,1,0,0,5,19.678920967843133,EXOSC7;ERI1;RPS21
regulation of viral life cycle (GO:1903900),3/12,0.01953037772410442,1,0,0,5,19.678920967843133,LAMP3;MVB12A;TRIM25
regulation of cholesterol homeostasis (GO:2000188),3/12,0.01953037772410442,1,0,0,5,19.678920967843133,VDR;NR1H2;NR1H4
activation of cysteine-type endopeptidase activity (GO:0097202),3/12,0.01953037772410442,1,0,0,5,19.678920967843133,IFI16;CIDEB;TBC1D10A
regulation of erythrocyte differentiation (GO:0045646),5/32,0.020257193169988103,1,0,0,3.125,12.185141656980141,STAT5B;SPI1;MAFB;STAT3;INHBA
unsaturated fatty acid metabolic process (GO:0033559),6/44,0.021431508882189775,1,0,0,2.727272727272727,10.480617442273918,CYP2J2;AWAT1;GSTP1;GSTA1;ALOX12B;ALOX12
peripheral nervous system development (GO:0007422),4/22,0.022111430851613167,1,0,0,3.6363636363636362,13.860583894809807,ALDH3A2;ADGRB1;NF1;PMP22
regulation of glucose import in response to insulin stimulus (GO:2001273),3/13,0.02446267254220388,1,0,0,4.615384615384615,17.125877967461363,OSBPL8;RARRES2;PIK3R1
myelination in peripheral nervous system (GO:0022011),3/13,0.02446267254220388,1,0,0,4.615384615384615,17.125877967461363,NF1;NCMAP;SOD1
dicarboxylic acid catabolic process (GO:0043649),3/13,0.02446267254220388,1,0,0,4.615384615384615,17.125877967461363,GAD1;ASPA;ACOT4
prostanoid biosynthetic process (GO:0046457),3/13,0.02446267254220388,1,0,0,4.615384615384615,17.125877967461363,PTGIS;EDN2;MIF
regulation of alcohol biosynthetic process (GO:1902930),5/34,0.02579993741840051,1,0,0,2.941176470588235,10.757009449120288,SEC14L2;HMGCS1;VDR;NFYB;LSS
cellular response to oxidative stress (GO:0034599),11/115,0.029044235960308994,1,0,0,1.9130434782608696,6.770136967977921,PRDX5;GSTP1;SESN2;PXMP2;GPX5;LONP1;HTRA2;CYBA;WNT16;FOXO1;SOD1
intrinsic apoptotic signaling pathway (GO:0097193),10/101,0.029580473987330068,1,0,0,1.9801980198019802,6.971565936466181,HINT1;CEBPB;APAF1;IFI16;CUL1;HTRA2;CIDEB;ZNF346;HIC1;POU4F2
establishment of mitotic spindle orientation (GO:0000132),3/14,0.030000982735417972,1,0,0,4.285714285714286,15.027964885753896,DCTN1;NDE1;NDEL1
Ras protein signal transduction (GO:0007265),18/223,0.03133798758559126,1,0,0,1.6143497757847531,5.590370996952428,DBNL;RAB39B;RABL2B;USP28;DNAJC27;CRKL;RND1;CCNA2;PAK1;RAB31;GRAP2;ELMO1;NF1;PAK6;ZNF304;CTNNAL1;PAK5;LAT
protein K48-linked ubiquitination (GO:0070936),6/48,0.0315323243147388,1,0,0,2.5,8.641855226449724,UBE2D4;ARIH2;RNF6;UBE2A;UBE2G2;RNF152
intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),6/48,0.0315323243147388,1,0,0,2.5,8.641855226449724,IFI16;BCL3;HTRA2;CIDEB;USP28;HIC1
sphingosine-1-phosphate signaling pathway (GO:0003376),2/6,0.032750693472061776,1,0,0,6.666666666666666,22.792207616037423,SPNS3;SPNS1
vitamin A metabolic process (GO:0006776),2/6,0.032750693472061776,1,0,0,6.666666666666666,22.792207616037423,RBP2;RPE65
negative regulation of keratinocyte differentiation (GO:0045617),2/6,0.032750693472061776,1,0,0,6.666666666666666,22.792207616037423,CDSN;HOXA7
negative regulation of translation in response to stress (GO:0032055),2/6,0.032750693472061776,1,0,0,6.666666666666666,22.792207616037423,RBM4;SESN2
protein retention in ER lumen (GO:0006621),2/6,0.032750693472061776,1,0,0,6.666666666666666,22.792207616037423,RER1;GPAA1
negative regulation of stress-activated protein kinase signaling cascade (GO:0070303),2/6,0.032750693472061776,1,0,0,6.666666666666666,22.792207616037423,GSTP1;FOXO1
negative regulation of cell size (GO:0045792),2/6,0.032750693472061776,1,0,0,6.666666666666666,22.792207616037423,DEPTOR;AKT1S1
photoreceptor cell differentiation (GO:0046530),2/6,0.032750693472061776,1,0,0,6.666666666666666,22.792207616037423,STAT3;MAPRE2
regulation of glial cell differentiation (GO:0045685),2/6,0.032750693472061776,1,0,0,6.666666666666666,22.792207616037423,SLC45A3;NF1
white fat cell differentiation (GO:0050872),2/6,0.032750693472061776,1,0,0,6.666666666666666,22.792207616037423,PER2;ADIG
cellular response to cold (GO:0070417),2/6,0.032750693472061776,1,0,0,6.666666666666666,22.792207616037423,NFKBIA;FOXO1
regulation of t-circle formation (GO:1904429),2/6,0.032750693472061776,1,0,0,6.666666666666666,22.792207616037423,RTEL1;ERCC1
nervous system development (GO:0007399),32/455,0.033212306304587116,1,0,0,1.4065934065934065,4.789218180102484,HDAC4;CHRNA3;DCTN1;GSTP1;ZC4H2;DLX6;NAB2;NRXN2;HAPLN3;GBA2;ESS2;HAPLN2;FXR2;DPYSL2;SALL4;PCDHA9;NDUFV2;GPM6B;NOM1;DBNL;APAF1;STAT3;LSAMP;INHBA;ALDH3A2;FGF17;MAFB;ADGRB1;NF1;PMP22;RBM45;NAIP
regulation of actin filament-based process (GO:0032970),7/62,0.03449145783432962,1,0,0,2.258064516129032,7.6030016426619955,EPHA5;MLST8;ARHGEF19;RICTOR;GRHL3;GPM6B;RND1
positive regulation of multi-organism process (GO:0043902),5/37,0.03578300819815846,1,0,0,2.7027027027027026,9.000762512391741,MVB12A;CYBA;INHBA;LHFPL2;BMP6
phosphatidylethanolamine biosynthetic process (GO:0006646),3/15,0.03614002285058795,1,0,0,4,13.281417446154263,PCYT2;LPIN2;ETNPPL
negative regulation of TORC1 signaling (GO:1904262),3/15,0.03614002285058795,1,0,0,4,13.281417446154263,SPAAR;SESN2;RNF152
positive regulation of cellular response to insulin stimulus (GO:1900078),3/15,0.03614002285058795,1,0,0,4,13.281417446154263,OSBPL8;RARRES2;PIK3R1
inhibition of cysteine-type endopeptidase activity (GO:0097340),3/15,0.03614002285058795,1,0,0,4,13.281417446154263,BCL2L12;CARD18;NAIP
translational elongation (GO:0006414),10/105,0.03726634023995018,1,0,0,1.9047619047619047,6.266028126060623,EEF2K;NEMF;MRPS2;GTPBP2;MRPL12;MRPL13;MRPL24;MRPS5;MRPL54;MRPL44
positive regulation of cyclin-dependent protein kinase activity (GO:1904031),4/26,0.038635239533284925,1,0,0,3.076923076923077,10.01104762372913,CCNT2;CCND2;CCNH;CKS1B
fat-soluble vitamin metabolic process (GO:0006775),4/26,0.038635239533284925,1,0,0,3.076923076923077,10.01104762372913,CBR1;RBP2;VDR;RPE65
negative regulation of DNA recombination (GO:0045910),3/16,0.04287015534900723,1,0,0,3.75,11.81092265495912,RTEL1;HELB;POLK
negative regulation of lipid storage (GO:0010888),3/16,0.04287015534900723,1,0,0,3.75,11.81092265495912,NFKBIA;OSBPL8;NR1H2
acyl-CoA metabolic process (GO:0006637),5/39,0.04359375073529034,1,0,0,2.564102564102564,8.032926847844928,ACSM3;HMGCS1;ACSL6;GLYAT;ACOT4
regulation of double-strand break repair via homologous recombination (GO:0010569),4/27,0.04362093265098386,1,0,0,2.962962962962963,9.280646332348267,RTEL1;HELB;POLK;SPIDR
microtubule polymerization (GO:0046785),4/27,0.04362093265098386,1,0,0,2.962962962962963,9.280646332348267,TUBGCP2;NDE1;RANBP9;NDEL1
"exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000467)",2/7,0.04435183521490911,1,0,0,5.7142857142857135,17.803435376080927,EXOSC7;ERI1
exonucleolytic trimming involved in rRNA processing (GO:0000459),2/7,0.04435183521490911,1,0,0,5.7142857142857135,17.803435376080927,EXOSC7;ERI1
pri-miRNA transcription from RNA polymerase II promoter (GO:0061614),2/7,0.04435183521490911,1,0,0,5.7142857142857135,17.803435376080927,FOSL1;SPI1
melanocyte differentiation (GO:0030318),2/7,0.04435183521490911,1,0,0,5.7142857142857135,17.803435376080927,MITF;HPS6
attachment of GPI anchor to protein (GO:0016255),2/7,0.04435183521490911,1,0,0,5.7142857142857135,17.803435376080927,PGAP1;GPAA1
activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO:0008635),2/7,0.04435183521490911,1,0,0,5.7142857142857135,17.803435376080927,APAF1;CASP3
positive regulation of gastrulation (GO:2000543),2/7,0.04435183521490911,1,0,0,5.7142857142857135,17.803435376080927,OSR1;OTX2
spindle assembly (GO:0051225),8/80,0.046246853342135685,1,0,0,2,6.147523706367922,GOLGA8CP;TUBGCP2;RCC1;ABRAXAS2;HAUS5;GOLGA8O;NAIP;GOLGA2P5
negative regulation of TOR signaling (GO:0032007),5/40,0.04785273553053826,1,0,0,2.5,7.599067484612446,SPAAR;DEPTOR;SESN2;AKT1S1;RNF152
regulation of cholesterol biosynthetic process (GO:0045540),5/40,0.04785273553053826,1,0,0,2.5,7.599067484612446,SEC14L2;HMGCS1;NFYB;LSS;SOD1
protein K11-linked ubiquitination (GO:0070979),4/28,0.04895013769244342,1,0,0,2.8571428571428568,8.619865991683946,UBE2D4;UBE2A;ANAPC10;ANAPC11
regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),7/67,0.04938993805127162,1,0,0,2.08955223880597,6.285391018194011,HHEX;CCNT2;CCND2;CCNH;GTF2H1;CKS1B;CDKN3
negative regulation of telomere maintenance (GO:0032205),3/17,0.05017800549335433,1,0,0,3.5294117647058822,10.56062995015536,RTEL1;TNKS2;ERCC1
defense response to fungus (GO:0050832),3/17,0.05017800549335433,1,0,0,3.5294117647058822,10.56062995015536,RARRES2;RNASE8;S100A12
positive regulation of telomere capping (GO:1904355),3/17,0.05017800549335433,1,0,0,3.5294117647058822,10.56062995015536,RTEL1;TNKS2;PNKP
regulation of cholesterol metabolic process (GO:0090181),5/41,0.05234904272896249,1,0,0,2.4390243902439024,7.194686897103624,SEC14L2;HMGCS1;NFYB;NR1H4;LSS
sulfur amino acid catabolic process (GO:0000098),2/8,0.05721089072209802,1,0,0,5,14.305055007400815,CBS;PCYOX1
negative regulation of anion transmembrane transport (GO:1903960),2/8,0.05721089072209802,1,0,0,5,14.305055007400815,TCAF2;OSR1
protein K6-linked ubiquitination (GO:0085020),2/8,0.05721089072209802,1,0,0,5,14.305055007400815,UBE2D4;RNF6
TORC1 signaling (GO:0038202),2/8,0.05721089072209802,1,0,0,5,14.305055007400815,AKT1S1;MLST8
basement membrane organization (GO:0071711),2/8,0.05721089072209802,1,0,0,5,14.305055007400815,FLRT2;CTSS
regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358),2/8,0.05721089072209802,1,0,0,5,14.305055007400815,PTGIS;PLIN5
succinate metabolic process (GO:0006105),2/8,0.05721089072209802,1,0,0,5,14.305055007400815,STAT5B;GAD1
kidney mesenchyme development (GO:0072074),2/8,0.05721089072209802,1,0,0,5,14.305055007400815,BASP1;OSR1
negative regulation of double-strand break repair via homologous recombination (GO:2000042),2/8,0.05721089072209802,1,0,0,5,14.305055007400815,HELB;POLK
establishment of mitotic spindle localization (GO:0040001),3/18,0.058047017485584544,1,0,0,3.333333333333333,9.488339835095955,DCTN1;NDE1;NDEL1
regulation of epithelial cell differentiation (GO:0030856),3/18,0.058047017485584544,1,0,0,3.333333333333333,9.488339835095955,CEBPB;OSR1;FOXN1
positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),4/30,0.06063113352204076,1,0,0,2.6666666666666665,7.474524702251736,CCNT2;CCND2;CCNH;CKS1B
"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",3/19,0.06645795649124922,1,0,0,3.157894736842105,8.561639256247336,EXOSC7;ERI1;RPS21
positive regulation of oxidoreductase activity (GO:0051353),3/19,0.06645795649124922,1,0,0,3.157894736842105,8.561639256247336,EDN2;FTMT;VDR
regulation of steroid biosynthetic process (GO:0050810),5/44,0.06726261217595207,1,0,0,2.2727272727272725,6.134433491895637,SEC14L2;HMGCS1;NFYB;NR1H4;LSS
negative regulation of circadian rhythm (GO:0042754),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,PER2;CRY1
negative regulation of leukocyte chemotaxis (GO:0002689),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,PADI2;MIF
vacuolar proton-transporting V-type ATPase complex assembly (GO:0070072),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,VMA21;ALDOB
response to UV-C (GO:0010225),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,BCL3;POLH
positive regulation of protein maturation (GO:1903319),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,CCBE1;TNP2
positive regulation of triglyceride biosynthetic process (GO:0010867),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,NR1H2;PLIN5
microtubule anchoring at centrosome (GO:0034454),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,DCTN1;HOOK3
long-chain fatty acid biosynthetic process (GO:0042759),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,ALOX12B;ALOX12
regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,HTRA2;ST18
negative regulation of protein exit from endoplasmic reticulum (GO:0070862),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,INSIG1;UBE2G2
positive regulation of phosphorylation of RNA polymerase II C-terminal domain (GO:1901409),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,CCNT2;CCNH
podosome assembly (GO:0071800),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,DBNL;NCF1B
flavonoid glucuronidation (GO:0052696),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,UGT1A1;UGT1A6
negative regulation of lipid localization (GO:1905953),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,NFKBIA;NR1H2
negative regulation of transcription by competitive promoter binding (GO:0010944),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,HHEX;DACH1
proton-transporting V-type ATPase complex assembly (GO:0070070),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,VMA21;ALDOB
histone phosphorylation (GO:0016572),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,CCNA2;NEK11
oxoacid metabolic process (GO:0043436),4/32,0.07364989211173907,1,0,0,2.5,6.521081502381298,SULT1C2;SULT1B1;MIF;HS3ST4
positive regulation of telomere maintenance (GO:0032206),4/32,0.07364989211173907,1,0,0,2.5,6.521081502381298,RTEL1;TNKS2;PNKP;ERCC1
negative regulation of cyclase activity (GO:0031280),3/20,0.07538936106098607,1,0,0,2.9999999999999996,7.755267341732064,GRM3;GABBR2;HRH4
phosphatidylethanolamine metabolic process (GO:0046337),3/20,0.07538936106098607,1,0,0,2.9999999999999996,7.755267341732064,PCYT2;LPIN2;ETNPPL
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),3/20,0.07538936106098607,1,0,0,2.9999999999999996,7.755267341732064,IFI16;BCL3;USP28
Arp2/3 complex-mediated actin nucleation (GO:0034314),3/20,0.07538936106098607,1,0,0,2.9999999999999996,7.755267341732064,ACTR2;ARPC1B;WHAMM
growth hormone receptor signaling pathway (GO:0060396),3/20,0.07538936106098607,1,0,0,2.9999999999999996,7.755267341732064,STAT5B;STAT3;PIK3R1
negative regulation of adenylate cyclase activity (GO:0007194),3/20,0.07538936106098607,1,0,0,2.9999999999999996,7.755267341732064,GRM3;GABBR2;HRH4
negative regulation of interferon-gamma production (GO:0032689),3/20,0.07538936106098607,1,0,0,2.9999999999999996,7.755267341732064,NR1H4;XCL1;INHBA
entrainment of circadian clock by photoperiod (GO:0043153),3/20,0.07538936106098607,1,0,0,2.9999999999999996,7.755267341732064,PER2;RBM4;CRY1
mitotic spindle organization (GO:0007052),7/74,0.07622483813171252,1,0,0,1.8918918918918919,4.869858207482098,TUBGCP2;STMN1;SBDS;RCC1;ABRAXAS2;NAIP;SPC25
macromolecular complex assembly (GO:0065003),10/120,0.07801496455589842,1,0,0,1.6666666666666665,4.251424362355472,CARD10;KMT2A;TUBGCP2;GPAA1;TSPAN4;GEMIN5;RANBP9;MITF;OTX2;MDM4
icosanoid metabolic process (GO:0006690),5/46,0.07838227433911542,1,0,0,2.1739130434782608,5.535124934351927,CYP2J2;PTGIS;AWAT1;ALOX12B;ALOX12
regulation of actin cytoskeleton organization (GO:0032956),7/75,0.08063866676431897,1,0,0,1.8666666666666667,4.699850414889133,EPHA5;MLST8;ARHGEF19;RICTOR;GRHL3;GPM6B;RND1
establishment of spindle orientation (GO:0051294),3/21,0.08481794993785322,1,0,0,2.8571428571428568,7.049280242253078,DCTN1;NDE1;NDEL1
protein O-linked glycosylation via threonine (GO:0018243),3/21,0.08481794993785322,1,0,0,2.8571428571428568,7.049280242253078,GALNT14;GALNT2;GALNT10
negative regulation of cAMP biosynthetic process (GO:0030818),3/21,0.08481794993785322,1,0,0,2.8571428571428568,7.049280242253078,GRM3;GABBR2;HRH4
photoperiodism (GO:0009648),3/21,0.08481794993785322,1,0,0,2.8571428571428568,7.049280242253078,PER2;RBM4;CRY1
negative regulation of cell cycle arrest (GO:0071157),3/21,0.08481794993785322,1,0,0,2.8571428571428568,7.049280242253078,HSP90AB1;CDK4;MIF
positive regulation of cellular protein metabolic process (GO:0032270),8/91,0.08495438234807376,1,0,0,1.7582417582417582,4.335192694176877,NFKBIA;FXR2;IST1;NR1H2;BCL3;PYM1;INHBA;TBC1D10A
hemopoiesis (GO:0030097),7/76,0.08519720761440963,1,0,0,1.8421052631578945,4.536712195036593,KMT2A;IFI16;ARMC6;PGM3;AHSP;INHBA;RUNX2
cellular response to growth hormone stimulus (GO:0071378),2/10,0.08609691405925976,1,0,0,4,9.809126838186547,STAT3;PIK3R1
cellular biogenic amine metabolic process (GO:0006576),2/10,0.08609691405925976,1,0,0,4,9.809126838186547,SULT1B1;SMS
"regulation of DNA-templated transcription, initiation (GO:2000142)",2/10,0.08609691405925976,1,0,0,4,9.809126838186547,FOSL1;MITF
creatine metabolic process (GO:0006600),2/10,0.08609691405925976,1,0,0,4,9.809126838186547,CKMT2;STAT5B
DNA dealkylation involved in DNA repair (GO:0006307),2/10,0.08609691405925976,1,0,0,4,9.809126838186547,ALKBH2;ASCC1
positive regulation of fertilization (GO:1905516),2/10,0.08609691405925976,1,0,0,4,9.809126838186547,LHFPL2;ZP4
positive regulation of reproductive process (GO:2000243),2/10,0.08609691405925976,1,0,0,4,9.809126838186547,INHBA;LHFPL2
DNA dealkylation (GO:0035510),2/10,0.08609691405925976,1,0,0,4,9.809126838186547,ALKBH2;ASCC1
protein-cofactor linkage (GO:0018065),2/10,0.08609691405925976,1,0,0,4,9.809126838186547,SDHAF2;GAD1
telomere maintenance via recombination (GO:0000722),2/10,0.08609691405925976,1,0,0,4,9.809126838186547,SNRNP40;ERCC1
negative regulation of embryonic development (GO:0045992),2/10,0.08609691405925976,1,0,0,4,9.809126838186547,LFNG;FUZ
regulation of double-strand break repair (GO:2000779),4/34,0.08796002427126849,1,0,0,2.352941176470588,5.719700793788988,RTEL1;HELB;SLF1;SPIDR
positive regulation of leukocyte migration (GO:0002687),4/34,0.08796002427126849,1,0,0,2.352941176470588,5.719700793788988,EDN2;TNFRSF18;XCL1;CXCL3
positive regulation of telomere maintenance via telomere lengthening (GO:1904358),4/34,0.08796002427126849,1,0,0,2.352941176470588,5.719700793788988,RTEL1;TNKS2;PNKP;FBXO4
anterior/posterior pattern specification (GO:0009952),4/34,0.08796002427126849,1,0,0,2.352941176470588,5.719700793788988,HHEX;CDX4;CDX2;BASP1
cellular protein catabolic process (GO:0044257),6/62,0.08873881335310585,1,0,0,1.9354838709677418,4.687854010251747,RNF123;LONP1;HTRA2;CTSW;UBE2G2;CTSS
cell cycle G1/S phase transition (GO:0044843),8/92,0.08919814687860968,1,0,0,1.7391304347826086,4.20329567741818,CCNA2;CCNH;CDK4;CUL1;RCC1;INHBA;CRLF3;CDKN3
cellular macromolecule catabolic process (GO:0044265),5/48,0.0904238200779985,1,0,0,2.0833333333333335,5.006765728864707,EXOSC7;RNASET2;HTRA2;UBE2G2;DIS3L2
regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),3/22,0.09471898702745883,1,0,0,2.727272727272727,6.427747642616689,HHEX;MMRN2;EPN2
sulfur amino acid metabolic process (GO:0000096),3/22,0.09471898702745883,1,0,0,2.727272727272727,6.427747642616689,CBS;SMS;PCYOX1
histone lysine methylation (GO:0034968),3/22,0.09471898702745883,1,0,0,2.727272727272727,6.427747642616689,KMT2A;SETDB2;DPY30
positive regulation of erythrocyte differentiation (GO:0045648),3/22,0.09471898702745883,1,0,0,2.727272727272727,6.427747642616689,STAT5B;STAT3;INHBA
negative regulation of sprouting angiogenesis (GO:1903671),3/22,0.09471898702745883,1,0,0,2.727272727272727,6.427747642616689,CARD10;MMRN2;EPN2
protein O-linked glycosylation via serine (GO:0018242),3/22,0.09471898702745883,1,0,0,2.727272727272727,6.427747642616689,GALNT14;GALNT2;GALNT10
negative regulation of lyase activity (GO:0051350),3/22,0.09471898702745883,1,0,0,2.727272727272727,6.427747642616689,GRM3;GABBR2;HRH4
RNA metabolic process (GO:0016070),14/191,0.09837144633280481,1,0,0,1.4659685863874343,3.3995880368694835,LIG1;DQX1;RNASET2;LSM1;DDX31;MRPL44;DHX40;HNRNPL;EXOSC7;LSM8;RBM4;HELB;SNRNP40;DIS3L2
isotype switching (GO:0045190),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,CCR6;HSPD1
L-phenylalanine metabolic process (GO:0006558),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,QDPR;ASRGL1
L-phenylalanine catabolic process (GO:0006559),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,QDPR;ASRGL1
interleukin-27-mediated signaling pathway (GO:0070106),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,STAT3;EBI3
microtubule anchoring at microtubule organizing center (GO:0072393),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,DCTN1;HOOK3
regulation of lipid kinase activity (GO:0043550),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,RBL1;PIK3R1
positive regulation of superoxide anion generation (GO:0032930),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,GSTP1;SOD1
xenobiotic glucuronidation (GO:0052697),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,UGT1A1;UGT1A6
protein localization to pre-autophagosomal structure (GO:0034497),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,PACS2;ATG9A
cellular response to interferon-beta (GO:0035458),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,HTRA2;UBE2G2
positive regulation of fatty acid biosynthetic process (GO:0045723),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,SLC45A3;NR1H2
metanephric mesenchyme development (GO:0072075),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,BASP1;OSR1
carbohydrate phosphorylation (GO:0046835),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,IPPK;IDNK
inhibition of cysteine-type endopeptidase activity involved in apoptotic process (GO:1990001),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,BCL2L12;NAIP
cyclooxygenase pathway (GO:0019371),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,CBR1;PTGIS
"negative regulation of translation, ncRNA-mediated (GO:0040033)",2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,RBM4;STAT3
erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,QDPR;ASRGL1
miRNA mediated inhibition of translation (GO:0035278),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,RBM4;STAT3
interleukin-35-mediated signaling pathway (GO:0070757),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,STAT3;EBI3
hepatocyte growth factor receptor signaling pathway (GO:0048012),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,PAK1;STMN1
regulation of cytoskeleton organization (GO:0051493),8/95,0.10265073154364955,1,0,0,1.6842105263157894,3.8339755940387668,EPHA5;STMN1;MLST8;ARHGEF19;RICTOR;GRHL3;GPM6B;RND1
zymogen activation (GO:0031638),4/36,0.10349974906541197,1,0,0,2.222222222222222,5.040413535040945,IFI16;CIDEB;PRSS12;TBC1D10A
regulation of cell morphogenesis involved in differentiation (GO:0010769),4/36,0.10349974906541197,1,0,0,2.222222222222222,5.040413535040945,CHRNA3;PAK1;FXR2;SSH2
regulation of telomere capping (GO:1904353),3/23,0.10506660809461679,1,0,0,2.6086956521739126,5.877810696891578,RTEL1;TNKS2;PNKP
metanephros development (GO:0001656),3/23,0.10506660809461679,1,0,0,2.6086956521739126,5.877810696891578,BASP1;OSR1;NF1
cellular response to interleukin-6 (GO:0071354),3/23,0.10506660809461679,1,0,0,2.6086956521739126,5.877810696891578,PTGIS;STAT3;ST18
coenzyme metabolic process (GO:0006732),5/51,0.11015447203407641,1,0,0,1.9607843137254901,4.325238445226717,ACSM3;PDZD11;ACSL6;GLYAT;ACOT4
protein K63-linked ubiquitination (GO:0070534),4/37,0.11170784333278796,1,0,0,2.1621621621621623,4.739174827095357,HECTD1;UBE2D4;ARIH2;RNF152
positive regulation of cell cycle (GO:0045787),7/82,0.11553692430953495,1,0,0,1.7073170731707317,3.6846721375201086,CCNT2;HSP90AB1;CCND2;CCNH;CDK4;MIF;CKS1B
actin nucleation (GO:0045010),3/24,0.11583411237416653,1,0,0,2.5,5.388990442839107,ACTR2;ARPC1B;WHAMM
positive regulation of lyase activity (GO:0051349),2/12,0.1183149351744569,1,0,0,3.333333333333333,7.114684225538833,FTMT;NF1
histone H3-K9 demethylation (GO:0033169),2/12,0.1183149351744569,1,0,0,3.333333333333333,7.114684225538833,KDM3A;KDM4E
regulation of oligodendrocyte differentiation (GO:0048713),2/12,0.1183149351744569,1,0,0,3.333333333333333,7.114684225538833,SLC45A3;NF1
sulfation (GO:0051923),2/12,0.1183149351744569,1,0,0,3.333333333333333,7.114684225538833,SULT1B1;SULT1C2
Golgi localization (GO:0051645),2/12,0.1183149351744569,1,0,0,3.333333333333333,7.114684225538833,HOOK3;YWHAZ
regulation of cholesterol storage (GO:0010885),2/12,0.1183149351744569,1,0,0,3.333333333333333,7.114684225538833,MSR1;NR1H2
histone H3 deacetylation (GO:0070932),2/12,0.1183149351744569,1,0,0,3.333333333333333,7.114684225538833,HDAC4;PER2
regulation of sequestering of triglyceride (GO:0010889),2/12,0.1183149351744569,1,0,0,3.333333333333333,7.114684225538833,OSBPL8;PLIN5
retina homeostasis (GO:0001895),4/38,0.12019452718952628,1,0,0,2.1052631578947367,4.4603027132352775,POTEJ;LCN1;RPE65;SOD1
chemical homeostasis (GO:0048878),4/38,0.12019452718952628,1,0,0,2.1052631578947367,4.4603027132352775,ACOXL;VDR;NR1H2;NR1H4
small GTPase mediated signal transduction (GO:0007264),8/99,0.12224070691787418,1,0,0,1.6161616161616161,3.3967889625023044,CCNA2;GRAP2;NF1;ZNF304;USP28;RIN2;LAT;CRKL
organophosphate ester transport (GO:0015748),3/25,0.1269942219814603,1,0,0,2.4,4.9526728554420085,OSBPL8;PRELID2;PCTP
prostaglandin metabolic process (GO:0006693),3/25,0.1269942219814603,1,0,0,2.4,4.9526728554420085,PTGIS;EDN2;MIF
negative regulation of epithelial to mesenchymal transition (GO:0010719),3/25,0.1269942219814603,1,0,0,2.4,4.9526728554420085,SDHAF2;FUZ;USF3
regulation of cellular protein localization (GO:1903827),3/25,0.1269942219814603,1,0,0,2.4,4.9526728554420085,RALB;SPIDR;NDEL1
signal transduction in response to DNA damage (GO:0042770),3/25,0.1269942219814603,1,0,0,2.4,4.9526728554420085,SESN2;BCL3;MDM4
positive regulation of fat cell differentiation (GO:0045600),4/39,0.1289489055490016,1,0,0,2.051282051282051,4.201721095583098,CEBPB;RARRES2;AAMDC;ADIG
positive regulation of reactive oxygen species metabolic process (GO:2000379),4/39,0.1289489055490016,1,0,0,2.051282051282051,4.201721095583098,GSTP1;ADGRB1;CYBA;SOD1
regulation of interleukin-1 beta production (GO:0032651),2/13,0.13537899404817505,1,0,0,3.076923076923077,6.1528525246417765,IFI16;GSTP1
negative regulation of macrophage derived foam cell differentiation (GO:0010745),2/13,0.13537899404817505,1,0,0,3.076923076923077,6.1528525246417765,NFKBIA;NR1H2
regulation of plasma membrane bounded cell projection organization (GO:0120035),2/13,0.13537899404817505,1,0,0,3.076923076923077,6.1528525246417765,NCS1;NDEL1
cellular response to exogenous dsRNA (GO:0071360),2/13,0.13537899404817505,1,0,0,3.076923076923077,6.1528525246417765,IFIH1;RALB
regulation of superoxide anion generation (GO:0032928),2/13,0.13537899404817505,1,0,0,3.076923076923077,6.1528525246417765,GSTP1;SOD1
regulation of triglyceride biosynthetic process (GO:0010866),2/13,0.13537899404817505,1,0,0,3.076923076923077,6.1528525246417765,NR1H2;PLIN5
tricarboxylic acid metabolic process (GO:0072350),2/13,0.13537899404817505,1,0,0,3.076923076923077,6.1528525246417765,STAT5B;IDH3B
placenta development (GO:0001890),2/13,0.13537899404817505,1,0,0,3.076923076923077,6.1528525246417765,ASCL2;SOD1
positive regulation of cholesterol efflux (GO:0010875),2/13,0.13537899404817505,1,0,0,3.076923076923077,6.1528525246417765,NFKBIA;NR1H2
poly(A)+ mRNA export from nucleus (GO:0016973),2/13,0.13537899404817505,1,0,0,3.076923076923077,6.1528525246417765,NXF1;HHEX
cellular response to interleukin-15 (GO:0071350),2/13,0.13537899404817505,1,0,0,3.076923076923077,6.1528525246417765,STAT5B;STAT3
establishment of chromosome localization (GO:0051303),2/13,0.13537899404817505,1,0,0,3.076923076923077,6.1528525246417765,NDE1;NDEL1
positive regulation of alpha-beta T cell proliferation (GO:0046641),2/13,0.13537899404817505,1,0,0,3.076923076923077,6.1528525246417765,EBI3;XCL1
interleukin-15-mediated signaling pathway (GO:0035723),2/13,0.13537899404817505,1,0,0,3.076923076923077,6.1528525246417765,STAT5B;STAT3
regulation of leukocyte migration (GO:0002685),2/13,0.13537899404817505,1,0,0,3.076923076923077,6.1528525246417765,TNFRSF18;HOXA7
negative regulation of cytokine-mediated signaling pathway (GO:0001960),4/40,0.1379595947094308,1,0,0,2,3.961588857315027,GSTP1;NR1H2;PADI2;CCDC3
positive regulation of glucose import (GO:0046326),3/26,0.1385193121264188,1,0,0,2.3076923076923075,4.561720443090936,OSBPL8;RARRES2;PIK3R1
lipid modification (GO:0030258),3/26,0.1385193121264188,1,0,0,2.3076923076923075,4.561720443090936,PLPP5;CYP4A22;DGKZ
positive regulation of DNA biosynthetic process (GO:2000573),5/55,0.13937991022954382,1,0,0,1.8181818181818181,3.582821649166955,HSP90AB1;RFC4;TNKS2;PNKP;FBXO4
negative regulation of cellular response to growth factor stimulus (GO:0090288),5/55,0.13937991022954382,1,0,0,1.8181818181818181,3.582821649166955,SPART;HHEX;BMPER;MMRN2;EPN2
protein modification by small protein conjugation (GO:0032446),25/398,0.14320486183558612,1,0,0,1.2562814070351758,2.44155662520867,UBE2D4;EPAS1;UBA5;CUL1;RNF6;ANAPC11;IFIH1;PCNP;HECTD1;RNF138;FBXO4;ARIH2;RNF152;TRIM23;FBXW5;KLHL28;KLHL22;MITF;KLHDC8B;UBE2G2;UBE2A;PIAS2;KCTD10;ASB9;NAIP
mitochondrial translational elongation (GO:0070125),7/87,0.14456531199301625,1,0,0,1.6091954022988504,3.1122223475945634,MRPS2;MRPL12;MRPL13;MRPL24;MRPS5;MRPL54;MRPL44
regulation of stress-activated MAPK cascade (GO:0032872),4/41,0.14721479282726987,1,0,0,1.951219512195122,3.7382684546071134,GSTP1;CARD9;FOXO1;MAPK8IP1
negative regulation of STAT cascade (GO:1904893),4/41,0.14721479282726987,1,0,0,1.951219512195122,3.7382684546071134,FLRT2;BCL3;SOCS4;ASPN
regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),3/27,0.15038161447469178,1,0,0,2.222222222222222,4.210175820273459,DDRGK1;UBA5;RNF6
negative regulation of myeloid leukocyte differentiation (GO:0002762),3/27,0.15038161447469178,1,0,0,2.222222222222222,4.210175820273459,MAFB;INHBA;HOXA7
regulation of fat cell differentiation (GO:0045598),6/72,0.15049803689681743,1,0,0,1.6666666666666665,3.1563420645887432,CEBPB;BBS12;RARRES2;FOXO1;AAMDC;ADIG
ubiquinone metabolic process (GO:0006743),2/14,0.15294200533335325,1,0,0,2.8571428571428568,5.364847084446157,COQ3;COQ8B
establishment or maintenance of actin cytoskeleton polarity (GO:0030950),2/14,0.15294200533335325,1,0,0,2.8571428571428568,5.364847084446157,RICTOR;RND1
negative regulation of interleukin-1 beta production (GO:0032691),2/14,0.15294200533335325,1,0,0,2.8571428571428568,5.364847084446157,GSTP1;CARD18
glucuronate metabolic process (GO:0019585),2/14,0.15294200533335325,1,0,0,2.8571428571428568,5.364847084446157,UGT1A1;UGT1A6
negative regulation of biomineral tissue development (GO:0070168),2/14,0.15294200533335325,1,0,0,2.8571428571428568,5.364847084446157,ECM1;ASPN
quinone biosynthetic process (GO:1901663),2/14,0.15294200533335325,1,0,0,2.8571428571428568,5.364847084446157,COQ3;COQ8B
negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),2/14,0.15294200533335325,1,0,0,2.8571428571428568,5.364847084446157,CARD10;MMRN2
fatty acid transport (GO:0015908),2/14,0.15294200533335325,1,0,0,2.8571428571428568,5.364847084446157,LCN1;MFSD2A
regulation of gastrulation (GO:0010470),2/14,0.15294200533335325,1,0,0,2.8571428571428568,5.364847084446157,OSR1;OTX2
cellular response to nitrogen compound (GO:1901699),2/14,0.15294200533335325,1,0,0,2.8571428571428568,5.364847084446157,NR1H4;SPIDR
interleukin-6-mediated signaling pathway (GO:0070102),2/14,0.15294200533335325,1,0,0,2.8571428571428568,5.364847084446157,STAT3;ST18
regulation of interferon-gamma biosynthetic process (GO:0045072),2/14,0.15294200533335325,1,0,0,2.8571428571428568,5.364847084446157,EBI3;INHBA
mitochondrial translational termination (GO:0070126),7/89,0.15706487379765424,1,0,0,1.5730337078651684,2.9118369551802306,MRPS2;MRPL12;MRPL13;MRPL24;MRPS5;MRPL54;MRPL44
transcription-coupled nucleotide-excision repair (GO:0006283),6/73,0.1575316394218323,1,0,0,1.643835616438356,3.03802020110663,XAB2;RFC4;LIG1;CCNH;ERCC1;GTF2H1
neuron differentiation (GO:0030182),10/139,0.15841964449431314,1,0,0,1.4388489208633093,2.651090343912608,EPHA5;NGRN;FXR2;CASP3;OTX2;INHBA;WNT16;RUNX2;POU4F2;MANF
fatty acid metabolic process (GO:0006631),8/106,0.16083721932026523,1,0,0,1.5094339622641508,2.758282997111417,PER2;STAT5B;ACSM3;NUDT19;ALOX12;ALOX12B;LPIN2;ACOT4
regulation of TORC1 signaling (GO:1903432),3/28,0.16255339603696525,1,0,0,2.142857142857143,3.893033014692501,SPAAR;SESN2;RNF152
positive regulation of lipid biosynthetic process (GO:0046889),3/28,0.16255339603696525,1,0,0,2.142857142857143,3.893033014692501,SLC45A3;NR1H2;PLIN5
transcription elongation from RNA polymerase I promoter (GO:0006362),3/28,0.16255339603696525,1,0,0,2.142857142857143,3.893033014692501,CCNH;POLR1B;GTF2H1
negative regulation of Wnt signaling pathway (GO:0030178),12/174,0.16258345303883592,1,0,0,1.379310344827586,2.5056053129318974,PSMB6;TLE1;HMGXB4;SDHAF2;PSMB3;DACT3;FUZ;IGFBP6;KREMEN2;NOTUM;MLLT3;HIC1
cholesterol homeostasis (GO:0042632),5/58,0.16328476821631294,1,0,0,1.7241379310344829,3.1245854451901107,ACSM3;VDR;INSIG1;NR1H2;NR1H4
sterol homeostasis (GO:0055092),5/58,0.16328476821631294,1,0,0,1.7241379310344829,3.1245854451901107,ACSM3;VDR;INSIG1;NR1H2;NR1H4
regulation of nucleic acid-templated transcription (GO:1903506),36/607,0.16445697387840066,1,0,0,1.186161449752883,2.141147505717322,CEBPB;KDM3A;ZNF350;ZNF471;MYCBP;CRABP2;NAB2;HOXD13;RNF6;ASCL2;HINT1;HMGXB4;DACH1;TBX22;SALL4;PAK6;ZNF304;HIVEP3;GPBP1L1;ZNF543;ZIK1;ZNF221;ZNF483;ASCC1;SP110;NFYB;STAT3;ESRRB;MITF;HIC1;UBTFL1;MAFB;ZNF836;ZNF417;ZNF773;ZNF354C
mitotic nuclear division (GO:0140014),6/74,0.1647057705275506,1,0,0,1.6216216216216217,2.924748009429989,TUBGCP2;NDE1;KLHL22;ABRAXAS2;NAIP;NDEL1
negative regulation of DNA metabolic process (GO:0051053),4/43,0.16640981850387015,1,0,0,1.8604651162790697,3.336375343076965,RTEL1;DACH1;KMT2A;ERCC1
nucleobase-containing compound catabolic process (GO:0034655),4/43,0.16640981850387015,1,0,0,1.8604651162790697,3.336375343076965,EXOSC7;RNASET2;ENTPD6;DIS3L2
negative regulation of kinase activity (GO:0033673),7/91,0.17003916876293382,1,0,0,1.5384615384615385,2.725733021512411,DEPTOR;FLRT2;GSTP1;AKT1S1;NF1;ASPN;SOCS4
ubiquinone biosynthetic process (GO:0006744),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,COQ3;COQ8B
lipoxygenase pathway (GO:0019372),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,ALOX12;ALOX12B
unsaturated fatty acid biosynthetic process (GO:0006636),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,ALOX12B;ALOX12
regulation of tumor necrosis factor secretion (GO:1904467),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,IFIH1;NR1H4
negative regulation of cell aging (GO:0090344),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,RBL1;MIF
intra-S DNA damage checkpoint (GO:0031573),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,HUS1;NEK11
regulation of macrophage chemotaxis (GO:0010758),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,RARRES2;MIF
positive regulation of double-strand break repair (GO:2000781),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,SLF1;SPIDR
protein O-linked fucosylation (GO:0036066),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,LFNG;ADAMTSL4
JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,STAT5B;STAT3
positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001269),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,HTRA2;ST18
negative regulation of anoikis (GO:2000811),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,TLE1;ZNF304
retinoid metabolic process (GO:0001523),6/75,0.17201595491043623,1,0,0,1.5999999999999999,2.8162688725816674,TTR;UGT1A1;RBP2;DHRS9;RARRES2;RPE65
nucleotide-excision repair (GO:0006289),8/108,0.17280406327587397,1,0,0,1.4814814814814814,2.6008843089787628,XAB2;RFC4;LIG1;CCNH;PNKP;ERCC1;HUS1;GTF2H1
positive regulation of cell differentiation (GO:0045597),13/194,0.17457490590345454,1,0,0,1.3402061855670102,2.3391977113709883,MSR1;CEBPB;HSP90AB1;RARRES2;FOXN1;RUNX2;POU4F2;BMP6;RBM4;CDH15;AAMDC;CDON;ADIG
regulation of macrophage derived foam cell differentiation (GO:0010743),3/29,0.17500711584969555,1,0,0,2.068965517241379,3.6060592632145636,NFKBIA;MSR1;NR1H2
positive regulation of myeloid cell differentiation (GO:0045639),3/29,0.17500711584969555,1,0,0,2.068965517241379,3.6060592632145636,STAT5B;STAT3;INHBA
regulation of embryonic development (GO:0045995),3/29,0.17500711584969555,1,0,0,2.068965517241379,3.6060592632145636,LFNG;CDX2;OTX2
microtubule cytoskeleton organization involved in mitosis (GO:1902850),4/44,0.17632454152329277,1,0,0,1.8181818181818181,3.155325447401995,STMN1;SBDS;RCC1;SPC25
myeloid cell differentiation (GO:0030099),4/44,0.17632454152329277,1,0,0,1.8181818181818181,3.155325447401995,IFI16;CASP3;AHSP;INHBA
regulation of cellular macromolecule biosynthetic process (GO:2000112),37/631,0.17786751334428186,1,0,0,1.172741679873217,2.0249921894298164,CEBPB;KDM3A;ZNF350;ZNF471;MYCBP;CRABP2;NAB2;HOXD13;RNF6;ASCL2;HINT1;HMGXB4;DACH1;TBX22;SALL4;PAK6;ZNF304;HIVEP3;GPBP1L1;ZNF543;ZIK1;ZNF221;ZNF483;ASCC1;SP110;NFYB;STAT3;ESRRB;MITF;HIC1;UBTFL1;MAFB;ZNF836;ZNF417;GEMIN5;ZNF773;ZNF354C
"transcription, DNA-templated (GO:0006351)",22/356,0.18000798093357026,1,0,0,1.2359550561797752,2.119358988326423,CEBPB;CCNT2;CRCP;CDX2;KMT2A;CCNH;EPAS1;HOXD13;GTF2H1;ELOA3;MRPL12;MLLT3;ASCL2;FOXN1;TAF5L;FOSL1;XAB2;FUBP3;SALL4;BCL3;HIVEP3;LZTS1
gene expression (GO:0010467),25/411,0.18131017953626952,1,0,0,1.2165450121654502,2.077306587989989,DQX1;MRPL13;ASCL2;HSPD1;RBM4;NXF1;HHEX;HELB;FIP1L1;RPL39;LZTS1;RPS13;UPF2;MRPS2;MRPL24;MRPS5;MRPL44;HNRNPL;DHX40;XAB2;SNRNP40;FUBP3;BCL3;RPL24;RPS21
nicotinamide nucleotide metabolic process (GO:0046496),4/45,0.18643368284604128,1,0,0,1.7777777777777777,2.98609722860718,PKM;NMRK2;ALDOB;NADK
regulation of leukocyte chemotaxis (GO:0002688),3/30,0.1877155615267818,1,0,0,2,3.345654864900365,EDN2;XCL1;CXCL3
activation of protein kinase B activity (GO:0032148),3/30,0.1877155615267818,1,0,0,2,3.345654864900365,OSBPL8;MLST8;RICTOR
regulation of intracellular estrogen receptor signaling pathway (GO:0033146),3/30,0.1877155615267818,1,0,0,2,3.345654864900365,PAK1;DDRGK1;UBA5
regulation of developmental growth (GO:0048638),3/30,0.1877155615267818,1,0,0,2,3.345654864900365,STAT5B;SPAAR;SOD1
phosphatidylinositol 3-kinase signaling (GO:0014065),3/30,0.1877155615267818,1,0,0,2,3.345654864900365,NF1;PIK3C2G;PIK3R1
response to estradiol (GO:0032355),3/30,0.1877155615267818,1,0,0,2,3.345654864900365,STAT5B;STAT3;POU4F2
positive regulation of reactive oxygen species biosynthetic process (GO:1903428),3/30,0.1877155615267818,1,0,0,2,3.345654864900365,HSP90AB1;ADGRB1;CYBA
DNA strand elongation involved in DNA replication (GO:0006271),2/16,0.18920318276808346,1,0,0,2.5,4.1623345006609895,RFC4;LIG1
cellular response to dsRNA (GO:0071359),2/16,0.18920318276808346,1,0,0,2.5,4.1623345006609895,IFIH1;RALB
regulation of reactive oxygen species biosynthetic process (GO:1903426),2/16,0.18920318276808346,1,0,0,2.5,4.1623345006609895,ADGRB1;CYBA
stabilization of membrane potential (GO:0030322),2/16,0.18920318276808346,1,0,0,2.5,4.1623345006609895,KCNK12;KCNK1
protein deacylation (GO:0035601),2/16,0.18920318276808346,1,0,0,2.5,4.1623345006609895,HDAC4;NOTUM
negative regulation of steroid biosynthetic process (GO:0010894),2/16,0.18920318276808346,1,0,0,2.5,4.1623345006609895,NR1H4;SOD1
extracellular matrix assembly (GO:0085029),2/16,0.18920318276808346,1,0,0,2.5,4.1623345006609895,FAM234B;GPM6B
regulation of steroid metabolic process (GO:0019218),2/16,0.18920318276808346,1,0,0,2.5,4.1623345006609895,UGT1A1;NR1H4
positive regulation of triglyceride metabolic process (GO:0090208),2/16,0.18920318276808346,1,0,0,2.5,4.1623345006609895,NR1H2;PLIN5
detection of visible light (GO:0009584),2/16,0.18920318276808346,1,0,0,2.5,4.1623345006609895,MAPRE2;RPE65
regulation of interferon-alpha production (GO:0032647),2/16,0.18920318276808346,1,0,0,2.5,4.1623345006609895,IFIH1;HSPD1
"positive regulation of DNA-templated transcription, initiation (GO:2000144)",2/16,0.18920318276808346,1,0,0,2.5,4.1623345006609895,FOSL1;MITF
skin development (GO:0043588),7/94,0.19033598855816936,1,0,0,1.4893617021276595,2.4707980540188315,CDSN;CASP3;STMN1;ALOX12B;ALOX12;WNT16;RPTN
T cell receptor signaling pathway (GO:0050852),11/163,0.19351846366375716,1,0,0,1.3496932515337423,2.2167123764108663,NFKBIA;PSMB6;PAK1;PSMB3;GRAP2;BTN1A1;CUL1;PIK3R1;HLA-DQA2;HLA-DRB1;LAT
visual perception (GO:0007601),6/78,0.19471584243590756,1,0,0,1.5384615384615385,2.5172523099552775,CRYGA;ATXN7;OPA3;NUDT19;RPE65;POU4F3
regulation of fibroblast proliferation (GO:0048145),4/46,0.19672429496904084,1,0,0,1.7391304347826086,2.82774269288294,CDK4;GSTP1;NF1;MIF
diterpenoid metabolic process (GO:0016101),5/62,0.19745752815386772,1,0,0,1.6129032258064515,2.616502846917968,ALDH3A2;TTR;RBP2;RARRES2;RPE65
alpha-amino acid metabolic process (GO:1901605),3/31,0.20065196718317338,1,0,0,1.9354838709677418,3.1087420224475646,CKMT2;STAT5B;CBS
termination of RNA polymerase I transcription (GO:0006363),3/31,0.20065196718317338,1,0,0,1.9354838709677418,3.1087420224475646,CCNH;POLR1B;GTF2H1
positive regulation of bone mineralization (GO:0030501),3/31,0.20065196718317338,1,0,0,1.9354838709677418,3.1087420224475646,OSR1;GPM6B;BMP6
regulation of protein kinase activity (GO:0045859),10/147,0.20122389293890539,1,0,0,1.3605442176870748,2.1814110144565944,DEPTOR;FLRT2;GSTP1;SPDYE1;AKT1S1;NF1;SOCS4;LAT;ASPN;SOD1
protein glycosylation (GO:0006486),9/130,0.20317246774459144,1,0,0,1.3846153846153846,2.206661629625701,SERP2;TNKS2;GALNT2;COG3;ALG2;B3GALT4;PGM3;ALG10B;GALNT10
translational termination (GO:0006415),7/96,0.20438472217151854,1,0,0,1.4583333333333333,2.3154704536306197,MRPS2;MRPL12;MRPL13;MRPL24;MRPS5;MRPL54;MRPL44
regulated exocytosis (GO:0045055),10/148,0.20689639195594445,1,0,0,1.3513513513513513,2.129104233745476,ECM1;RAB31;TMED10;APOOL;RARRES2;CTSW;LHFPL2;GTPBP2;MANF;SOD1
negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),4/47,0.20718336704116536,1,0,0,1.7021276595744679,2.679406036964871,NFKBIA;TLE1;GSTP1;NR1H4
postreplication repair (GO:0006301),4/47,0.20718336704116536,1,0,0,1.7021276595744679,2.679406036964871,RFC4;TRIM25;UBE2A;POLH
negative regulation of JAK-STAT cascade (GO:0046426),4/47,0.20718336704116536,1,0,0,1.7021276595744679,2.679406036964871,FLRT2;BCL3;SOCS4;ASPN
positive regulation of protein processing (GO:0010954),2/17,0.20773987788556972,1,0,0,2.352941176470588,3.6975731035436015,CCBE1;TNP2
regulation of multicellular organism growth (GO:0040014),2/17,0.20773987788556972,1,0,0,2.352941176470588,3.6975731035436015,STAT5B;SOD1
positive regulation of cholesterol transport (GO:0032376),2/17,0.20773987788556972,1,0,0,2.352941176470588,3.6975731035436015,NFKBIA;NR1H2
cellular glucuronidation (GO:0052695),2/17,0.20773987788556972,1,0,0,2.352941176470588,3.6975731035436015,UGT1A1;UGT1A6
regulation of telomere maintenance via telomere lengthening (GO:1904356),2/17,0.20773987788556972,1,0,0,2.352941176470588,3.6975731035436015,RTEL1;TNKS2
positive regulation of fatty acid metabolic process (GO:0045923),2/17,0.20773987788556972,1,0,0,2.352941176470588,3.6975731035436015,SLC45A3;NR1H2
positive regulation of response to biotic stimulus (GO:0002833),2/17,0.20773987788556972,1,0,0,2.352941176470588,3.6975731035436015,CYBA;BMP6
negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),2/17,0.20773987788556972,1,0,0,2.352941176470588,3.6975731035436015,GSTP1;CCDC3
negative regulation of intracellular transport (GO:0032387),2/17,0.20773987788556972,1,0,0,2.352941176470588,3.6975731035436015,INSIG1;SLC25A5
negative regulation of cellular carbohydrate metabolic process (GO:0010677),2/17,0.20773987788556972,1,0,0,2.352941176470588,3.6975731035436015,HDAC4;SOGA1
3'-UTR-mediated mRNA stabilization (GO:0070935),2/17,0.20773987788556972,1,0,0,2.352941176470588,3.6975731035436015,ANGEL2;DAZ4
serine family amino acid metabolic process (GO:0009069),2/17,0.20773987788556972,1,0,0,2.352941176470588,3.6975731035436015,CBS;GLYAT
cellular response to inorganic substance (GO:0071241),2/17,0.20773987788556972,1,0,0,2.352941176470588,3.6975731035436015,SPIDR;FOXO1
phosphatidylcholine biosynthetic process (GO:0006656),3/32,0.21379011498548872,1,0,0,1.875,2.8926759681127634,PCTP;LPIN2;MFSD2A
central nervous system neuron differentiation (GO:0021953),3/32,0.21379011498548872,1,0,0,1.875,2.8926759681127634,GRID2;ZC4H2;GBA2
GPI anchor biosynthetic process (GO:0006506),3/32,0.21379011498548872,1,0,0,1.875,2.8926759681127634,PGAP1;GPAA1;PIGA
positive regulation of TOR signaling (GO:0032008),3/32,0.21379011498548872,1,0,0,1.875,2.8926759681127634,HTR6;MLST8;RICTOR
positive regulation of telomere maintenance via telomerase (GO:0032212),3/32,0.21379011498548872,1,0,0,1.875,2.8926759681127634,TNKS2;PNKP;FBXO4
cellular response to DNA damage stimulus (GO:0006974),20/329,0.2138377482987315,1,0,0,1.21580547112462,1.8754258201194354,RTEL1;SLF1;RFC4;LIG1;PNKP;HUS1;CIDEB;HTRA2;GTF2H1;UBE2A;USP28;SPIDR;HIC1;FOXO1;HELB;ERCC1;BCL3;CRY1;POLK;POLH
protein O-linked glycosylation (GO:0006493),8/115,0.21759147223531877,1,0,0,1.391304347826087,2.1219282850272605,LFNG;GALNT14;ADAMTSL4;GALNT2;B3GALT4;PGM3;GALNT10;B4GALT5
endosome to lysosome transport (GO:0008333),4/48,0.21779787247025076,1,0,0,1.6666666666666665,2.540313061339135,HMGXB4;HOOK3;UBXN6;CACNG5
regulation of cell cycle arrest (GO:0071156),4/48,0.21779787247025076,1,0,0,1.6666666666666665,2.540313061339135,HSP90AB1;CDK4;MIF;CRLF3
positive regulation of chemotaxis (GO:0050921),4/48,0.21779787247025076,1,0,0,1.6666666666666665,2.540313061339135,EDN2;RARRES2;XCL1;CXCL3
sensory perception of light stimulus (GO:0050953),6/81,0.21846581133310103,1,0,0,1.4814814814814814,2.253519624534179,CRYGA;ATXN7;OPA3;NUDT19;RPE65;POU4F3
negative regulation of cell cycle process (GO:0010948),6/81,0.21846581133310103,1,0,0,1.4814814814814814,2.253519624534179,HSP90AB1;APAF1;NME6;CDK4;MGA;MIF
histone modification (GO:0016570),7/98,0.21881398496006546,1,0,0,1.4285714285714284,2.1707618483434215,CCNA2;HDAC4;USP36;ATXN7;PADI2;UBE2A;NEK11
glycolipid metabolic process (GO:0006664),5/65,0.2245509341987312,1,0,0,1.5384615384615385,2.2979272602185437,PGAP1;GM2A;ARSD;GBA2;SUMF1
regulation of JAK-STAT cascade (GO:0046425),5/65,0.2245509341987312,1,0,0,1.5384615384615385,2.2979272602185437,FLRT2;BCL3;CRLF3;ASPN;SOCS4
defense response to Gram-positive bacterium (GO:0050830),5/65,0.2245509341987312,1,0,0,1.5384615384615385,2.2979272602185437,RNASE8;RARRES2;DEFB4A;RPL39;LYZL4
membrane lipid metabolic process (GO:0006643),2/18,0.22645148897005046,1,0,0,2.222222222222222,3.3004989638462865,AGMO;ALOX12B
regulation of viral process (GO:0050792),2/18,0.22645148897005046,1,0,0,2.222222222222222,3.3004989638462865,LAMP3;MVB12A
mitotic recombination (GO:0006312),2/18,0.22645148897005046,1,0,0,2.222222222222222,3.3004989638462865,SNRNP40;ERCC1
anion transmembrane transport (GO:0098656),2/18,0.22645148897005046,1,0,0,2.222222222222222,3.3004989638462865,SLC35B1;LRRIQ4
glucan biosynthetic process (GO:0009250),2/18,0.22645148897005046,1,0,0,2.222222222222222,3.3004989638462865,PER2;GBE1
anterior/posterior axis specification (GO:0009948),2/18,0.22645148897005046,1,0,0,2.222222222222222,3.3004989638462865,CDX4;CDX2
negative regulation of fibroblast proliferation (GO:0048147),2/18,0.22645148897005046,1,0,0,2.222222222222222,3.3004989638462865,GSTP1;NF1
regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),2/18,0.22645148897005046,1,0,0,2.222222222222222,3.3004989638462865,HTRA2;SOD1
regulation of cholesterol efflux (GO:0010874),2/18,0.22645148897005046,1,0,0,2.222222222222222,3.3004989638462865,NFKBIA;NR1H2
glycogen biosynthetic process (GO:0005978),2/18,0.22645148897005046,1,0,0,2.222222222222222,3.3004989638462865,PER2;GBE1
negative regulation of binding (GO:0051100),6/82,0.22659177650802834,1,0,0,1.4634146341463412,2.172593007559255,NFKBIA;RALB;PEX19;IFI16;CARD18;ZNF304
glycogen metabolic process (GO:0005977),3/33,0.22710442121127872,1,0,0,1.8181818181818181,2.695173385335862,PER2;GBE1;STBD1
oligosaccharide biosynthetic process (GO:0009312),3/33,0.22710442121127872,1,0,0,1.8181818181818181,2.695173385335862,GALNT14;GALNT2;GALNT10
intra-Golgi vesicle-mediated transport (GO:0006891),3/33,0.22710442121127872,1,0,0,1.8181818181818181,2.695173385335862,GOLGA5;COG3;COPZ1
transcription initiation from RNA polymerase I promoter (GO:0006361),3/33,0.22710442121127872,1,0,0,1.8181818181818181,2.695173385335862,CCNH;POLR1B;GTF2H1
positive regulation of biomineral tissue development (GO:0070169),3/33,0.22710442121127872,1,0,0,1.8181818181818181,2.695173385335862,OSR1;GPM6B;BMP6
transcription from RNA polymerase I promoter (GO:0006360),3/33,0.22710442121127872,1,0,0,1.8181818181818181,2.695173385335862,CCNH;POLR1B;GTF2H1
antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),4/49,0.22855481299593203,1,0,0,1.6326530612244896,2.4097619846443257,REG1A;S100A12;DEFB4A;RPL39
lipid homeostasis (GO:0055088),4/49,0.22855481299593203,1,0,0,1.6326530612244896,2.4097619846443257,ACOXL;VDR;NR1H2;NR1H4
intracellular steroid hormone receptor signaling pathway (GO:0030518),5/66,0.23381942521025603,1,0,0,1.5151515151515151,2.201827497975576,KDM3A;MED13;PADI2;PIAS2;POU4F2
purine ribonucleotide metabolic process (GO:0009150),5/66,0.23381942521025603,1,0,0,1.5151515151515151,2.201827497975576,SULT1C2;SULT1B1;HINT1;CTNS;NADK
regulation of bone mineralization (GO:0030500),4/50,0.2394412597417243,1,0,0,1.5999999999999999,2.287115446802478,ECM1;OSR1;GPM6B;BMP6
regulation of cellular protein metabolic process (GO:0032268),4/50,0.2394412597417243,1,0,0,1.5999999999999999,2.287115446802478,NFKBIA;NR1H2;GEMIN5;INHBA
positive regulation of JUN kinase activity (GO:0043507),4/50,0.2394412597417243,1,0,0,1.5999999999999999,2.287115446802478,MAP3K2;PAK1;DBNL;TNFRSF11A
negative regulation of DNA binding (GO:0043392),3/34,0.24057000906593404,1,0,0,1.7647058823529411,2.5142543537821203,NFKBIA;PER2;IFI16
positive regulation of muscle cell differentiation (GO:0051149),3/34,0.24057000906593404,1,0,0,1.7647058823529411,2.5142543537821203,RBM4;CDH15;CDON
regulation of JUN kinase activity (GO:0043506),3/34,0.24057000906593404,1,0,0,1.7647058823529411,2.5142543537821203,PAK1;GSTP1;TNFRSF11A
regulation of TOR signaling (GO:0032006),5/67,0.2431934021901658,1,0,0,1.4925373134328357,2.1102959080752326,HTR6;DEPTOR;AKT1S1;MLST8;RICTOR
primary alcohol metabolic process (GO:0034308),2/19,0.24527425978553977,1,0,0,2.1052631578947367,2.958691088070133,ALDH3A2;DHRS9
error-free translesion synthesis (GO:0070987),2/19,0.24527425978553977,1,0,0,2.1052631578947367,2.958691088070133,RFC4;POLH
negative regulation of double-strand break repair (GO:2000780),2/19,0.24527425978553977,1,0,0,2.1052631578947367,2.958691088070133,HELB;POLK
vesicle transport along microtubule (GO:0047496),2/19,0.24527425978553977,1,0,0,2.1052631578947367,2.958691088070133,NDE1;NDEL1
acylglycerol biosynthetic process (GO:0046463),2/19,0.24527425978553977,1,0,0,2.1052631578947367,2.958691088070133,AGMO;LPIN2
Rac protein signal transduction (GO:0016601),2/19,0.24527425978553977,1,0,0,2.1052631578947367,2.958691088070133,DBNL;ELMO1
excitatory postsynaptic potential (GO:0060079),2/19,0.24527425978553977,1,0,0,2.1052631578947367,2.958691088070133,CHRNA3;GRID2
purine ribonucleoside bisphosphate metabolic process (GO:0034035),2/19,0.24527425978553977,1,0,0,2.1052631578947367,2.958691088070133,SULT1B1;SULT1C2
positive regulation of lipid storage (GO:0010884),2/19,0.24527425978553977,1,0,0,2.1052631578947367,2.958691088070133,MSR1;PLIN5
intracellular estrogen receptor signaling pathway (GO:0030520),2/19,0.24527425978553977,1,0,0,2.1052631578947367,2.958691088070133,PADI2;POU4F2
positive regulation of interferon-alpha production (GO:0032727),2/19,0.24527425978553977,1,0,0,2.1052631578947367,2.958691088070133,IFIH1;HSPD1
cellular response to interleukin-7 (GO:0098761),2/19,0.24527425978553977,1,0,0,2.1052631578947367,2.958691088070133,STAT5B;STAT3
histone deubiquitination (GO:0016578),2/19,0.24527425978553977,1,0,0,2.1052631578947367,2.958691088070133,USP36;ATXN7
macromolecule biosynthetic process (GO:0009059),2/19,0.24527425978553977,1,0,0,2.1052631578947367,2.958691088070133,GALNT2;EIF4G2
negative regulation of protein localization to cell periphery (GO:1904376),2/19,0.24527425978553977,1,0,0,2.1052631578947367,2.958691088070133,MRAP;LZTFL1
positive regulation of pri-miRNA transcription from RNA polymerase II promoter (GO:1902895),2/19,0.24527425978553977,1,0,0,2.1052631578947367,2.958691088070133,SPI1;STAT3
interleukin-7-mediated signaling pathway (GO:0038111),2/19,0.24527425978553977,1,0,0,2.1052631578947367,2.958691088070133,STAT5B;STAT3
positive regulation of transcription regulatory region DNA binding (GO:2000679),2/19,0.24527425978553977,1,0,0,2.1052631578947367,2.958691088070133,DDRGK1;POU4F2
triglyceride biosynthetic process (GO:0019432),2/19,0.24527425978553977,1,0,0,2.1052631578947367,2.958691088070133,AGMO;LPIN2
response to interferon-beta (GO:0035456),2/19,0.24527425978553977,1,0,0,2.1052631578947367,2.958691088070133,HTRA2;UBE2G2
protein polyubiquitination (GO:0000209),17/283,0.2517235860592716,1,0,0,1.2014134275618373,1.6572581244827387,FBXW5;UBE2D4;FBXO17;CUL1;RNF6;UBE2G2;UBE2A;ANAPC10;ANAPC11;PSMB6;HECTD1;TNKS2;RNF138;PSMB3;FBXO4;ARIH2;RNF152
lipid phosphorylation (GO:0046834),3/35,0.25416276879858296,1,0,0,1.7142857142857142,2.3481949631326344,PIK3C2G;PIK3R1;DGKZ
regulation of cyclin-dependent protein kinase activity (GO:1904029),3/35,0.25416276879858296,1,0,0,1.7142857142857142,2.3481949631326344,CCNT2;GTF2H1;CDKN3
"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",3/35,0.25416276879858296,1,0,0,1.7142857142857142,2.3481949631326344,EXOSC7;LSM1;DIS3L2
regulation of microtubule polymerization (GO:0031113),3/35,0.25416276879858296,1,0,0,1.7142857142857142,2.3481949631326344,PAK1;DCTN1;STMN1
erythrocyte differentiation (GO:0030218),3/35,0.25416276879858296,1,0,0,1.7142857142857142,2.3481949631326344,CASP3;AHSP;INHBA
transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),23/396,0.2581210302453805,1,0,0,1.1616161616161615,1.5732077765320356,EPHA5;ACTR2;CHRNA3;ARPC1B;STAT3;CYBA;PIK3R1;PILRA;SHB;SOGA1;FGF3;FOXO1;FGF17;PAK1;FLRT2;GRAP2;CASP3;STMN1;ANOS1;ELMO1;ELMO2;EPHB4;FGF22
stimulatory C-type lectin receptor signaling pathway (GO:0002223),8/121,0.25904531858348734,1,0,0,1.322314049586777,1.7861186874223587,NFKBIA;PSMB6;PAK1;CLEC4D;PSMB3;CARD9;ICAM2;CUL1
positive regulation of proteolysis (GO:0045862),4/52,0.26155152638965784,1,0,0,1.5384615384615385,2.0632676511450203,CCBE1;IST1;TNP2;TBC1D10A
positive regulation of ossification (GO:0045778),4/52,0.26155152638965784,1,0,0,1.5384615384615385,2.0632676511450203,OSR1;RUNX2;GPM6B;BMP6
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),2/20,0.2641503607881601,1,0,0,2,2.66247357905395,CLDN20;CLDN9
regulation of anoikis (GO:2000209),2/20,0.2641503607881601,1,0,0,2,2.66247357905395,TLE1;ZNF304
regulation of cell development (GO:0060284),2/20,0.2641503607881601,1,0,0,2,2.66247357905395,PER2;ASCL2
glial cell development (GO:0021782),2/20,0.2641503607881601,1,0,0,2,2.66247357905395,NF1;SOX10
aromatic amino acid family catabolic process (GO:0009074),2/20,0.2641503607881601,1,0,0,2,2.66247357905395,QDPR;ASRGL1
vesicle cytoskeletal trafficking (GO:0099518),2/20,0.2641503607881601,1,0,0,2,2.66247357905395,NDE1;NDEL1
eye morphogenesis (GO:0048592),2/20,0.2641503607881601,1,0,0,2,2.66247357905395,STAT3;NF1
dopaminergic neuron differentiation (GO:0071542),2/20,0.2641503607881601,1,0,0,2,2.66247357905395,OTX2;MANF
positive regulation of DNA-directed DNA polymerase activity (GO:1900264),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,RFC4
positive regulation of protein glycosylation (GO:0060050),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,ALG10B
negative regulation of cholesterol storage (GO:0010887),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,NR1H2
hindlimb morphogenesis (GO:0035137),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,OSR1
smooth muscle tissue development (GO:0048745),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,NF1
regulation of fat cell proliferation (GO:0070344),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,PER2
polyamine biosynthetic process (GO:0006596),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,SMS
vocal learning (GO:0042297),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,NRXN2
succinyl-CoA metabolic process (GO:0006104),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,ACOT4
arginine biosynthetic process (GO:0006526),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,ASL
negative regulation of chromosome organization (GO:2001251),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,ERCC1
nuclear polyadenylation-dependent ncRNA catabolic process (GO:0071046),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,EXOSC7
negative regulation of transforming growth factor beta production (GO:0071635),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,HSP90AB1
vitamin K metabolic process (GO:0042373),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,CBR1
SCF complex assembly (GO:0010265),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,CUL1
COPI coating of Golgi vesicle (GO:0048205),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,TMED10
embryonic skeletal joint development (GO:0072498),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,OSR1
cellular response to iron ion (GO:0071281),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,BMP6
lipoxin biosynthetic process (GO:2001301),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,ALOX12
T-helper 17 cell lineage commitment (GO:0072540),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,STAT3
viral release from host cell (GO:0019076),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,IST1
positive regulation of myelination (GO:0031643),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,NCMAP
spinal cord motor neuron differentiation (GO:0021522),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,ZC4H2
prepulse inhibition (GO:0060134),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,GRID2
activation of transmembrane receptor protein tyrosine kinase activity (GO:0007171),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,CHRNA3
negative regulation of acute inflammatory response (GO:0002674),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,GSTP1
regulation of nuclease activity (GO:0032069),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,OASL
negative regulation of glycolytic process (GO:0045820),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,HDAC4
negative regulation of oligodendrocyte differentiation (GO:0048715),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,NF1
chromatin silencing at telomere (GO:0006348),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,DPY30
cellular triglyceride homeostasis (GO:0035356),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,NR1H4
negative regulation of lymphocyte differentiation (GO:0045620),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,INHBA
negative regulation of lymphocyte migration (GO:2000402),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,PADI2
positive regulation of humoral immune response (GO:0002922),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,ZP4
nuclear polyadenylation-dependent rRNA catabolic process (GO:0071035),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,EXOSC7
response to DNA damage checkpoint signaling (GO:0072423),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,APAF1
muscle tissue development (GO:0060537),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,NF1
negative regulation of glucocorticoid receptor signaling pathway (GO:2000323),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,CRY1
negative regulation of muscle cell apoptotic process (GO:0010656),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,ALOX12
Golgi transport vesicle coating (GO:0048200),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,TMED10
nucleobase metabolic process (GO:0009112),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,TTR
negative regulation of neural precursor cell proliferation (GO:2000178),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,NF1
glomerular epithelial cell differentiation (GO:0072311),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,BASP1
peroxisomal membrane transport (GO:0015919),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,PEX19
renal filtration cell differentiation (GO:0061318),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,BASP1
exit from host cell (GO:0035891),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,IST1
negative regulation of coenzyme metabolic process (GO:0051198),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,HDAC4
phosphorylation of RNA polymerase II C-terminal domain (GO:0070816),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,GTF2H1
transcription initiation from RNA polymerase III promoter (GO:0006384),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,CRCP
spermine metabolic process (GO:0008215),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,SMS
pyrimidine-containing compound transmembrane transport (GO:0072531),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,SLC19A3
COPI-coated vesicle budding (GO:0035964),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,TMED10
rescue of stalled ribosome (GO:0072344),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,NEMF
negative regulation of interferon-gamma-mediated signaling pathway (GO:0060336),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,NR1H2
glandular epithelial cell development (GO:0002068),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,BMP6
citrate metabolic process (GO:0006101),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,STAT5B
negative regulation of response to interferon-gamma (GO:0060331),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,NR1H2
positive regulation of flagellated sperm motility (GO:1902093),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,TACR2
blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:0002043),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,BMPER
embryonic skeletal joint morphogenesis (GO:0060272),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,OSR1
pronephros development (GO:0048793),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,OSR1
lipid hydroxylation (GO:0002933),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,CYP4A22
regulation of chemokine-mediated signaling pathway (GO:0070099),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,PADI2
interphase microtubule nucleation by interphase microtubule organizing center (GO:0051415),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,TUBGCP2
regulation of interferon-alpha secretion (GO:1902739),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,IFIH1
negative regulation of amino acid transport (GO:0051956),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,OSR1
type B pancreatic cell development (GO:0003323),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,BMP6
cerebral cortex cell migration (GO:0021795),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,HTR6
regulation of tooth mineralization (GO:0070170),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,ASPN
"retrograde transport, vesicle recycling within Golgi (GO:0000301)",1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,GOLGA5
negative regulation of erythrocyte differentiation (GO:0045647),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,MAFB
positive regulation of cholesterol storage (GO:0010886),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,MSR1
regulation of aldosterone biosynthetic process (GO:0032347),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,BMP6
telencephalon cell migration (GO:0022029),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,HTR6
regulation of cell cycle checkpoint (GO:1901976),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,CRY1
glycosyl compound catabolic process (GO:1901658),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,GBA2
SREBP signaling pathway (GO:0032933),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,INSIG1
positive regulation of sodium ion transmembrane transport (GO:1902307),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,GLRX
lipoprotein catabolic process (GO:0042159),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,NOTUM
positive regulation of interferon-alpha secretion (GO:1902741),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,IFIH1
regulation of cardiac muscle hypertrophy in response to stress (GO:1903242),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,FOXO1
regulation of anion channel activity (GO:0010359),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,TCAF2
imitative learning (GO:0098596),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,NRXN2
regulation of biosynthetic process (GO:0009889),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,GSTP1
positive regulation of fever generation (GO:0031622),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,TNFRSF11A
mesenchymal cell differentiation involved in kidney development (GO:0072161),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,OSR1
glomerulus vasculature development (GO:0072012),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,OSR1
endosome to lysosome transport via multivesicular body sorting pathway (GO:0032510),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,UBXN6
positive regulation of oxidative stress-induced cell death (GO:1903209),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,SOD1
venous blood vessel morphogenesis (GO:0048845),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,CCBE1
positive regulation of intracellular estrogen receptor signaling pathway (GO:0033148),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,PAK1
astrocyte differentiation (GO:0048708),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,STAT3
tRNA catabolic process (GO:0016078),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,EXOSC7
regulation of DNA-directed DNA polymerase activity (GO:1900262),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,RFC4
glutamate catabolic process (GO:0006538),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,GAD1
amine metabolic process (GO:0009308),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,SULT1C2
snRNA transcription from RNA polymerase III promoter (GO:0042796),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,SNAPC1
regulation of microtubule nucleation (GO:0010968),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,DCTN1
neuron remodeling (GO:0016322),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,RND1
response to lipid (GO:0033993),9/140,0.2670012236522016,1,0,0,1.2857142857142856,1.6977883340897255,STAT5B;VDR;TNFRSF18;NR1H2;STAT3;NR1H4;ALPL;TNFRSF11A;CXCL3
carbohydrate biosynthetic process (GO:0016051),3/36,0.2678594070249647,1,0,0,1.6666666666666665,2.1954883946257717,GALNT14;GALNT2;GALNT10
regulation of muscle cell differentiation (GO:0051147),3/36,0.2678594070249647,1,0,0,1.6666666666666665,2.1954883946257717,RBM4;CDH15;CDON
regulation of response to DNA damage stimulus (GO:2001020),3/36,0.2678594070249647,1,0,0,1.6666666666666665,2.1954883946257717,CRY1;POLH;IER3
positive regulation of cellular component biogenesis (GO:0044089),6/87,0.2685502192059934,1,0,0,1.379310344827586,1.813403236377029,GRID2;SLF1;CEP295;SYNPO2;ERCC1;SPIDR
stress-activated protein kinase signaling cascade (GO:0031098),5/70,0.2718688550208947,1,0,0,1.4285714285714284,1.860622113738027,MAP3K2;PAK1;CUL1;PAK6;PAK5
vascular endothelial growth factor receptor signaling pathway (GO:0048010),5/70,0.2718688550208947,1,0,0,1.4285714285714284,1.860622113738027,ELMO1;ELMO2;CYBA;PIK3R1;SHB
G1/S transition of mitotic cell cycle (GO:0000082),7/105,0.2718705093844258,1,0,0,1.3333333333333333,1.7365725259764115,CCNH;CDK4;CUL1;RCC1;INHBA;CRLF3;CDKN3
neutrophil chemotaxis (GO:0030593),4/53,0.272750159994601,1,0,0,1.5094339622641508,1.9610551964847422,EDN2;XCL1;S100A12;CXCL3
positive regulation of protein complex assembly (GO:0031334),6/88,0.2771694338705115,1,0,0,1.3636363636363635,1.7497176615936614,FOSL1;SLF1;ERCC1;MITF;GTF2H1;SPIDR
regulation of cell cycle (GO:0051726),13/215,0.2800310091269687,1,0,0,1.2093023255813953,1.5392664330992478,MAP3K2;STAT3;HTRA2;INHBA;CKS1B;PER2;PAK1;RBL1;CDK4;PAK6;PAK5;SIPA1;LIN52
innate immune response activating cell surface receptor signaling pathway (GO:0002220),8/124,0.28061953631387226,1,0,0,1.2903225806451613,1.639684503717075,NFKBIA;PSMB6;PAK1;CLEC4D;PSMB3;CARD9;ICAM2;CUL1
platelet degranulation (GO:0002576),8/124,0.28061953631387226,1,0,0,1.2903225806451613,1.639684503717075,ECM1;APOOL;RARRES2;CTSW;LHFPL2;GTPBP2;MANF;SOD1
defense response to Gram-negative bacterium (GO:0050829),5/71,0.2815854896327663,1,0,0,1.408450704225352,1.7849565976318464,RNASE8;RARRES2;ADGRB1;DEFB4A;LYZL4
response to insulin (GO:0032868),5/71,0.2815854896327663,1,0,0,1.408450704225352,1.7849565976318464,RAB31;PKM;TBC1D4;PIK3R1;FOXO1
myelination (GO:0042552),3/37,0.2816374857336128,1,0,0,1.6216216216216217,2.054812778279635,NF1;MAL2;SOX10
regulation of sodium ion transmembrane transporter activity (GO:2000649),3/37,0.2816374857336128,1,0,0,1.6216216216216217,2.054812778279635,NETO1;OSR1;GLRX
regulation of osteoclast differentiation (GO:0045670),3/37,0.2816374857336128,1,0,0,1.6216216216216217,2.054812778279635,CEBPB;MAFB;POU4F2
"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",3/37,0.2816374857336128,1,0,0,1.6216216216216217,2.054812778279635,RFC4;ERCC1;GTF2H1
positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),2/21,0.28302745680273733,1,0,0,1.9047619047619047,2.404212124839451,SESN2;RUNX2
epoxygenase P450 pathway (GO:0019373),2/21,0.28302745680273733,1,0,0,1.9047619047619047,2.404212124839451,CYP2J2;CYP2C18
histone lysine demethylation (GO:0070076),2/21,0.28302745680273733,1,0,0,1.9047619047619047,2.404212124839451,KDM3A;KDM4E
negative regulation of ion transmembrane transporter activity (GO:0032413),2/21,0.28302745680273733,1,0,0,1.9047619047619047,2.404212124839451,TCAF2;OSR1
negative regulation of macroautophagy (GO:0016242),2/21,0.28302745680273733,1,0,0,1.9047619047619047,2.404212124839451,PHF23;LZTS1
positive regulation of T cell mediated immunity (GO:0002711),2/21,0.28302745680273733,1,0,0,1.9047619047619047,2.404212124839451,XCL1;HSPD1
negative regulation of cytokine biosynthetic process (GO:0042036),2/21,0.28302745680273733,1,0,0,1.9047619047619047,2.404212124839451,BCL3;INHBA
negative regulation of G-protein coupled receptor protein signaling pathway (GO:0045744),2/21,0.28302745680273733,1,0,0,1.9047619047619047,2.404212124839451,STMN1;CRY1
regulation of macrophage activation (GO:0043030),2/21,0.28302745680273733,1,0,0,1.9047619047619047,2.404212124839451,MIF;HSPD1
embryonic skeletal system morphogenesis (GO:0048704),2/21,0.28302745680273733,1,0,0,1.9047619047619047,2.404212124839451,OSR1;FUZ
non-motile cilium assembly (GO:1905515),2/21,0.28302745680273733,1,0,0,1.9047619047619047,2.404212124839451,DCTN1;FUZ
"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",2/21,0.28302745680273733,1,0,0,1.9047619047619047,2.404212124839451,ERCC1;GTF2H1
cellular response to alkaloid (GO:0071312),2/21,0.28302745680273733,1,0,0,1.9047619047619047,2.404212124839451,CASP3;SPIDR
embryonic skeletal system development (GO:0048706),2/21,0.28302745680273733,1,0,0,1.9047619047619047,2.404212124839451,OSR1;FUZ
phosphatidylserine acyl-chain remodeling (GO:0036150),2/21,0.28302745680273733,1,0,0,1.9047619047619047,2.404212124839451,OSBPL8;PLA1A
glycosphingolipid metabolic process (GO:0006687),4/54,0.2840279876642483,1,0,0,1.4814814814814814,1.8647148112043361,GM2A;ARSD;GBA2;SUMF1
mitochondrial translation (GO:0032543),7/107,0.28762785288726417,1,0,0,1.3084112149532707,1.6303952679093834,MRPS2;MRPL12;MRPL13;MRPL24;MRPS5;MRPL54;MRPL44
Rho protein signal transduction (GO:0007266),5/72,0.2913681345785638,1,0,0,1.3888888888888888,1.712732977852415,PAK1;PAK6;CTNNAL1;PAK5;RND1
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),5/72,0.2913681345785638,1,0,0,1.3888888888888888,1.712732977852415,PSMB6;FBXW5;PSMB3;FBXO4;CUL1
negative regulation of cell cycle (GO:0045786),5/72,0.2913681345785638,1,0,0,1.3888888888888888,1.712732977852415,HHEX;ANGEL2;HTRA2;INHBA;SIPA1
cellular macromolecule biosynthetic process (GO:0034645),21/367,0.2928323393109401,1,0,0,1.1444141689373295,1.4055180460534273,RFC4;HUS1;MRPS2;INHBA;GTPBP2;MRPL13;MRPL24;ASCL2;MRPS5;XAB2;HELB;EEF2K;FUBP3;GRWD1;BCL3;RPL24;RPL39;RPS21;LZTS1;RPS13;EIF4G2
neuron development (GO:0048666),9/144,0.2941001791610385,1,0,0,1.25,1.5297935302978645,EPHA5;FXR2;STMN1;TBC1D24;PPP1R9A;GBA2;MAPRE2;GPM6B;MANF
regulation of cellular catabolic process (GO:0031329),4/55,0.2953729340320737,1,0,0,1.4545454545454544,1.773842236930121,IFI16;LAMP3;RAB39B;SOGA1
positive regulation of cysteine-type endopeptidase activity (GO:2001056),4/55,0.2953729340320737,1,0,0,1.4545454545454544,1.773842236930121,IFI16;HTRA2;CIDEB;TBC1D10A
fat cell differentiation (GO:0045444),4/55,0.2953729340320737,1,0,0,1.4545454545454544,1.773842236930121,PER2;OSBPL8;FOXO1;ADIG
regulation of cellular amide metabolic process (GO:0034248),3/38,0.29547545275268733,1,0,0,1.5789473684210524,1.9250044986274375,TMED10;NR1H4;GEMIN5
monocarboxylic acid metabolic process (GO:0032787),7/108,0.29558593657898286,1,0,0,1.296296296296296,1.5799203089302307,PER2;STAT5B;UGT1A1;PDZD11;GLYAT;GBA2;ACOT4
ATP hydrolysis coupled proton transport (GO:0015991),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,ATP4A
protein localization to basolateral plasma membrane (GO:1903361),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,PDZD11
membrane raft polarization (GO:0001766),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,MAL2
phosphate ion transmembrane transport (GO:0035435),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,SLC20A1
inner ear receptor stereocilium organization (GO:0060122),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,SOD1
regulation of entry of bacterium into host cell (GO:2000535),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,EXOC2
negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901029),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,SLC25A5
venous blood vessel development (GO:0060841),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,CCBE1
bleb assembly (GO:0032060),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,PMP22
tyrosine metabolic process (GO:0006570),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,DCT
ATP hydrolysis coupled cation transmembrane transport (GO:0099132),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,ATP4A
negative regulation of leukocyte migration (GO:0002686),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,HOXA7
negative regulation of keratinocyte proliferation (GO:0010839),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,VDR
regulation of chromatin assembly or disassembly (GO:0001672),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,PADI2
regulation of monocyte chemotactic protein-1 production (GO:0071637),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,GSTP1
positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,ANAPC11
postsynaptic density assembly (GO:0097107),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,NRXN2
mitochondrial DNA metabolic process (GO:0032042),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,LONP1
brown fat cell differentiation (GO:0050873),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,ADIG
tachykinin receptor signaling pathway (GO:0007217),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,TACR2
"neurotransmitter receptor transport, postsynaptic endosome to lysosome (GO:0098943)",1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,CACNG5
regulation of mitochondrial fusion (GO:0010635),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,VAT1
positive regulation of histone H3-K9 methylation (GO:0051574),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,ZNF304
oxaloacetate metabolic process (GO:0006107),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,STAT5B
radial glial cell differentiation (GO:0060019),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,STAT3
positive regulation of mast cell degranulation (GO:0043306),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,SNX4
sulfur amino acid biosynthetic process (GO:0000097),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,CBS
regulation of lymphocyte migration (GO:2000401),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,CCR6
glycoside catabolic process (GO:0016139),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,GBA2
regulation of low-density lipoprotein particle clearance (GO:0010988),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,NR1H4
ribosomal protein import into nucleus (GO:0006610),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,IPO4
cytoplasmic sequestering of NF-kappaB (GO:0007253),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,NFKBIA
regulation of natural killer cell chemotaxis (GO:2000501),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,XCL1
left/right pattern formation (GO:0060972),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,SETDB2
negative regulation of striated muscle tissue development (GO:0045843),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,FGF3
retrograde axonal transport (GO:0008090),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,SOD1
negative regulation of telomere capping (GO:1904354),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,ERCC1
cellular response to leptin stimulus (GO:0044320),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,STAT3
membrane raft distribution (GO:0031580),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,MAL2
cellular response to sterol depletion (GO:0071501),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,INSIG1
valine metabolic process (GO:0006573),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,STAT5B
L-cysteine metabolic process (GO:0046439),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,CBS
positive regulation of phospholipid biosynthetic process (GO:0071073),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,NR1H4
heme catabolic process (GO:0042167),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,UGT1A1
chromatin-mediated maintenance of transcription (GO:0048096),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,PADI2
fructose metabolic process (GO:0006000),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,ALDOB
establishment of protein localization to peroxisome (GO:0072663),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,PEX19
morphogenesis of a polarized epithelium (GO:0001738),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,FUZ
porphyrin-containing compound catabolic process (GO:0006787),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,UGT1A1
positive regulation of macrophage migration (GO:1905523),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,RARRES2
regulation of histone H3-K9 acetylation (GO:2000615),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,KMT2A
cellular response to hydroxyurea (GO:0072711),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,SPIDR
regulation of atrial cardiac muscle cell membrane repolarization (GO:0060372),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,KCNA5
regulation of vitamin D biosynthetic process (GO:0060556),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,VDR
positive regulation of mitotic sister chromatid separation (GO:1901970),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,ANAPC11
positive regulation of protein kinase A signaling (GO:0010739),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,MIF
negative regulation of nitric oxide metabolic process (GO:1904406),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,PTGIS
peptidyl-lysine deacetylation (GO:0034983),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,HDAC4
regulation of RNA biosynthetic process (GO:2001141),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,MITF
negative regulation of T cell mediated immunity (GO:0002710),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,XCL1
regulation of pinocytosis (GO:0048548),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,NR1H2
positive regulation of fatty acid beta-oxidation (GO:0032000),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,PLIN5
regulation of glucocorticoid receptor signaling pathway (GO:2000322),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,CRY1
thiamine-containing compound metabolic process (GO:0042723),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,SLC19A3
"endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000447)",1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,RPS21
positive regulation of sequestering of triglyceride (GO:0010890),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,PLIN5
regulation of establishment of protein localization (GO:0070201),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,SPIDR
negative regulation of epidermal cell differentiation (GO:0045605),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,HOXA7
vascular smooth muscle contraction (GO:0014829),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,EDN2
ethanol catabolic process (GO:0006068),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,SULT1B1
cell differentiation in spinal cord (GO:0021515),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,ZC4H2
forebrain neuron differentiation (GO:0021879),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,INHBA
negative regulation of nitric oxide biosynthetic process (GO:0045019),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,PTGIS
alditol metabolic process (GO:0019400),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,COQ3
SA node cell action potential (GO:0086015),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,KCNA5
regulation of calcidiol 1-monooxygenase activity (GO:0060558),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,VDR
negative regulation of T cell cytokine production (GO:0002725),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,XCL1
ethanol metabolic process (GO:0006067),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,SULT1B1
regulation of RNA polymerase II regulatory region sequence-specific DNA binding (GO:1903025),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,DDRGK1
positive regulation of macrophage chemotaxis (GO:0010759),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,RARRES2
"fructose 1,6-bisphosphate metabolic process (GO:0030388)",1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,ALDOB
outer mitochondrial membrane organization (GO:0007008),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,TOMM20L
kidney epithelium development (GO:0072073),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,OSR1
"regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095)",1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,MLLT3
negative regulation of cardiac muscle tissue development (GO:0055026),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,FGF3
amino acid import across plasma membrane (GO:0089718),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,SLC1A6
store-operated calcium entry (GO:0002115),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,ORAI2
T-helper 1 type immune response (GO:0042088),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,EBI3
regulation of transcription involved in cell fate commitment (GO:0060850),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,CEBPB
metanephric nephron tubule development (GO:0072234),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,OSR1
marginal zone B cell differentiation (GO:0002315),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,LFNG
"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,XCL1
negative regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle (GO:0031658),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,CDK4
positive regulation of neurological system process (GO:0031646),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,NCMAP
regulation of interferon-gamma-mediated signaling pathway (GO:0060334),2/22,0.30185830293267685,1,0,0,1.8181818181818181,2.1778137587293127,HSP90AB1;NR1H2
glutathione derivative biosynthetic process (GO:1901687),2/22,0.30185830293267685,1,0,0,1.8181818181818181,2.1778137587293127,GSTP1;GSTA1
protein homotrimerization (GO:0070207),2/22,0.30185830293267685,1,0,0,1.8181818181818181,2.1778137587293127,HTRA2;MIF
positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),2/22,0.30185830293267685,1,0,0,1.8181818181818181,2.1778137587293127,DDRGK1;ECSCR
"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",2/22,0.30185830293267685,1,0,0,1.8181818181818181,2.1778137587293127,ERCC1;GTF2H1
hematopoietic progenitor cell differentiation (GO:0002244),2/22,0.30185830293267685,1,0,0,1.8181818181818181,2.1778137587293127,ARMC6;INHBA
regulation of transcription from RNA polymerase III promoter (GO:0006359),2/22,0.30185830293267685,1,0,0,1.8181818181818181,2.1778137587293127,PRDX5;NAB2
positive regulation of interleukin-10 production (GO:0032733),2/22,0.30185830293267685,1,0,0,1.8181818181818181,2.1778137587293127,XCL1;HSPD1
STAT cascade (GO:0097696),2/22,0.30185830293267685,1,0,0,1.8181818181818181,2.1778137587293127,STAT5B;STAT3
positive regulation of biosynthetic process (GO:0009891),2/22,0.30185830293267685,1,0,0,1.8181818181818181,2.1778137587293127,ADGRB1;CYBA
negative regulation of protein import into nucleus (GO:0042308),2/22,0.30185830293267685,1,0,0,1.8181818181818181,2.1778137587293127,NF1;DACT3
ncRNA catabolic process (GO:0034661),2/22,0.30185830293267685,1,0,0,1.8181818181818181,2.1778137587293127,EXOSC7;DIS3L2
glutathione derivative metabolic process (GO:1901685),2/22,0.30185830293267685,1,0,0,1.8181818181818181,2.1778137587293127,GSTP1;GSTA1
regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),2/22,0.30185830293267685,1,0,0,1.8181818181818181,2.1778137587293127,EPHA5;NR1H4
positive regulation of transcription from RNA polymerase II promoter (GO:0045944),46/848,0.30304716631735346,1,0,0,1.0849056603773584,1.295232872027862,HDAC4;CEBPB;SPI1;CCNT2;ZNF350;KMT2A;CCNH;EPAS1;INSIG1;CITED4;HOXD13;PIK3R1;FOXO1;BCL2L12;HHEX;MED13;YY2;IFI16;DDRGK1;ZNF304;OTX2;HOXA7;AAMDC;STAT5B;CDX4;VDR;OSR1;NR1H2;STAT3;ESRRB;NR1H4;GTF2H1;MITF;GRHL3;INHBA;BMP6;ST18;POU4F2;RUNX2;POU4F3;NFKBIA;RBL1;FUBP3;CRLF3;LPIN2;ZNF750
negative regulation of protein kinase activity (GO:0006469),7/109,0.3035915104348741,1,0,0,1.2844036697247707,1.5311019042060257,DEPTOR;FLRT2;GSTP1;AKT1S1;NF1;SOCS4;ASPN
DNA-dependent DNA replication (GO:0006261),4/56,0.30677317565166196,1,0,0,1.4285714285714284,1.6880666371405524,HELB;RFC4;PNKP;POLK
granulocyte chemotaxis (GO:0071621),4/56,0.30677317565166196,1,0,0,1.4285714285714284,1.6880666371405524,EDN2;XCL1;S100A12;CXCL3
cellular iron ion homeostasis (GO:0006879),4/56,0.30677317565166196,1,0,0,1.4285714285714284,1.6880666371405524,FTMT;CUL1;BMP6;SOD1
regulation of proteasomal protein catabolic process (GO:0061136),3/39,0.3093526636827237,1,0,0,1.5384615384615385,1.8050359176351607,DDRGK1;LAMP3;ECSCR
purine ribonucleoside monophosphate metabolic process (GO:0009167),3/39,0.3093526636827237,1,0,0,1.5384615384615385,1.8050359176351607,IMPDH2;CTNS;NADK
regulation of RNA metabolic process (GO:0051252),3/39,0.3093526636827237,1,0,0,1.5384615384615385,1.8050359176351607,USP36;MITF;OASL
glucose homeostasis (GO:0042593),5/74,0.31110059336369467,1,0,0,1.3513513513513513,1.577890496988918,GCGR;STAT3;CRY1;PIK3R1;FOXO1
regulation of mitotic cell cycle (GO:0007346),10/165,0.3118918000294854,1,0,0,1.2121212121212122,1.4122411467844365,MAP3K2;PAK1;RBL1;DCTN1;ANGEL2;RCC1;PAK6;PAK5;CKS1B;NEK11
IRE1-mediated unfolded protein response (GO:0036498),4/57,0.31821716196314576,1,0,0,1.4035087719298245,1.6070473403738648,DCTN1;SRPRA;KDELR3;YIF1A
exogenous drug catabolic process (GO:0042738),2/23,0.32060036735466374,1,0,0,1.7391304347826086,1.9783650312564471,CYP2J2;CYP2C18
"nucleotide-excision repair, DNA gap filling (GO:0006297)",2/23,0.32060036735466374,1,0,0,1.7391304347826086,1.9783650312564471,RFC4;LIG1
positive regulation of cell cycle G1/S phase transition (GO:1902808),2/23,0.32060036735466374,1,0,0,1.7391304347826086,1.9783650312564471,CCND2;DDRGK1
glycolytic process (GO:0006096),2/23,0.32060036735466374,1,0,0,1.7391304347826086,1.9783650312564471,PKM;ALDOB
TOR signaling (GO:0031929),2/23,0.32060036735466374,1,0,0,1.7391304347826086,1.9783650312564471,AKT1S1;MLST8
regulation of smooth muscle contraction (GO:0006940),2/23,0.32060036735466374,1,0,0,1.7391304347826086,1.9783650312564471,CHRNA3;TACR2
histone H3-K4 methylation (GO:0051568),2/23,0.32060036735466374,1,0,0,1.7391304347826086,1.9783650312564471,KMT2A;DPY30
negative regulation of transcription factor import into nucleus (GO:0042992),2/23,0.32060036735466374,1,0,0,1.7391304347826086,1.9783650312564471,NFKBIA;NF1
positive regulation of ion transmembrane transporter activity (GO:0032414),2/23,0.32060036735466374,1,0,0,1.7391304347826086,1.9783650312564471,GLRX;CTSS
regulation of cell size (GO:0008361),2/23,0.32060036735466374,1,0,0,1.7391304347826086,1.9783650312564471,DEPTOR;AKT1S1
regulation of androgen receptor signaling pathway (GO:0060765),2/23,0.32060036735466374,1,0,0,1.7391304347826086,1.9783650312564471,RNF6;PIAS2
NAD metabolic process (GO:0019674),2/23,0.32060036735466374,1,0,0,1.7391304347826086,1.9783650312564471,NMRK2;NADK
proteolysis involved in cellular protein catabolic process (GO:0051603),6/93,0.32110195783620454,1,0,0,1.2903225806451613,1.465802039518082,PSMB6;RNF123;PSMB3;LONP1;CTSW;CTSS
"nucleotide-excision repair, DNA incision (GO:0033683)",3/40,0.3232493972692518,1,0,0,1.4999999999999998,1.693996688892286,RFC4;ERCC1;GTF2H1
positive regulation of mitotic cell cycle phase transition (GO:1901992),3/40,0.3232493972692518,1,0,0,1.4999999999999998,1.693996688892286,CCND2;CDK4;ANAPC11
androgen receptor signaling pathway (GO:0030521),3/40,0.3232493972692518,1,0,0,1.4999999999999998,1.693996688892286,KDM3A;MED13;PIAS2
negative regulation of catabolic process (GO:0009895),3/40,0.3232493972692518,1,0,0,1.4999999999999998,1.693996688892286,HDAC4;ADGRB1;MDM4
"DNA-templated transcription, initiation (GO:0006352)",11/186,0.3274334996806609,1,0,0,1.1827956989247312,1.3205562675579576,CRCP;MED13;CCNH;VDR;CDK4;POLR1B;NR1H2;ESRRB;NR1H4;GTF2H1;RUNX2
phospholipid transport (GO:0015914),4/58,0.3296936338803053,1,0,0,1.379310344827586,1.5304709488498607,PRELID2;OSBPL8;PCTP;MFSD2A
neutrophil migration (GO:1990266),4/58,0.3296936338803053,1,0,0,1.379310344827586,1.5304709488498607,EDN2;XCL1;S100A12;CXCL3
nucleic acid-templated transcription (GO:0097659),5/76,0.3310054642700082,1,0,0,1.3157894736842104,1.4547636781220141,XAB2;FUBP3;BCL3;LZTS1;ASCL2
positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition (GO:0051437),5/76,0.3310054642700082,1,0,0,1.3157894736842104,1.4547636781220141,PSMB6;PSMB3;CUL1;ANAPC10;ANAPC11
negative regulation of cell differentiation (GO:0045596),9/150,0.33592380981134945,1,0,0,1.2,1.3090450814951031,NFKBIA;SDHAF2;BBS12;OSR1;NR1H2;ESRRB;USF3;FOXO1;POU4F2
regulation of DNA methylation (GO:0044030),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,KMT2A
regulation of stress-activated protein kinase signaling cascade (GO:0070302),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,GSTP1
cellular response to nitric oxide (GO:0071732),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,FOXO1
stress-induced premature senescence (GO:0090400),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,WNT16
neurotransmitter receptor diffusion trapping (GO:0099628),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,CACNG5
cellular response to prostaglandin E stimulus (GO:0071380),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,PTGER2
microtubule nucleation by microtubule organizing center (GO:0051418),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,TUBGCP2
negative regulation of glial cell differentiation (GO:0045686),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,NF1
regulation of amyloid precursor protein catabolic process (GO:1902991),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,TMED10
positive regulation of membrane potential (GO:0045838),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,GLRX
myelin maintenance (GO:0043217),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,SOD1
negative regulation of interleukin-1 production (GO:0032692),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,GSTP1
cellular response to interleukin-21 (GO:0098757),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,STAT3
phenol-containing compound biosynthetic process (GO:0046189),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,DCT
T-helper 17 cell differentiation (GO:0072539),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,STAT3
development of primary female sexual characteristics (GO:0046545),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,LHFPL2
negative regulation of platelet aggregation (GO:0090331),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,ALOX12
negative regulation of lipase activity (GO:0060192),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,PLIN5
regulation of histone H4 acetylation (GO:0090239),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,SPI1
lagging strand elongation (GO:0006273),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,LIG1
positive regulation of transforming growth factor beta production (GO:0071636),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,XCL1
positive regulation of mitotic metaphase/anaphase transition (GO:0045842),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,ANAPC11
cellular response to reactive nitrogen species (GO:1902170),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,FOXO1
interleukin-21-mediated signaling pathway (GO:0038114),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,STAT3
cellular cation homeostasis (GO:0030003),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,TESMIN
establishment of Golgi localization (GO:0051683),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,YWHAZ
DNA damage induced protein phosphorylation (GO:0006975),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,CRY1
negative regulation of protein complex disassembly (GO:0043242),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,PHF23
excitatory synapse assembly (GO:1904861),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,GRID2
Schwann cell development (GO:0014044),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,NF1
T-helper cell lineage commitment (GO:0002295),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,STAT3
atrial cardiac muscle cell to AV node cell signaling (GO:0086026),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,KCNA5
regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043619),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,SESN2
central nervous system myelination (GO:0022010),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,SOX10
"negative regulation of retrograde protein transport, ER to cytosol (GO:1904153)",1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,UBE2G2
deadenylation-dependent decapping of nuclear-transcribed mRNA (GO:0000290),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,LSM1
regulation of toll-like receptor 2 signaling pathway (GO:0034135),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,CYBA
positive regulation of protein localization to cell surface (GO:2000010),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,HSP90AB1
positive regulation of metanephros development (GO:0072216),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,BASP1
response to hydroxyurea (GO:0072710),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,SPIDR
negative regulation of centriole replication (GO:0046600),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,MDM1
negative regulation of biosynthetic process (GO:0009890),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,GSTP1
histone H4 deacetylation (GO:0070933),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,HDAC4
B cell mediated immunity (GO:0019724),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,HSPD1
positive regulation of immunoglobulin mediated immune response (GO:0002891),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,XCL1
regulation of protein ADP-ribosylation (GO:0010835),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,PNKP
fatty acid alpha-oxidation (GO:0001561),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,ALDH3A2
cardiac muscle hypertrophy (GO:0003300),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,HDAC4
polyol transport (GO:0015791),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,PGAP1
regulation of lipid transport (GO:0032368),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,NR1H2
leptin-mediated signaling pathway (GO:0033210),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,STAT3
peripheral nervous system axon ensheathment (GO:0032292),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,NF1
peroxisomal transport (GO:0043574),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,PEX19
nucleotide phosphorylation (GO:0046939),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,PNKP
positive regulation of chromatin silencing (GO:0031937),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,ZNF304
regulation of long term synaptic depression (GO:1900452),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,GRID2
mitochondrial tRNA modification (GO:0070900),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,MTO1
positive regulation of lipoprotein lipase activity (GO:0051006),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,NR1H2
snoRNA 3'-end processing (GO:0031126),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,FBLL1
U4 snRNA 3'-end processing (GO:0034475),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,EXOSC7
phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,PIK3C2G
aldehyde biosynthetic process (GO:0046184),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,KDM3A
postsynaptic neurotransmitter receptor diffusion trapping (GO:0098970),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,CACNG5
response to ammonium ion (GO:0060359),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,CHRNA3
response to leptin (GO:0044321),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,STAT3
regulation of T-helper 2 cell cytokine production (GO:2000551),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,XCL1
pantothenate metabolic process (GO:0015939),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,PDZD11
positive regulation of non-canonical Wnt signaling pathway (GO:2000052),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,MLLT3
response to vitamin D (GO:0033280),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,ALPL
polyol biosynthetic process (GO:0046173),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,IPPK
monocyte chemotaxis (GO:0002548),3/41,0.3371468638537048,1,0,0,1.4634146341463412,1.5910780182096236,S100A12;XCL1;TNFRSF11A
gluconeogenesis (GO:0006094),3/41,0.3371468638537048,1,0,0,1.4634146341463412,1.5910780182096236,PER2;CRY1;ALDOB
positive regulation of microtubule polymerization (GO:0031116),2/24,0.33921547884608483,1,0,0,1.6666666666666665,1.8018662378583004,PAK1;DCTN1
positive regulation of neutrophil chemotaxis (GO:0090023),2/24,0.33921547884608483,1,0,0,1.6666666666666665,1.8018662378583004,XCL1;CXCL3
cellular lipid catabolic process (GO:0044242),2/24,0.33921547884608483,1,0,0,1.6666666666666665,1.8018662378583004,NUDT19;LPIN2
negative regulation of protein localization to membrane (GO:1905476),2/24,0.33921547884608483,1,0,0,1.6666666666666665,1.8018662378583004,MRAP;LZTFL1
proteasomal ubiquitin-independent protein catabolic process (GO:0010499),2/24,0.33921547884608483,1,0,0,1.6666666666666665,1.8018662378583004,PSMB6;PSMB3
ATP generation from ADP (GO:0006757),2/24,0.33921547884608483,1,0,0,1.6666666666666665,1.8018662378583004,PKM;ALDOB
drug catabolic process (GO:0042737),2/24,0.33921547884608483,1,0,0,1.6666666666666665,1.8018662378583004,CYP2J2;CYP2C18
negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),2/24,0.33921547884608483,1,0,0,1.6666666666666665,1.8018662378583004,HHEX;CDK4
positive regulation of microtubule polymerization or depolymerization (GO:0031112),2/24,0.33921547884608483,1,0,0,1.6666666666666665,1.8018662378583004,PAK1;DCTN1
ERAD pathway (GO:0036503),5/77,0.34100404859306127,1,0,0,1.2987012987012985,1.397221985795033,TRIM25;AUP1;UBE2G2;UGGT1;UBXN6
ribosome biogenesis (GO:0042254),13/226,0.34198126943154117,1,0,0,1.1504424778761062,1.234423986294144,NOM1;TEX10;DDX31;SDAD1;EXOSC7;ERI1;SBDS;ZNF658;RPL24;RPL39;RPS21;RPS13;DIS3L2
protein stabilization (GO:0050821),9/152,0.35009569492044973,1,0,0,1.1842105263157894,1.2428866750394152,USP36;HSP90AB1;PEX19;CCNH;COG3;MDM4;AHSP;PIK3R1;HSPD1
fibroblast growth factor receptor signaling pathway (GO:0008543),5/78,0.3510237868632946,1,0,0,1.282051282051282,1.3421811397066412,FGF17;FLRT2;ANOS1;FGF3;FGF22
cellular response to radiation (GO:0071478),3/42,0.3510272087326468,1,0,0,1.4285714285714284,1.4955593439482697,IFI16;HUS1;SPIDR
translesion synthesis (GO:0019985),3/42,0.3510272087326468,1,0,0,1.4285714285714284,1.4955593439482697,RFC4;TRIM25;POLH
negative regulation of cell growth (GO:0030308),7/115,0.35239484145081534,1,0,0,1.2173913043478262,1.269742811049461,NME6;SESN2;DACT3;RNF6;INHBA;CRLF3;SIPA1
response to reactive oxygen species (GO:0000302),4/60,0.3527005497730227,1,0,0,1.3333333333333333,1.3895145106479536,PRDX5;GSTP1;PXMP2;SOD1
"positive regulation of transcription, DNA-templated (GO:0045893)",59/1120,0.35600688182921686,1,0,0,1.0535714285714286,1.0881340682647158,SPI1;CCNT2;CCNH;CITED4;ETS2;CKS1B;HHEX;MED13;YY2;HOXA7;OSR1;MITF;SOX10;PIAS2;RUNX2;RBL1;PADI2;ZNF750;HDAC4;CEBPB;KDM3A;ZNF350;KMT2A;EPAS1;RNF6;HOXD13;PIK3R1;MRPL12;MLLT3;FOXO1;BCL2L12;SEC14L2;IFI16;DDRGK1;HIVEP3;ZNF304;OTX2;AAMDC;MAP3K2;STAT5B;CDX4;VDR;NR1H2;STAT3;ESRRB;NR1H4;GTF2H1;GRHL3;INHBA;BMP6;ST18;POU4F2;POU4F3;FOSL1;NFKBIA;FUBP3;BCL3;CRLF3;LPIN2
antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),6/97,0.3569285827398046,1,0,0,1.2371134020618557,1.2744984316239885,DCTN6;DCTN5;DCTN1;HLA-DQA2;HLA-DRB1;CTSS
antigen processing and presentation of exogenous peptide antigen (GO:0002478),6/97,0.3569285827398046,1,0,0,1.2371134020618557,1.2744984316239885,DCTN6;DCTN5;DCTN1;HLA-DQA2;HLA-DRB1;CTSS
glycolytic process through glucose-6-phosphate (GO:0061620),2/25,0.3576694978288805,1,0,0,1.5999999999999999,1.645033455050064,PKM;ALDOB
canonical glycolysis (GO:0061621),2/25,0.3576694978288805,1,0,0,1.5999999999999999,1.645033455050064,PKM;ALDOB
glucose catabolic process to pyruvate (GO:0061718),2/25,0.3576694978288805,1,0,0,1.5999999999999999,1.645033455050064,PKM;ALDOB
regulation of telomere maintenance (GO:0032204),2/25,0.3576694978288805,1,0,0,1.5999999999999999,1.645033455050064,RTEL1;ERCC1
"protein import into nucleus, translocation (GO:0000060)",2/25,0.3576694978288805,1,0,0,1.5999999999999999,1.645033455050064,BCL3;IPO4
glial cell differentiation (GO:0010001),2/25,0.3576694978288805,1,0,0,1.5999999999999999,1.645033455050064,STAT3;SOX10
misfolded or incompletely synthesized protein catabolic process (GO:0006515),2/25,0.3576694978288805,1,0,0,1.5999999999999999,1.645033455050064,LONP1;UGGT1
regulation of interleukin-10 production (GO:0032653),2/25,0.3576694978288805,1,0,0,1.5999999999999999,1.645033455050064,XCL1;HSPD1
"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",2/25,0.3576694978288805,1,0,0,1.5999999999999999,1.645033455050064,MIF;HIC1
"RNA splicing, via transesterification reactions (GO:0000375)",2/25,0.3576694978288805,1,0,0,1.5999999999999999,1.645033455050064,SNRNP40;LSM1
monocarboxylic acid catabolic process (GO:0072329),2/25,0.3576694978288805,1,0,0,1.5999999999999999,1.645033455050064,NUDT19;LPIN2
regulation of glucose metabolic process (GO:0010906),2/25,0.3576694978288805,1,0,0,1.5999999999999999,1.645033455050064,SLC45A3;GCGR
negative regulation of cellular protein localization (GO:1903828),2/25,0.3576694978288805,1,0,0,1.5999999999999999,1.645033455050064,GPM6B;LZTFL1
ncRNA 3'-end processing (GO:0043628),2/25,0.3576694978288805,1,0,0,1.5999999999999999,1.645033455050064,ERI1;CT45A6
positive regulation of neutrophil migration (GO:1902624),2/25,0.3576694978288805,1,0,0,1.5999999999999999,1.645033455050064,XCL1;CXCL3
3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),2/25,0.3576694978288805,1,0,0,1.5999999999999999,1.645033455050064,SULT1C2;SULT1B1
regulation of nervous system development (GO:0051960),2/25,0.3576694978288805,1,0,0,1.5999999999999999,1.645033455050064,PER2;ASCL2
positive regulation of embryonic development (GO:0040019),2/25,0.3576694978288805,1,0,0,1.5999999999999999,1.645033455050064,OSR1;OTX2
L-amino acid transport (GO:0015807),2/25,0.3576694978288805,1,0,0,1.5999999999999999,1.645033455050064,CTNS;SLC1A6
neutrophil degranulation (GO:0043312),26/479,0.360992146274285,1,0,0,1.0855949895615866,1.1061117321640468,HSP90AB1;TMEM179B;GSTP1;SLC2A3;CTSS;TTR;GM2A;STBD1;S100A12;VAT1;CAP1;ACTR2;DBNL;APAF1;IST1;RNASET2;CYBA;MIF;CLEC4D;RAB31;PKM;IMPDH2;PADI2;CYSTM1;CEACAM8;PAFAH1B2
actin cytoskeleton reorganization (GO:0031532),4/61,0.36421006738242967,1,0,0,1.3114754098360655,1.3246222552325246,PAK1;RICTOR;WHAMM;ATP2C1
positive regulation of leukocyte chemotaxis (GO:0002690),4/61,0.36421006738242967,1,0,0,1.3114754098360655,1.3246222552325246,EDN2;RARRES2;XCL1;CXCL3
RNA catabolic process (GO:0006401),3/43,0.36487351009848823,1,0,0,1.3953488372093021,1.4067970229812217,EXOSC7;RNASET2;DIS3L2
protein transmembrane import into intracellular organelle (GO:0044743),3/43,0.36487351009848823,1,0,0,1.3953488372093021,1.4067970229812217,PEX19;TOMM20L;HSPD1
development of primary male sexual characteristics (GO:0046546),3/43,0.36487351009848823,1,0,0,1.3953488372093021,1.4067970229812217,INHBA;LHFPL2;RBMY1B
response to unfolded protein (GO:0006986),3/43,0.36487351009848823,1,0,0,1.3953488372093021,1.4067970229812217,HSP90AB1;HSPB2;HSPD1
positive regulation of interleukin-6 production (GO:0032755),3/43,0.36487351009848823,1,0,0,1.3953488372093021,1.4067970229812217,IFIH1;CYBA;HSPD1
substantia nigra development (GO:0021762),3/43,0.36487351009848823,1,0,0,1.3953488372093021,1.4067970229812217,BASP1;PADI2;COX6B1
antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),6/98,0.3659360545830404,1,0,0,1.2244897959183672,1.2309755205294757,DCTN6;DCTN5;DCTN1;HLA-DQA2;HLA-DRB1;CTSS
type B pancreatic cell differentiation (GO:0003309),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,BMP6
inositol metabolic process (GO:0006020),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,IPPK
removal of superoxide radicals (GO:0019430),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,SOD1
positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter (GO:1901838),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,IPPK
acidic amino acid transport (GO:0015800),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,SLC1A6
positive regulation of production of molecular mediator of immune response (GO:0002702),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,XCL1
ornithine metabolic process (GO:0006591),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,ASL
positive regulation of protein sumoylation (GO:0033235),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,HDAC4
positive regulation of voltage-gated potassium channel activity (GO:1903818),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,ALG10B
actin filament reorganization (GO:0090527),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,WHAMM
regulation of organ growth (GO:0046620),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,SOD1
poly-N-acetyllactosamine biosynthetic process (GO:0030311),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,B3GALT4
neuron maturation (GO:0042551),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,RND1
cellular response to interleukin-4 (GO:0071353),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,XCL1
postsynaptic membrane assembly (GO:0097104),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,NRXN2
short-chain fatty acid metabolic process (GO:0046459),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,ACOT4
regulation of T-helper 1 type immune response (GO:0002825),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,XCL1
negative regulation of mitotic nuclear division (GO:0045839),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,NME6
negative regulation of catenin import into nucleus (GO:0035414),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,DACT3
regulation of interferon-gamma secretion (GO:1902713),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,NR1H4
potassium ion export (GO:0071435),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,KCNA5
vasodilation (GO:0042311),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,SOD1
mature B cell differentiation involved in immune response (GO:0002313),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,LFNG
homocysteine metabolic process (GO:0050667),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,CBS
embryonic forelimb morphogenesis (GO:0035115),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,OSR1
neurotrophin TRK receptor signaling pathway (GO:0048011),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,CASP3
nuclear migration (GO:0007097),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,HOOK3
central nervous system neuron development (GO:0021954),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,GBA2
regulation of endoplasmic reticulum unfolded protein response (GO:1900101),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,PIK3R1
negative regulation of gluconeogenesis (GO:0045721),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,SOGA1
myelin assembly (GO:0032288),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,NCMAP
L-ascorbic acid metabolic process (GO:0019852),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,SLC2A3
response to leucine (GO:0043201),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,SESN2
virion attachment to host cell (GO:0019062),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,HSP90AB1
columnar/cuboidal epithelial cell differentiation (GO:0002065),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,CDX2
positive regulation of T cell chemotaxis (GO:0010820),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,XCL1
positive regulation of autophagosome assembly (GO:2000786),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,RALB
Golgi vesicle budding (GO:0048194),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,TMED10
"nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' (GO:0034427)",1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,EXOSC7
production of siRNA involved in RNA interference (GO:0030422),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,MRPL44
mitotic DNA replication checkpoint (GO:0033314),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,HUS1
interleukin-23-mediated signaling pathway (GO:0038155),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,STAT3
negative regulation of alcohol biosynthetic process (GO:1902931),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,SOD1
regulation of bile acid biosynthetic process (GO:0070857),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,NR1H4
engulfment of apoptotic cell (GO:0043652),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,ADGRB1
cellular response to superoxide (GO:0071451),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,SOD1
regulation of methylation-dependent chromatin silencing (GO:0090308),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,ZNF304
peroxisome fission (GO:0016559),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,PEX19
postsynaptic density organization (GO:0097106),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,NRXN2
regulation of leukocyte activation (GO:0002694),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,MIF
response to interleukin-4 (GO:0070670),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,XCL1
protein autoprocessing (GO:0016540),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,HTRA2
ether lipid metabolic process (GO:0046485),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,AGMO
cellular response to leucine (GO:0071233),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,SESN2
regulation of flagellated sperm motility (GO:1901317),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,TACR2
negative regulation of microtubule polymerization (GO:0031115),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,STMN1
tRNA wobble uridine modification (GO:0002098),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,MTO1
nuclear RNA surveillance (GO:0071027),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,EXOSC7
lipoprotein biosynthetic process (GO:0042158),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,ALOX12B
serine family amino acid catabolic process (GO:0009071),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,CBS
regulation of nephron tubule epithelial cell differentiation (GO:0072182),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,OSR1
positive regulation of triglyceride lipase activity (GO:0061365),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,NR1H2
Golgi inheritance (GO:0048313),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,YWHAZ
histone H3-K4 trimethylation (GO:0080182),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,KMT2A
response to vitamin (GO:0033273),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,ALPL
vitamin transmembrane transport (GO:0035461),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,SLC19A3
apoptotic process (GO:0006915),13/231,0.3710240035258014,1,0,0,1.1255411255411256,1.1159611035656396,APAF1;CIDEB;CGB3;HSPD1;NFKBIA;CASP3;ELMO1;LTA;PAK6;CARD18;RNF152;PAK5;IER3
"retrograde vesicle-mediated transport, Golgi to ER (GO:0006890)",5/80,0.37109875658286956,1,0,0,1.25,1.239108826933398,TMED10;RER1;COG3;KDELR3;COPZ1
regulation of hydrolase activity (GO:0051336),5/80,0.37109875658286956,1,0,0,1.25,1.239108826933398,EPHA5;CFAP100;VMA21;NF1;SOD1
"regulation of transcription, DNA-templated (GO:0006355)",83/1598,0.3727110803714831,1,0,0,1.0387984981226532,1.025243988283068,SPI1;NAB2;CITED4;CGB3;ETS2;CKS1B;HHEX;HINT1;MED13;YY2;DACH1;BASP1;SALL4;HOXA7;ZIK1;TCF19;ZNF483;TLE1;SP110;MITF;SOX10;PIAS2;HIC1;RUNX2;UBTFL1;ZNF836;CRY1;XCL1;HDAC4;CEBPB;KDM3A;ZNF471;ZNF350;MYCBP;CRABP2;KMT2A;SRCAP;EPAS1;TSHZ1;RNF6;HOXD13;MRPL12;MLLT3;ASCL2;FOXO1;HSPD1;SEC14L2;HMGXB4;IFI16;TBX22;PAK6;HIVEP3;ZNF304;GPBP1L1;OTX2;ZNF543;ZNF221;MAP3K2;STAT5B;CDX4;CDX2;VDR;ASCC1;NFYB;NR1H2;STAT3;ESRRB;SETDB2;GRHL3;INHBA;FOXN1;TARBP1;PER2;FOSL1;TADA2B;MAFB;FUBP3;ZNF417;BCL3;ZNF658;CRLF3;ZNF773;ZNF354C
positive regulation of type I interferon production (GO:0032481),4/62,0.37571023981047774,1,0,0,1.2903225806451613,1.263144608372761,IFIH1;CRCP;IFI16;HSPD1
second-messenger-mediated signaling (GO:0019932),4/62,0.37571023981047774,1,0,0,1.2903225806451613,1.263144608372761,EDN2;CCR6;PPP1R9A;LAT
regulation of translational initiation (GO:0006446),4/62,0.37571023981047774,1,0,0,1.2903225806451613,1.263144608372761,RBM4;DAZ4;EIF4G2;EIF1
response to growth factor (GO:0070848),2/26,0.3759320092394212,1,0,0,1.5384615384615385,1.5051491975911149,STAT5B;HTRA2
regulation of transcription regulatory region DNA binding (GO:2000677),2/26,0.3759320092394212,1,0,0,1.5384615384615385,1.5051491975911149,PER2;POU4F2
snRNA processing (GO:0016180),2/26,0.3759320092394212,1,0,0,1.5384615384615385,1.5051491975911149,INTS5;CT45A6
regulation of pri-miRNA transcription from RNA polymerase II promoter (GO:1902893),2/26,0.3759320092394212,1,0,0,1.5384615384615385,1.5051491975911149,SPI1;STAT3
regulation of NF-kappaB import into nucleus (GO:0042345),2/26,0.3759320092394212,1,0,0,1.5384615384615385,1.5051491975911149,NFKBIA;BCL3
positive regulation of granulocyte chemotaxis (GO:0071624),2/26,0.3759320092394212,1,0,0,1.5384615384615385,1.5051491975911149,XCL1;CXCL3
tRNA methylation (GO:0030488),2/26,0.3759320092394212,1,0,0,1.5384615384615385,1.5051491975911149,MTO1;TARBP1
regulation of histone acetylation (GO:0035065),2/26,0.3759320092394212,1,0,0,1.5384615384615385,1.5051491975911149,TADA2B;KMT2A
GPI anchor metabolic process (GO:0006505),2/26,0.3759320092394212,1,0,0,1.5384615384615385,1.5051491975911149,PGAP1;PIGA
snRNA 3'-end processing (GO:0034472),2/26,0.3759320092394212,1,0,0,1.5384615384615385,1.5051491975911149,EXOSC7;CT45A6
plasma membrane bounded cell projection organization (GO:0120036),7/118,0.37711178989119853,1,0,0,1.1864406779661016,1.1570330972966532,CFAP61;STMN1;TBC1D24;MNS1;PPP1R9A;GPM6B;MANF
positive regulation of protein serine/threonine kinase activity (GO:0071902),7/118,0.37711178989119853,1,0,0,1.1864406779661016,1.1570330972966532,CARD10;CCNT2;CCND2;RALB;CCNH;S100A12;CKS1B
neutrophil activation involved in immune response (GO:0002283),26/483,0.3771724571148385,1,0,0,1.0766045548654244,1.0497462321022473,HSP90AB1;TMEM179B;GSTP1;SLC2A3;CTSS;TTR;GM2A;STBD1;S100A12;VAT1;CAP1;ACTR2;DBNL;APAF1;IST1;RNASET2;CYBA;MIF;CLEC4D;RAB31;PKM;IMPDH2;PADI2;CYSTM1;CEACAM8;PAFAH1B2
sprouting angiogenesis (GO:0002040),3/44,0.3786697727707907,1,0,0,1.3636363636363635,1.3242146804495836,CCBE1;BMPER;EPHB4
hexose biosynthetic process (GO:0019319),3/44,0.3786697727707907,1,0,0,1.3636363636363635,1.3242146804495836,PER2;CRY1;ALDOB
positive regulation of macroautophagy (GO:0016239),3/44,0.3786697727707907,1,0,0,1.3636363636363635,1.3242146804495836,RALB;SESN2;PAFAH1B2
regulation of T cell activation (GO:0050863),3/44,0.3786697727707907,1,0,0,1.3636363636363635,1.3242146804495836,TNFAIP8L2;LAT;HSPD1
protein N-linked glycosylation via asparagine (GO:0018279),3/44,0.3786697727707907,1,0,0,1.3636363636363635,1.3242146804495836,UBE2G2;UGGT1;ASGR2
transcription from RNA polymerase II promoter (GO:0006366),26/485,0.38531204842867156,1,0,0,1.0721649484536082,1.022525595761703,CEBPB;SPI1;CCNT2;KMT2A;CCNH;EPAS1;HOXD13;MLLT3;TAF5L;MED13;FIP1L1;SNAPC1;SALL4;HIVEP3;CDX2;VDR;NR1H2;ESRRB;NR1H4;GTF2H1;ELOA3;FOXN1;RUNX2;FOSL1;CDK4;INTS5
response to cytokine (GO:0034097),8/138,0.38588815366024015,1,0,0,1.1594202898550725,1.1040089378109808,HDAC4;IL1RL2;LAMP3;CASP3;STAT3;TNFRSF11A;PTPN7;POU4F2
iron ion homeostasis (GO:0055072),4/63,0.38719146599357773,1,0,0,1.2698412698412698,1.204871065559935,FTMT;CUL1;BMP6;SOD1
positive regulation of ubiquitin protein ligase activity (GO:1904668),5/82,0.39117601725719064,1,0,0,1.2195121951219512,1.1446312783908745,PSMB6;PSMB3;CUL1;ANAPC10;ANAPC11
ephrin receptor signaling pathway (GO:0048013),5/82,0.39117601725719064,1,0,0,1.2195121951219512,1.1446312783908745,EPHA5;ACTR2;PAK1;ARPC1B;EPHB4
peptidyl-asparagine modification (GO:0018196),3/45,0.3924009183942127,1,0,0,1.3333333333333333,1.2472949477860094,UBE2G2;UGGT1;ASGR2
regulation of protein ubiquitination (GO:0031396),6/101,0.39300017337866283,1,0,0,1.188118811881188,1.109637892212941,PER2;HSP90AB1;PHF23;ADGRB1;FBXO4;CRY1
neutrophil mediated immunity (GO:0002446),26/487,0.39347974650973844,1,0,0,1.0677618069815193,0.9959288602329642,HSP90AB1;TMEM179B;GSTP1;SLC2A3;CTSS;TTR;GM2A;STBD1;S100A12;VAT1;CAP1;ACTR2;DBNL;APAF1;IST1;RNASET2;CYBA;MIF;CLEC4D;RAB31;PKM;IMPDH2;PADI2;CYSTM1;CEACAM8;PAFAH1B2
phosphatidylinositol phosphorylation (GO:0046854),2/27,0.39397603610044213,1,0,0,1.4814814814814814,1.3799484349837585,PIK3C2G;PIK3R1
regulation of protein localization to nucleus (GO:1900180),2/27,0.39397603610044213,1,0,0,1.4814814814814814,1.3799484349837585,CARD10;SESN2
regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),2/27,0.39397603610044213,1,0,0,1.4814814814814814,1.3799484349837585,HTRA2;INHBA
transcription from RNA polymerase III promoter (GO:0006383),2/27,0.39397603610044213,1,0,0,1.4814814814814814,1.3799484349837585,CRCP;SNAPC1
phosphatidylserine metabolic process (GO:0006658),2/27,0.39397603610044213,1,0,0,1.4814814814814814,1.3799484349837585,OSBPL8;PLA1A
negative regulation of organelle assembly (GO:1902116),2/27,0.39397603610044213,1,0,0,1.4814814814814814,1.3799484349837585,PHF23;MDM1
protein localization to chromosome (GO:0034502),2/27,0.39397603610044213,1,0,0,1.4814814814814814,1.3799484349837585,SLF1;TNKS2
regulation of autophagy of mitochondrion (GO:1903146),2/27,0.39397603610044213,1,0,0,1.4814814814814814,1.3799484349837585,USP36;HTRA2
regulation of protein localization to cell surface (GO:2000008),2/27,0.39397603610044213,1,0,0,1.4814814814814814,1.3799484349837585,HSP90AB1;GPM6B
adrenal gland development (GO:0030325),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,NF1
ganglion development (GO:0061548),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,POU4F2
negative regulation of sodium ion transmembrane transport (GO:1902306),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,OSR1
cellular response to thyroid hormone stimulus (GO:0097067),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,CTSS
regulation of myeloid leukocyte differentiation (GO:0002761),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,CEBPB
macrophage chemotaxis (GO:0048246),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,EDN2
regulation of actin filament length (GO:0030832),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,SSH2
"energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988)",1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,ATP4A
response to acidic pH (GO:0010447),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,CTSS
glycine metabolic process (GO:0006544),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,GLYAT
pyroptosis (GO:0070269),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,GSDMC
detection of light stimulus involved in sensory perception (GO:0050962),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,RPE65
regulation of triglyceride catabolic process (GO:0010896),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,PLIN5
L-glutamate transport (GO:0015813),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,SLC1A6
aspartate family amino acid metabolic process (GO:0009066),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,SMS
mesenchymal to epithelial transition (GO:0060231),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,BASP1
ESCRT III complex disassembly (GO:1904903),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,IST1
regulation of protein exit from endoplasmic reticulum (GO:0070861),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,INSIG1
positive regulation of acrosome reaction (GO:2000344),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,ZP4
"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,MRPL44
regulation of transforming growth factor beta production (GO:0071634),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,XCL1
astrocyte development (GO:0014002),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,NF1
positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,PAK1
positive regulation of lipase activity (GO:0060193),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,PLIN5
cell differentiation involved in metanephros development (GO:0072202),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,OSR1
neurotransmitter receptor transport (GO:0099637),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,CACNG5
telomere maintenance in response to DNA damage (GO:0043247),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,RTEL1
glycerolipid metabolic process (GO:0046486),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,DGKZ
primary miRNA processing (GO:0031053),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,MRPL44
negative regulation of autophagosome assembly (GO:1902902),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,PHF23
primary alcohol catabolic process (GO:0034310),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,SULT1B1
macrophage migration (GO:1905517),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,EDN2
negative regulation of interleukin-1 beta secretion (GO:0050713),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,CARD18
protein localization to synapse (GO:0035418),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,NRXN2
regulation of fatty acid beta-oxidation (GO:0031998),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,PLIN5
nuclear mRNA surveillance (GO:0071028),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,EXOSC7
insulin-like growth factor receptor signaling pathway (GO:0048009),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,PIK3R1
DNA replication-dependent nucleosome assembly (GO:0006335),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,IPO4
cytochrome complex assembly (GO:0017004),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,CYBA
regulation of DNA damage checkpoint (GO:2000001),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,CRY1
negative regulation of centrosome duplication (GO:0010826),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,MDM1
maintenance of apical/basal cell polarity (GO:0035090),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,PDZD11
negative regulation of stem cell differentiation (GO:2000737),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,ESRRB
ganglioside biosynthetic process (GO:0001574),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,B3GALT4
tRNA wobble base modification (GO:0002097),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,MTO1
negative regulation of sodium ion transmembrane transporter activity (GO:2000650),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,OSR1
ESCRT complex disassembly (GO:1904896),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,IST1
detection of light stimulus involved in visual perception (GO:0050908),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,RPE65
positive regulation of lipid localization (GO:1905954),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,PLIN5
chaperone-mediated protein transport (GO:0072321),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,PEX19
cellular response to leucine starvation (GO:1990253),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,SESN2
DNA replication-dependent nucleosome organization (GO:0034723),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,IPO4
neurotransmitter receptor internalization (GO:0099590),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,CACNG5
poly-N-acetyllactosamine metabolic process (GO:0030309),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,B3GALT4
positive regulation of execution phase of apoptosis (GO:1900119),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,PTGIS
negative regulation of homotypic cell-cell adhesion (GO:0034111),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,ALOX12
regulation of neuroblast proliferation (GO:1902692),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,NF1
positive regulation of vacuole organization (GO:0044090),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,RALB
regulation of phospholipid metabolic process (GO:1903725),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,PIK3R1
telomeric loop disassembly (GO:0090657),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,RTEL1
maintenance of epithelial cell apical/basal polarity (GO:0045199),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,PDZD11
forelimb morphogenesis (GO:0035136),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,OSR1
thyroid hormone generation (GO:0006590),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,DUOX1
positive regulation of type 2 immune response (GO:0002830),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,XCL1
regulation of T cell chemotaxis (GO:0010819),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,XCL1
Golgi organization (GO:0007030),7/121,0.40189970418865884,1,0,0,1.1570247933884297,1.054689090068788,GOLGA8CP;GOLGA5;TMED10;COG3;GOLGA8O;YWHAZ;GOLGA2P5
central nervous system development (GO:0007417),12/217,0.4022049425089577,1,0,0,1.1059907834101383,1.0073292310058564,ALDH3A2;VCX3B;FXR2;GSTP1;STAT3;NF1;CTNS;HAPLN3;GBA2;SOX10;PAFAH1B2;HAPLN2
cellular response to ionizing radiation (GO:0071479),3/46,0.40605277189227273,1,0,0,1.3043478260869563,1.175572366691541,IFI16;HUS1;SPIDR
interleukin-12-mediated signaling pathway (GO:0035722),3/46,0.40605277189227273,1,0,0,1.3043478260869563,1.175572366691541,SERPINB2;MIF;SOD1
negative regulation of protein modification by small protein conjugation or removal (GO:1903321),3/46,0.40605277189227273,1,0,0,1.3043478260869563,1.175572366691541,PER2;ADGRB1;CRY1
cellular response to interleukin-12 (GO:0071349),3/46,0.40605277189227273,1,0,0,1.3043478260869563,1.175572366691541,SERPINB2;MIF;SOD1
mitotic spindle assembly (GO:0090307),3/46,0.40605277189227273,1,0,0,1.3043478260869563,1.175572366691541,TUBGCP2;ABRAXAS2;NAIP
transcription initiation from RNA polymerase II promoter (GO:0006367),9/160,0.4073910770526227,1,0,0,1.125,1.0102293873083648,MED13;CCNH;VDR;CDK4;NR1H2;ESRRB;NR1H4;GTF2H1;RUNX2
modification-dependent protein catabolic process (GO:0019941),8/141,0.4088949518804498,1,0,0,1.1347517730496453,1.0148051033155423,KCTD10;LONP1;ARIH2;TRIM25;RNF6;UBE2A;UBE2G2;PCYOX1
protein deubiquitination (GO:0016579),14/257,0.4098675291066845,1,0,0,1.0894941634241244,0.9717430192405929,USP36;ABRAXAS2;USP28;TADA2B;IFIH1;PSMB6;NFKBIA;CCNA2;RNF123;TNKS2;PSMB3;ATXN7;TRIM25;MDM4
O-glycan processing (GO:0016266),4/65,0.41006047139933866,1,0,0,1.2307692307692308,1.0971700171589474,GALNT14;GALNT2;GALNT10;B4GALT5
negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),2/28,0.4117777723443979,1,0,0,1.4285714285714284,1.2675306609542623,CRY1;PIAS2
cellular response to alcohol (GO:0097306),2/28,0.4117777723443979,1,0,0,1.4285714285714284,1.2675306609542623,PTGER2;SPIDR
negative regulation of homeostatic process (GO:0032845),2/28,0.4117777723443979,1,0,0,1.4285714285714284,1.2675306609542623,MAFB;ERCC1
carboxylic acid catabolic process (GO:0046395),2/28,0.4117777723443979,1,0,0,1.4285714285714284,1.2675306609542623,LYVE1;ACOT4
negative regulation of proteasomal protein catabolic process (GO:1901799),2/28,0.4117777723443979,1,0,0,1.4285714285714284,1.2675306609542623,HSP90AB1;LAMP3
"synaptic transmission, cholinergic (GO:0007271)",2/28,0.4117777723443979,1,0,0,1.4285714285714284,1.2675306609542623,RIC3;CHRNA3
negative regulation of response to DNA damage stimulus (GO:2001021),2/28,0.4117777723443979,1,0,0,1.4285714285714284,1.2675306609542623,RTEL1;MIF
chondrocyte differentiation (GO:0002062),2/28,0.4117777723443979,1,0,0,1.4285714285714284,1.2675306609542623,OSR1;RUNX2
positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),2/28,0.4117777723443979,1,0,0,1.4285714285714284,1.2675306609542623,HTRA2;INHBA
regulation of fatty acid biosynthetic process (GO:0042304),2/28,0.4117777723443979,1,0,0,1.4285714285714284,1.2675306609542623,SLC45A3;NR1H2
primary neural tube formation (GO:0014020),2/28,0.4117777723443979,1,0,0,1.4285714285714284,1.2675306609542623,FUZ;GRHL3
positive regulation of fibroblast proliferation (GO:0048146),2/28,0.4117777723443979,1,0,0,1.4285714285714284,1.2675306609542623,CDK4;MIF
ER to Golgi vesicle-mediated transport (GO:0006888),10/180,0.41252988449997713,1,0,0,1.111111111111111,0.9838295872876737,DCTN6;DCTN5;PGAP1;TMED10;DCTN1;COG3;WHAMM;BET1L;COPZ1;YIF1A
tumor necrosis factor-mediated signaling pathway (GO:0033209),7/123,0.4184152232009605,1,0,0,1.1382113821138211,0.9917019313802579,NFKBIA;PSMB6;PSMB3;TNFRSF18;LTA;TNFRSF11A;ST18
negative regulation of cellular biosynthetic process (GO:0031327),3/47,0.4196120451603213,1,0,0,1.276595744680851,1.1086272722292005,PTGIS;NR1H4;SOGA1
positive regulation of tumor necrosis factor production (GO:0032760),3/47,0.4196120451603213,1,0,0,1.276595744680851,1.1086272722292005,IFIH1;CYBA;MIF
positive regulation of organelle assembly (GO:1902117),3/47,0.4196120451603213,1,0,0,1.276595744680851,1.1086272722292005,RALB;CEP295;FUZ
peptide metabolic process (GO:0006518),6/104,0.4200266801120024,1,0,0,1.1538461538461537,1.0008888988224178,GSTA5;GSTP1;GDAP1L1;GSTA1;CTNS;SOD1
positive regulation of cellular protein localization (GO:1903829),4/66,0.421430857889875,1,0,0,1.2121212121212122,1.0473933978386722,CARD10;HSP90AB1;DDRGK1;SESN2
anterograde trans-synaptic signaling (GO:0098916),13/240,0.4239711734951957,1,0,0,1.0833333333333333,0.9295972975261219,GABBR2;CHRNA3;OR10H3;GAD1;TACR2;GPR1;NRXN2;SLC1A6;GRM3;GABRR2;HTR6;PMP22;PRLHR
mitotic cell cycle phase transition (GO:0044772),12/221,0.4268281136170111,1,0,0,1.085972850678733,0.9245689314229618,CCNA2;CCNH;CDK4;DCTN1;NDE1;CUL1;RCC1;INHBA;HAUS5;CRLF3;CDKN3;NEK11
"nucleotide-excision repair, preincision complex assembly (GO:0006294)",2/29,0.42931633359945176,1,0,0,1.379310344827586,1.1662913895494167,CCNH;GTF2H1
tube closure (GO:0060606),2/29,0.42931633359945176,1,0,0,1.379310344827586,1.1662913895494167,FUZ;GRHL3
regulation of neutrophil chemotaxis (GO:0090022),2/29,0.42931633359945176,1,0,0,1.379310344827586,1.1662913895494167,XCL1;CXCL3
positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),2/29,0.42931633359945176,1,0,0,1.379310344827586,1.1662913895494167,CEBPB;SESN2
lysosome localization (GO:0032418),2/29,0.42931633359945176,1,0,0,1.379310344827586,1.1662913895494167,HPS6;NDEL1
regulation of keratinocyte differentiation (GO:0045616),2/29,0.42931633359945176,1,0,0,1.379310344827586,1.1662913895494167,VDR;HOXA7
skeletal muscle organ development (GO:0060538),2/29,0.42931633359945176,1,0,0,1.379310344827586,1.1662913895494167,MYL6;BASP1
regulation of cellular biosynthetic process (GO:0031326),2/29,0.42931633359945176,1,0,0,1.379310344827586,1.1662913895494167,NR1H4;MITF
striated muscle tissue development (GO:0014706),2/29,0.42931633359945176,1,0,0,1.379310344827586,1.1662913895494167,MYL6;NDUFV2
positive regulation of posttranscriptional gene silencing (GO:0060148),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,STAT3
formation of extrachromosomal circular DNA (GO:0001325),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,ERCC1
positive regulation of endothelial cell apoptotic process (GO:2000353),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,ECSCR
regulation of stem cell population maintenance (GO:2000036),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,ESRRB
replicative senescence (GO:0090399),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,WNT16
positive regulation of cell cycle phase transition (GO:1901989),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,DDRGK1
negative regulation of blood vessel diameter (GO:0097756),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,EDN2
cellular response to prostaglandin stimulus (GO:0071379),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,PTGER2
postsynapse assembly (GO:0099068),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,NRXN2
regulation of feeding behavior (GO:0060259),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,STAT3
mononuclear cell differentiation (GO:1903131),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,IFI16
regulation of leukocyte cell-cell adhesion (GO:1903037),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,LAT
interleukin-2-mediated signaling pathway (GO:0038110),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,STAT5B
negative regulation of nuclear division (GO:0051784),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,NME6
negative regulation of leukocyte cell-cell adhesion (GO:1903038),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,TNFAIP8L2
UV-damage excision repair (GO:0070914),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,ERCC1
negative regulation of JUN kinase activity (GO:0043508),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,GSTP1
negative regulation of bone mineralization (GO:0030502),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,ECM1
regulation of vascular endothelial growth factor signaling pathway (GO:1900746),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,CCBE1
mesonephros development (GO:0001823),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,OSR1
T cell differentiation in thymus (GO:0033077),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,CCR6
regulation of long-term neuronal synaptic plasticity (GO:0048169),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,NETO1
cellular response to sterol (GO:0036315),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,INSIG1
positive regulation of tumor necrosis factor secretion (GO:1904469),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,IFIH1
urea cycle (GO:0000050),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,ASL
"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,RPS21
biotin metabolic process (GO:0006768),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,PDZD11
positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,CEBPB
purine nucleobase metabolic process (GO:0006144),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,TTR
positive regulation of myoblast fusion (GO:1901741),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,ADGRB1
response to axon injury (GO:0048678),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,SOD1
negative regulation of myotube differentiation (GO:0010832),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,HDAC4
monocyte differentiation (GO:0030224),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,IFI16
negative regulation of cellular senescence (GO:2000773),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,RBL1
cytidine to uridine editing (GO:0016554),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,APOBEC3B
positive regulation of glycoprotein biosynthetic process (GO:0010560),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,ALG10B
negative regulation of histone acetylation (GO:0035067),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,SPI1
transcytosis (GO:0045056),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,MFSD2A
regulation of chromatin binding (GO:0035561),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,ZNF304
negative regulation of protein localization to cell surface (GO:2000009),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,GPM6B
cellular response to interleukin-2 (GO:0071352),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,STAT5B
response to sterol (GO:0036314),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,INSIG1
histone mRNA catabolic process (GO:0071044),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,LSM1
icosanoid biosynthetic process (GO:0046456),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,ALOX12
progesterone metabolic process (GO:0042448),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,DHRS9
protein kinase C signaling (GO:0070528),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,PRSS33
methionine metabolic process (GO:0006555),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,SMS
camera-type eye morphogenesis (GO:0048593),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,NF1
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,MIF
t-circle formation (GO:0090656),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,ERCC1
response to nitric oxide (GO:0071731),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,FOXO1
photoreceptor cell development (GO:0042461),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,MAPRE2
heart process (GO:0003015),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,SOD1
negative regulation of cardiac muscle hypertrophy (GO:0010614),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,FOXO1
establishment of synaptic vesicle localization (GO:0097480),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,TMEM230
cellular response to increased oxygen levels (GO:0036295),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,FOXO1
glycerol metabolic process (GO:0006071),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,COQ3
positive regulation of fatty acid oxidation (GO:0046321),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,PLIN5
magnesium ion transport (GO:0015693),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,MRS2
positive regulation of sodium ion transmembrane transporter activity (GO:2000651),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,GLRX
positive regulation of glucose metabolic process (GO:0010907),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,SLC45A3
response to thyroid hormone (GO:0097066),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,CTSS
L-serine metabolic process (GO:0006563),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,CBS
embryonic hemopoiesis (GO:0035162),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,KMT2A
glutathione biosynthetic process (GO:0006750),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,GGCT
regulation of autophagosome maturation (GO:1901096),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,PHF23
telomere maintenance via telomere trimming (GO:0090737),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,ERCC1
"regulation of symbiosis, encompassing mutualism through parasitism (GO:0043903)",1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,EXOC2
positive regulation of interferon-gamma biosynthetic process (GO:0045078),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,EBI3
UDP-N-acetylglucosamine biosynthetic process (GO:0006048),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,PGM3
spinal cord development (GO:0021510),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,NF1
cellular protein complex assembly (GO:0043623),8/144,0.4318797311110838,1,0,0,1.111111111111111,0.9328979218937584,CHRNA3;HSP90AB1;BBS12;LONP1;TOMM20L;CUL1;CYBA;HSPD1
protein modification by small protein removal (GO:0070646),14/261,0.43256781589264026,1,0,0,1.0727969348659003,0.8990211733412427,USP36;ABRAXAS2;USP28;TADA2B;IFIH1;PSMB6;NFKBIA;CCNA2;RNF123;TNKS2;PSMB3;ATXN7;TRIM25;MDM4
positive regulation of autophagy (GO:0010508),4/67,0.4327475179328833,1,0,0,1.1940298507462686,1.0001203826990046,SESN2;RNF152;PAFAH1B2;FOXO1
negative regulation of mitotic cell cycle (GO:0045930),3/48,0.43306631871249,1,0,0,1.25,1.0460805021359667,NME6;ANGEL2;MCPH1
regulation of autophagy (GO:0010506),11/203,0.4362426845468669,1,0,0,1.083743842364532,0.8990268295649474,USP36;IFI16;LAMP3;CASP3;MLST8;RAB39B;HTRA2;SOGA1;RNF152;FOXO1;EIF4G2
regulation of MAPK cascade (GO:0043408),11/203,0.4362426845468669,1,0,0,1.083743842364532,0.8990268295649474,EPHA5;PAK1;GSTP1;NF1;PAK6;ALOX12B;TNFRSF11A;INHBA;EPHB4;PAK5;BMP6
response to endoplasmic reticulum stress (GO:0034976),6/106,0.43796290568349927,1,0,0,1.1320754716981132,0.9346653536744506,CEBPB;DDRGK1;UBA5;TRIM25;PIK3R1;UBXN6
positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:2000060),5/87,0.44104723204673524,1,0,0,1.1494252873563218,0.9409233415212925,PSMB6;PSMB3;CUL1;ANAPC10;ANAPC11
regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),11/204,0.4426837323435653,1,0,0,1.0784313725490196,0.878813387268268,NFKBIA;ECM1;TLE1;SLC20A1;GSTP1;CARD9;BCL3;NR1H4;TRIM25;S100A12;ATP2C1
RNA methylation (GO:0001510),3/49,0.44640402063272916,1,0,0,1.2244897959183672,0.987588809585937,FBLL1;MTO1;TARBP1
gonad development (GO:0008406),3/49,0.44640402063272916,1,0,0,1.2244897959183672,0.987588809585937,BASP1;INHBA;RBMY1B
negative regulation of stress-activated MAPK cascade (GO:0032873),2/30,0.44657352514826887,1,0,0,1.3333333333333333,1.0748682963163632,GSTP1;FOXO1
regulation of cell migration involved in sprouting angiogenesis (GO:0090049),2/30,0.44657352514826887,1,0,0,1.3333333333333333,1.0748682963163632,CARD10;MMRN2
multivesicular body assembly (GO:0036258),2/30,0.44657352514826887,1,0,0,1.3333333333333333,1.0748682963163632,IST1;MVB12A
activation of JUN kinase activity (GO:0007257),2/30,0.44657352514826887,1,0,0,1.3333333333333333,1.0748682963163632,MAP3K2;DBNL
cellular response to starvation (GO:0009267),6/107,0.44689369780524896,1,0,0,1.1214953271028036,0.903291056261686,RALB;IFI16;SESN2;ZFYVE1;RNF152;FOXO1
regulation of stem cell differentiation (GO:2000736),5/88,0.4509193850280069,1,0,0,1.1363636363636362,0.9050757984351353,PSMB6;SPI1;KMT2A;PSMB3;ESRRB
negative regulation of angiogenesis (GO:0016525),4/69,0.45518892642326336,1,0,0,1.1594202898550725,0.9125133023815558,HHEX;ADGRB1;ECSCR;EPN2
response to organic cyclic compound (GO:0014070),4/69,0.45518892642326336,1,0,0,1.1594202898550725,0.9125133023815558,STAT5B;CHRNA3;STAT3;ALPL
positive regulation of nucleic acid-templated transcription (GO:1903508),26/502,0.4552655671825553,1,0,0,1.0358565737051793,0.815088984866276,HDAC4;KDM3A;SPI1;KMT2A;RNF6;MRPL12;MLLT3;FOXO1;ETS2;CKS1B;SEC14L2;MED13;HIVEP3;OTX2;MAP3K2;NR1H2;STAT3;ESRRB;MITF;INHBA;SOX10;PIAS2;RUNX2;FUBP3;BCL3;CRLF3
"DNA-templated transcription, elongation (GO:0006354)",6/108,0.45579415117862115,1,0,0,1.111111111111111,0.8730155491595808,CCNT2;CCNH;POLR1B;ELOA3;GTF2H1;MLLT3
negative regulation of protein ubiquitination (GO:0031397),3/50,0.4596144044474325,1,0,0,1.2,0.9328408706750739,PER2;ADGRB1;CRY1
"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,UBE2G2
regulation of myoblast fusion (GO:1901739),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,ADGRB1
regulation of nitric-oxide synthase biosynthetic process (GO:0051769),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,GSTP1
regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter (GO:1901836),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,IPPK
peptidyl-arginine modification (GO:0018195),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,PADI2
positive regulation of interleukin-1 production (GO:0032732),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,IFI16
regulation of DNA-dependent DNA replication (GO:0090329),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,BMP6
regulation of protein glycosylation (GO:0060049),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,ALG10B
retinol metabolic process (GO:0042572),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,DHRS9
negative regulation of metabolic process (GO:0009892),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,GSTP1
negative regulation of ERAD pathway (GO:1904293),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,UBE2G2
carbohydrate derivative transport (GO:1901264),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,MFSD2A
modification-dependent macromolecule catabolic process (GO:0043632),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,DIS3L2
regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,MIF
cellular modified amino acid catabolic process (GO:0042219),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,PCYOX1
amino sugar biosynthetic process (GO:0046349),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,PGM3
viral RNA genome replication (GO:0039694),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,PIK3C2G
cell differentiation in hindbrain (GO:0021533),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,GRID2
UDP-N-acetylglucosamine metabolic process (GO:0006047),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,PGM3
oligodendrocyte development (GO:0014003),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,SOX10
histone arginine methylation (GO:0034969),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,NR1H4
serine family amino acid biosynthetic process (GO:0009070),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,CBS
positive regulation of T-helper 1 type immune response (GO:0002827),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,XCL1
regulation of rRNA processing (GO:2000232),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,USP36
pre-mRNA cleavage required for polyadenylation (GO:0098789),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,FIP1L1
cell wall macromolecule catabolic process (GO:0016998),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,LYZL4
nonribosomal peptide biosynthetic process (GO:0019184),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,GGCT
positive regulation of keratinocyte differentiation (GO:0045618),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,VDR
regulation of bone remodeling (GO:0046850),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,NF1
DNA ligation involved in DNA repair (GO:0051103),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,LIG1
polyamine metabolic process (GO:0006595),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,SMS
cellular glucan metabolic process (GO:0006073),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,GBE1
phasic smooth muscle contraction (GO:0014821),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,EDN2
somatic hypermutation of immunoglobulin genes (GO:0016446),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,POLK
eye photoreceptor cell development (GO:0042462),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,MAPRE2
response to prostaglandin E (GO:0034695),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,PTGER2
positive regulation of ruffle assembly (GO:1900029),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,NDEL1
regulation of interleukin-8 biosynthetic process (GO:0045414),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,BCL3
cytoplasmic translational initiation (GO:0002183),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,RBM4
vasoconstriction (GO:0042310),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,EDN2
regulation of mononuclear cell migration (GO:0071675),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,RARRES2
positive regulation of peptidase activity (GO:0010952),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,DDRGK1
response to interleukin-6 (GO:0070741),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,PTGIS
purine nucleoside monophosphate biosynthetic process (GO:0009127),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,IMPDH2
negative regulation of epithelial cell differentiation (GO:0030857),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,OSR1
positive regulation of DNA-dependent DNA replication (GO:2000105),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,BMP6
positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,PIK3R1
negative regulation of interleukin-1 secretion (GO:0050711),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,CARD18
negative regulation of ATP metabolic process (GO:1903579),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,HDAC4
"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,MIF
positive regulation of cyclase activity (GO:0031281),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,NF1
cellular response to fatty acid (GO:0071398),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,NR1H4
transcription from mitochondrial promoter (GO:0006390),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,MRPL12
regulation of T cell differentiation in thymus (GO:0033081),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,SOD1
plasma membrane tubulation (GO:0097320),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,WHAMM
endosome transport via multivesicular body sorting pathway (GO:0032509),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,UBXN6
negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,FUZ
negative regulation of androgen receptor signaling pathway (GO:0060766),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,PIAS2
positive regulation of T cell cytokine production (GO:0002726),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,XCL1
regulation of catabolic process (GO:0009894),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,RARRES2
positive regulation of SMAD protein import into nucleus (GO:0060391),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,BMP6
eye photoreceptor cell differentiation (GO:0001754),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,STAT3
regulation of neuron apoptotic process (GO:0043523),5/89,0.460744839318766,1,0,0,1.1235955056179774,0.8706863855115896,GRID2;AKT1S1;NF1;NAIP;SOD1
negative regulation of canonical Wnt signaling pathway (GO:0090090),8/148,0.46236222561490486,1,0,0,1.0810810810810811,0.8339531426705211,PSMB6;SDHAF2;PSMB3;FUZ;IGFBP6;KREMEN2;NOTUM;MLLT3
negative regulation of blood vessel endothelial cell migration (GO:0043537),2/31,0.46353362563600886,1,0,0,1.2903225806451613,0.9920985153401862,CARD10;MMRN2
organelle transport along microtubule (GO:0072384),2/31,0.46353362563600886,1,0,0,1.2903225806451613,0.9920985153401862,NDE1;NDEL1
anterograde axonal transport (GO:0008089),2/31,0.46353362563600886,1,0,0,1.2903225806451613,0.9920985153401862,FXR2;SOD1
multivesicular body organization (GO:0036257),2/31,0.46353362563600886,1,0,0,1.2903225806451613,0.9920985153401862,IST1;MVB12A
nucleobase-containing small molecule interconversion (GO:0015949),2/31,0.46353362563600886,1,0,0,1.2903225806451613,0.9920985153401862,NME6;GLRX
liver development (GO:0001889),2/31,0.46353362563600886,1,0,0,1.2903225806451613,0.9920985153401862,CEBPB;NF1
gene silencing by miRNA (GO:0035195),2/31,0.46353362563600886,1,0,0,1.2903225806451613,0.9920985153401862,RBM4;STAT3
positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),6/109,0.4646603211324838,1,0,0,1.1009174311926606,0.8437966596577015,APAF1;CASP3;CARD18;HTRA2;ST18;HSPD1
regulation of Wnt signaling pathway (GO:0030111),6/109,0.4646603211324838,1,0,0,1.1009174311926606,0.8437966596577015,HHEX;TLE1;HMGXB4;DACT3;NOTUM;HIC1
Rab protein signal transduction (GO:0032482),4/70,0.4662992293725246,1,0,0,1.1428571428571428,0.8719174032140833,RAB31;RAB39B;RABL2B;DNAJC27
interferon-gamma-mediated signaling pathway (GO:0060333),4/70,0.4662992293725246,1,0,0,1.1428571428571428,0.8719174032140833,TRIM25;HLA-DQA2;HLA-DRB1;OASL
negative regulation of developmental process (GO:0051093),4/70,0.4662992293725246,1,0,0,1.1428571428571428,0.8719174032140833,VAT1;FUZ;MIF;POU4F2
calcium-mediated signaling (GO:0019722),4/70,0.4662992293725246,1,0,0,1.1428571428571428,0.8719174032140833,EDN2;CCR6;PPP1R9A;LAT
positive regulation of response to external stimulus (GO:0032103),5/90,0.4705185605943169,1,0,0,1.111111111111111,0.8376887467502594,NFKBIA;RARRES2;S100A12;CYBA;BMP6
protein ubiquitination (GO:0016567),26/506,0.47177903125247966,1,0,0,1.0276679841897234,0.7720299796706346,UBE2D4;EPAS1;CUL1;RNF6;ANAPC11;PSMB6;PCNP;HECTD1;TNKS2;RNF138;PSMB3;FBXO4;ARIH2;TRIM25;RNF152;TRIM23;FBXW5;FBXO17;KLHL28;KLHL22;KLHDC8B;UBE2G2;UBE2A;KCTD10;ASB9;NAIP
regulation of programmed cell death (GO:0043067),14/268,0.472217021741417,1,0,0,1.044776119402985,0.7839128732393905,MAP3K2;PTGIS;APAF1;TNFRSF18;CIDEB;TNFRSF11A;INHBA;POU4F2;BMP6;PAK1;BCL3;AKT1S1;PAK6;PAK5
response to organonitrogen compound (GO:0010243),3/51,0.47268752481329424,1,0,0,1.176470588235294,0.881553803378603,NR1H4;TRIM25;UBXN6
regulation of telomere maintenance via telomerase (GO:0032210),3/51,0.47268752481329424,1,0,0,1.176470588235294,0.881553803378603,TNKS2;PNKP;FBXO4
cellular response to insulin stimulus (GO:0032869),6/110,0.4734883847029237,1,0,0,1.0909090909090908,0.8155940698683591,RAB31;PKM;TBC1D4;PIK3R1;SOGA1;FOXO1
cellular response to peptide hormone stimulus (GO:0071375),6/110,0.4734883847029237,1,0,0,1.0909090909090908,0.8155940698683591,RAB31;PKM;TBC1D4;GCGR;PIK3R1;FOXO1
generation of neurons (GO:0048699),7/130,0.47572414988888423,1,0,0,1.0769230769230769,0.8000645797585316,PER2;NGRN;CASP3;WNT16;ASCL2;RUNX2;POU4F2
recombinational repair (GO:0000725),4/71,0.47732691074516864,1,0,0,1.1267605633802817,0.8332999159019496,RNF138;HUS1;POLK;SPIDR
negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436),4/71,0.47732691074516864,1,0,0,1.1267605633802817,0.8332999159019496,PSMB6;PSMB3;ANAPC10;ANAPC11
chemical synaptic transmission (GO:0007268),15/289,0.4786650407120942,1,0,0,1.0380622837370241,0.7647967628604242,GABBR2;RIC3;CHRNA3;GRID2;OR10H3;GAD1;TACR2;GPR1;NRXN2;SLC1A6;GRM3;GABRR2;HTR6;PMP22;PRLHR
7-methylguanosine mRNA capping (GO:0006370),2/32,0.4801831856912929,1,0,0,1.25,0.9169845137852034,CCNH;GTF2H1
cellular response to amino acid stimulus (GO:0071230),2/32,0.4801831856912929,1,0,0,1.25,0.9169845137852034,SPAAR;SESN2
regulation of glutamate receptor signaling pathway (GO:1900449),2/32,0.4801831856912929,1,0,0,1.25,0.9169845137852034,NETO1;CACNG5
ceramide biosynthetic process (GO:0046513),2/32,0.4801831856912929,1,0,0,1.25,0.9169845137852034,B3GALT4;ALOX12B
protein trimerization (GO:0070206),2/32,0.4801831856912929,1,0,0,1.25,0.9169845137852034,HTRA2;MIF
negative regulation of BMP signaling pathway (GO:0030514),2/32,0.4801831856912929,1,0,0,1.25,0.9169845137852034,SPART;BMPER
7-methylguanosine RNA capping (GO:0009452),2/32,0.4801831856912929,1,0,0,1.25,0.9169845137852034,CCNH;GTF2H1
positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),2/32,0.4801831856912929,1,0,0,1.25,0.9169845137852034,CYBA;MIF
purine ribonucleoside triphosphate metabolic process (GO:0009205),2/32,0.4801831856912929,1,0,0,1.25,0.9169845137852034,CTNS;NADK
negative regulation of fat cell differentiation (GO:0045599),2/32,0.4801831856912929,1,0,0,1.25,0.9169845137852034,BBS12;FOXO1
regulation of nitric oxide biosynthetic process (GO:0045428),2/32,0.4801831856912929,1,0,0,1.25,0.9169845137852034,HSP90AB1;PTGIS
global genome nucleotide-excision repair (GO:0070911),2/32,0.4801831856912929,1,0,0,1.25,0.9169845137852034,ERCC1;GTF2H1
lipid transport (GO:0006869),5/91,0.48023571472567267,1,0,0,1.0989010989010988,0.8060200255732013,PRELID2;OSBPL8;NR1H4;PCTP;MFSD2A
regulation of cell-matrix adhesion (GO:0001952),3/52,0.4856142127878605,1,0,0,1.1538461538461537,0.8334701205650645,NF1;HOXA7;GPM6B
regulation of DNA binding (GO:0051101),3/52,0.4856142127878605,1,0,0,1.1538461538461537,0.8334701205650645,NFKBIA;IFI16;BCL3
DNA strand elongation (GO:0022616),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,RFC4
response to iron ion (GO:0010039),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,BMP6
positive regulation of histone H3-K4 methylation (GO:0051571),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,KMT2A
sodium ion export from cell (GO:0036376),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,ATP4A
regulation of granulocyte chemotaxis (GO:0071622),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,RARRES2
mitochondrial genome maintenance (GO:0000002),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,LONP1
regulation of lymphocyte activation (GO:0051249),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,LAT
atrial cardiac muscle cell action potential (GO:0086014),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,KCNA5
glucosamine-containing compound metabolic process (GO:1901071),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,PGM3
regulation of cell aging (GO:0090342),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,MIF
DNA replication-independent nucleosome organization (GO:0034724),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,IPO4
positive regulation of cellular carbohydrate metabolic process (GO:0010676),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,SLC45A3
negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,SOCS4
mRNA cleavage involved in mRNA processing (GO:0098787),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,FIP1L1
regulation of macromolecule biosynthetic process (GO:0010556),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,MITF
positive regulation of T cell mediated cytotoxicity (GO:0001916),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,XCL1
sodium ion export (GO:0071436),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,ATP4A
positive regulation of actin nucleation (GO:0051127),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,WHAMM
regulation of axon guidance (GO:1902667),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,POU4F2
regulation of macrophage differentiation (GO:0045649),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,INHBA
cellular potassium ion homeostasis (GO:0030007),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,ATP4A
phosphate ion transport (GO:0006817),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,SLC20A1
synaptic vesicle localization (GO:0097479),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,TMEM230
regulation of execution phase of apoptosis (GO:1900117),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,PTGIS
ER-associated misfolded protein catabolic process (GO:0071712),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,UGGT1
positive regulation of muscle contraction (GO:0045933),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,TACR2
negative regulation of reactive oxygen species biosynthetic process (GO:1903427),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,PTGIS
RNA interference (GO:0016246),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,MRPL44
nucleotide metabolic process (GO:0009117),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,PNKP
diacylglycerol metabolic process (GO:0046339),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,DGKZ
regulation of T cell cytokine production (GO:0002724),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,XCL1
glomerular visceral epithelial cell differentiation (GO:0072112),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,BASP1
negative regulation of chemokine production (GO:0032682),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,GSTP1
response to fatty acid (GO:0070542),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,NR1H4
mitotic DNA integrity checkpoint (GO:0044774),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,HUS1
ribonucleoprotein complex disassembly (GO:0032988),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,LIME1
pre-miRNA processing (GO:0031054),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,MRPL44
glycoprotein biosynthetic process (GO:0009101),4/72,0.48826565745953704,1,0,0,1.111111111111111,0.7965507124555724,SERP2;COG3;B3GALT4;ALG10B
negative regulation of cysteine-type endopeptidase activity (GO:2000117),4/72,0.48826565745953704,1,0,0,1.111111111111111,0.7965507124555724,IFI16;LAMP3;CARD18;NAIP
regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439),4/72,0.48826565745953704,1,0,0,1.111111111111111,0.7965507124555724,PSMB6;PSMB3;ANAPC10;ANAPC11
Golgi vesicle transport (GO:0048193),14/271,0.4891014448178256,1,0,0,1.033210332103321,0.7389369006425444,DCTN6;DCTN5;PGAP1;TMED10;DCTN1;COG3;COPZ1;YIF1A;BET1L;GOLGA5;RER1;NUDT19;KDELR3;WHAMM
"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",6/112,0.49101551898111034,1,0,0,1.0714285714285714,0.7620852265724269,UPF2;PYM1;RPL24;RPL39;RPS21;RPS13
inflammatory response (GO:0006954),13/252,0.4944560974084455,1,0,0,1.0317460317460316,0.7266555458225812,HDAC4;CEBPB;PTGER2;TNFRSF18;STAT3;CYBA;TNFRSF11A;CXCL3;PRDX5;HRH4;CARD18;XCL1;LAT
positive regulation of adenylate cyclase activity (GO:0045762),2/33,0.496510840077104,1,0,0,1.2121212121212122,0.8486666215153239,CAP1;NF1
"chemical synaptic transmission, postsynaptic (GO:0099565)",2/33,0.496510840077104,1,0,0,1.2121212121212122,0.8486666215153239,CHRNA3;GRID2
negative regulation of neurogenesis (GO:0050768),2/33,0.496510840077104,1,0,0,1.2121212121212122,0.8486666215153239,NF1;HOOK3
regulation of T cell differentiation (GO:0045580),2/33,0.496510840077104,1,0,0,1.2121212121212122,0.8486666215153239,TNFRSF18;SOD1
negative regulation of mitochondrion organization (GO:0010823),2/33,0.496510840077104,1,0,0,1.2121212121212122,0.8486666215153239,VAT1;SLC25A5
neural tube closure (GO:0001843),2/33,0.496510840077104,1,0,0,1.2121212121212122,0.8486666215153239,FUZ;GRHL3
response to exogenous dsRNA (GO:0043330),2/33,0.496510840077104,1,0,0,1.2121212121212122,0.8486666215153239,IFIH1;RALB
regulation of autophagosome assembly (GO:2000785),2/33,0.496510840077104,1,0,0,1.2121212121212122,0.8486666215153239,RALB;PHF23
cellular response to glucose starvation (GO:0042149),2/33,0.496510840077104,1,0,0,1.2121212121212122,0.8486666215153239,IFI16;SESN2
mRNA stabilization (GO:0048255),2/33,0.496510840077104,1,0,0,1.2121212121212122,0.8486666215153239,ANGEL2;DAZ4
regulation of postsynaptic membrane potential (GO:0060078),2/33,0.496510840077104,1,0,0,1.2121212121212122,0.8486666215153239,CHRNA3;GRID2
positive regulation of catalytic activity (GO:0043085),2/33,0.496510840077104,1,0,0,1.2121212121212122,0.8486666215153239,FTMT;SOD1
establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),2/33,0.496510840077104,1,0,0,1.2121212121212122,0.8486666215153239,PDZD11;CRB3
exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay (GO:0043928),2/33,0.496510840077104,1,0,0,1.2121212121212122,0.8486666215153239,EXOSC7;LSM1
regulation of DNA recombination (GO:0000018),2/33,0.496510840077104,1,0,0,1.2121212121212122,0.8486666215153239,RTEL1;SPIDR
positive regulation of Notch signaling pathway (GO:0045747),2/33,0.496510840077104,1,0,0,1.2121212121212122,0.8486666215153239,STAT3;EPN2
cellular glucose homeostasis (GO:0001678),2/33,0.496510840077104,1,0,0,1.2121212121212122,0.8486666215153239,PIK3R1;FOXO1
regulation of neurotransmitter receptor activity (GO:0099601),2/33,0.496510840077104,1,0,0,1.2121212121212122,0.8486666215153239,NETO1;CACNG5
positive regulation of organelle organization (GO:0010638),2/33,0.496510840077104,1,0,0,1.2121212121212122,0.8486666215153239,CEP295;HTRA2
protein N-linked glycosylation (GO:0006487),4/73,0.49910951364629225,1,0,0,1.095890410958904,0.7615668395449564,PGM3;UBE2G2;UGGT1;ASGR2
nucleic acid phosphodiester bond hydrolysis (GO:0090305),4/73,0.49910951364629225,1,0,0,1.095890410958904,0.7615668395449564,RFC4;ERI1;ERCC1;GTF2H1
positive regulation of proteasomal protein catabolic process (GO:1901800),4/73,0.49910951364629225,1,0,0,1.095890410958904,0.7615668395449564,DDRGK1;RNF138;ARIH2;ECSCR
cotranslational protein targeting to membrane (GO:0006613),5/93,0.4994819883860412,1,0,0,1.075268817204301,0.7464341299256831,SRPRA;RPL24;RPL39;RPS21;RPS13
cellular response to organic substance (GO:0071310),7/133,0.49985934680088157,1,0,0,1.0526315789473684,0.7299247647707883,STAT5B;IL1RL2;STAT3;NR1H4;HTRA2;PTPN7;POU4F2
Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),7/133,0.49985934680088157,1,0,0,1.0526315789473684,0.7299247647707883,ACTR2;PAK1;HSP90AB1;ARPC1B;ELMO1;ELMO2;PIK3R1
cytokine-mediated signaling pathway (GO:0019221),32/633,0.5006562420148305,1,0,0,1.0110584518167456,0.6994861872576856,EBI3;CUL1;TNFRSF11A;PIK3R1;CXCL3;FOXO1;CRKL;OASL;PSMB6;DUOX1;IL1RL2;FLRT2;PSMB3;CASP3;TRIM25;HLA-DQA2;SOCS4;STAT5B;SERPINB2;EDN2;TNFRSF18;STAT3;MIF;YWHAZ;ST18;ASPN;SOD1;IL22RA1;NFKBIA;LTA;XCL1;HLA-DRB1
nuclear-transcribed mRNA catabolic process (GO:0000956),9/174,0.5070452262105105,1,0,0,1.0344827586206895,0.7025742163430991,UPF2;EXOSC7;LSM1;PYM1;RPL24;RPL39;RPS21;RPS13;DIS3L2
Fc-gamma receptor signaling pathway (GO:0038094),7/134,0.5078263565499047,1,0,0,1.044776119402985,0.7079567094869852,ACTR2;PAK1;HSP90AB1;ARPC1B;ELMO1;ELMO2;PIK3R1
cellular response to fibroblast growth factor stimulus (GO:0044344),5/94,0.509002443009079,1,0,0,1.0638297872340425,0.7184068753385349,FGF17;FLRT2;ANOS1;FGF3;FGF22
"regulation of gene expression, epigenetic (GO:0040029)",4/74,0.5098528753630284,1,0,0,1.0810810810810811,0.7282519724998587,HDAC4;SPI1;IFI16;POLR1B
cellular response to nutrient levels (GO:0031669),3/54,0.5109953414593842,1,0,0,1.111111111111111,0.7459942281531415,RALB;ZFYVE1;FOXO1
cytoplasmic translation (GO:0002181),3/54,0.5109953414593842,1,0,0,1.111111111111111,0.7459942281531415,RPL24;RPL39;RPS21
neuron cell-cell adhesion (GO:0007158),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,NRXN2
ribonucleoside monophosphate biosynthetic process (GO:0009156),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,IMPDH2
mitotic cell cycle arrest (GO:0071850),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,MCPH1
acetyl-CoA metabolic process (GO:0006084),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,HMGCS1
lipid particle organization (GO:0034389),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,PLIN5
positive regulation of osteoclast differentiation (GO:0045672),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,POU4F2
regulation of lipase activity (GO:0060191),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,PLIN5
regulation of nucleocytoplasmic transport (GO:0046822),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,RBM4
regulation of phosphate metabolic process (GO:0019220),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,RICTOR
regulation of platelet aggregation (GO:0090330),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,ALOX12
positive regulation of response to cytokine stimulus (GO:0060760),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,IFIH1
negative regulation of Rho protein signal transduction (GO:0035024),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,STMN1
regulation of monocyte differentiation (GO:0045655),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,HOXA7
modified amino acid transport (GO:0072337),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,CTNS
negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,MIF
thymus development (GO:0048538),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,SOD1
oligodendrocyte differentiation (GO:0048709),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,SOX10
hydrogen peroxide catabolic process (GO:0042744),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,PRDX5
cell migration involved in sprouting angiogenesis (GO:0002042),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,EPHB4
regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle (GO:0031657),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,CDK4
response to ethanol (GO:0045471),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,SOD1
monosaccharide transport (GO:0015749),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,SLC45A3
"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,HIC1
oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,ALG2
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,EBI3
glycoside metabolic process (GO:0016137),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,GBA2
regulation of synapse organization (GO:0050807),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,FXR2
purine nucleotide catabolic process (GO:0006195),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,HINT1
positive regulation of heart rate (GO:0010460),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,EDN2
histone H4-K16 acetylation (GO:0043984),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,KMT2A
regulation of protein modification by small protein conjugation or removal (GO:1903320),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,HSP90AB1
positive regulation of transporter activity (GO:0032411),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,KMT2A
regulation of response to interferon-gamma (GO:0060330),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,HSP90AB1
estrogen metabolic process (GO:0008210),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,UGT1A1
positive regulation of smooth muscle contraction (GO:0045987),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,TACR2
apoptotic mitochondrial changes (GO:0008637),2/34,0.5125071338352726,1,0,0,1.176470588235294,0.7864007628092599,GGCT;HSPD1
response to amino acid (GO:0043200),2/34,0.5125071338352726,1,0,0,1.176470588235294,0.7864007628092599,SPAAR;SESN2
negative regulation of T cell activation (GO:0050868),2/34,0.5125071338352726,1,0,0,1.176470588235294,0.7864007628092599,CEBPB;TNFAIP8L2
regulation of axon extension (GO:0030516),2/34,0.5125071338352726,1,0,0,1.176470588235294,0.7864007628092599,RNF6;POU4F2
response to glucagon (GO:0033762),2/34,0.5125071338352726,1,0,0,1.176470588235294,0.7864007628092599,GCGR;CRY1
regulation of gene expression (GO:0010468),52/1037,0.5125684668320631,1,0,0,1.0028929604628736,0.6702544092543148,USP36;NAB2;HINT1;DACH1;SALL4;LAMP3;ZIK1;ZNF483;TLE1;SP110;OSR1;MITF;MIF;WNT16;HIC1;UBTFL1;RBL1;ZNF836;HDAC4;CEBPB;KDM3A;ZNF471;ZNF350;MYCBP;CRABP2;RNF6;HOXD13;ALOX12B;ASCL2;HMGXB4;IFI16;TBX22;DDRGK1;PAK6;HIVEP3;ZNF304;GPBP1L1;ZNF543;ZNF221;MSR1;VDR;ASCC1;NFYB;STAT3;ESRRB;INHBA;MAFB;FUBP3;CDK4;ZNF417;ZNF773;ZNF354C
Fc receptor mediated stimulatory signaling pathway (GO:0002431),7/135,0.5157499226195729,1,0,0,1.037037037037037,0.6866567317716777,ACTR2;PAK1;HSP90AB1;ARPC1B;ELMO1;ELMO2;PIK3R1
epithelium development (GO:0060429),6/115,0.5169320021309768,1,0,0,1.0434782608695652,0.6885328038765365,SULT1B1;CBR1;DHRS9;VDR;OSR1;GSTA1
transcription elongation from RNA polymerase II promoter (GO:0006368),5/95,0.5184489993734346,1,0,0,1.0526315789473684,0.6914880189626921,CCNT2;CCNH;GTF2H1;ELOA3;MLLT3
interleukin-1-mediated signaling pathway (GO:0070498),5/95,0.5184489993734346,1,0,0,1.0526315789473684,0.6914880189626921,PSMB6;NFKBIA;PSMB3;CUL1;ST18
C-terminal protein lipidation (GO:0006501),4/75,0.520490485053102,1,0,0,1.0666666666666667,0.6965159162578138,NTM;LSAMP;ALPL;LYPD4
proteasomal protein catabolic process (GO:0010498),12/237,0.5242381291495107,1,0,0,1.0126582278481011,0.6539840536183389,PSMB6;PCNP;FBXW5;KCTD10;PSMB3;CUL1;TRIM25;RNF6;UBE2A;ANAPC10;UBXN6;ANAPC11
sphingolipid metabolic process (GO:0006665),6/116,0.5254581276778527,1,0,0,1.0344827586206895,0.6656739028524064,ALDH3A2;GM2A;ALOX12B;ARSD;GBA2;SUMF1
chromatin remodeling (GO:0006338),6/116,0.5254581276778527,1,0,0,1.0344827586206895,0.6656739028524064,TADA2B;HDAC4;UBTFL1;HMGXB4;SP110;PADI2
positive regulation of protein metabolic process (GO:0051247),5/96,0.5278178232072942,1,0,0,1.0416666666666667,0.6656292568931363,NFKBIA;NR1H2;ASB9;INHBA;FOXO1
epithelial cell differentiation (GO:0030855),5/96,0.5278178232072942,1,0,0,1.0416666666666667,0.6656292568931363,CBR1;SULT1B1;DHRS9;BASP1;GSTA1
cholesterol biosynthetic process (GO:0006695),2/35,0.5281643594916885,1,0,0,1.1428571428571428,0.7295402934851642,HMGCS1;LSS
regulation of mitochondrial membrane potential (GO:0051881),2/35,0.5281643594916885,1,0,0,1.1428571428571428,0.7295402934851642,SPART;SOD1
positive regulation of telomerase activity (GO:0051973),2/35,0.5281643594916885,1,0,0,1.1428571428571428,0.7295402934851642,HSP90AB1;PNKP
negative regulation of tumor necrosis factor production (GO:0032720),2/35,0.5281643594916885,1,0,0,1.1428571428571428,0.7295402934851642,GSTP1;NR1H4
carbohydrate catabolic process (GO:0016052),2/35,0.5281643594916885,1,0,0,1.1428571428571428,0.7295402934851642,PKM;ALDOB
positive regulation of osteoblast differentiation (GO:0045669),2/35,0.5281643594916885,1,0,0,1.1428571428571428,0.7295402934851642,BMP6;RUNX2
protein kinase B signaling (GO:0043491),2/35,0.5281643594916885,1,0,0,1.1428571428571428,0.7295402934851642,AKT1S1;FOXO1
double-strand break repair via homologous recombination (GO:0000724),4/76,0.531017425175643,1,0,0,1.0526315789473684,0.666274150005563,RNF138;HUS1;POLK;SPIDR
regulation of hematopoietic stem cell differentiation (GO:1902036),4/76,0.531017425175643,1,0,0,1.0526315789473684,0.666274150005563,PSMB6;SPI1;KMT2A;PSMB3
positive regulation of JNK cascade (GO:0046330),4/76,0.531017425175643,1,0,0,1.0526315789473684,0.666274150005563,PAK1;CARD9;TNFRSF11A;WNT16
response to interleukin-1 (GO:0070555),4/76,0.531017425175643,1,0,0,1.0526315789473684,0.666274150005563,HDAC4;PTGIS;XCL1;TNFRSF11A
cellular defense response (GO:0006968),3/56,0.5356989644779965,1,0,0,1.0714285714285714,0.6687674026318335,FOSL1;IL1RL2;CCR6
phosphatidylinositol-mediated signaling (GO:0048015),3/56,0.5356989644779965,1,0,0,1.0714285714285714,0.6687674026318335,NF1;PIK3C2G;PIK3R1
positive regulation of peptidyl-lysine acetylation (GO:2000758),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,TADA2B
positive regulation of alpha-beta T cell activation (GO:0046635),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,EBI3
NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,PTGIS
membrane repolarization during cardiac muscle cell action potential (GO:0086013),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,KCNA5
fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,ACOXL
apoptotic DNA fragmentation (GO:0006309),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,CASP3
retinoic acid metabolic process (GO:0042573),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,UGT1A1
vitamin D metabolic process (GO:0042359),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,VDR
selective autophagy (GO:0061912),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,STBD1
maintenance of protein location in nucleus (GO:0051457),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,BCL3
regulation of B cell differentiation (GO:0045577),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,INHBA
autonomic nervous system development (GO:0048483),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,NF1
positive regulation of mesonephros development (GO:0061213),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,BASP1
"protein localization to chromosome, telomeric region (GO:0070198)",1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,TNKS2
"phototransduction, visible light (GO:0007603)",1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,MAPRE2
positive regulation of CREB transcription factor activity (GO:0032793),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,EPHA5
L-alpha-amino acid transmembrane transport (GO:1902475),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,SLC1A6
G-protein coupled glutamate receptor signaling pathway (GO:0007216),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,GRM3
regulation of mitotic metaphase/anaphase transition (GO:0030071),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,ANAPC11
positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,CARD9
positive regulation of cytokine production involved in immune response (GO:0002720),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,XCL1
regulation of interleukin-4 production (GO:0032673),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,CEBPB
regulation of centriole replication (GO:0046599),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,MDM1
negative regulation of interleukin-2 production (GO:0032703),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,XCL1
regulation of cell-substrate junction assembly (GO:0090109),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,GPM6B
mitotic chromosome condensation (GO:0007076),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,PHF23
negative regulation of lipid catabolic process (GO:0050995),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,PLIN5
pyrimidine-containing compound metabolic process (GO:0072527),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,SLC19A3
positive regulation of phosphoprotein phosphatase activity (GO:0032516),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,HSP90AB1
cellular biogenic amine biosynthetic process (GO:0042401),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,SMS
fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,ACOXL
ganglioside metabolic process (GO:0001573),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,B3GALT4
negative regulation of signal transduction by p53 class mediator (GO:1901797),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,MIF
negative regulation of platelet activation (GO:0010544),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,ALOX12
negative regulation of cytokine production involved in immune response (GO:0002719),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,XCL1
positive regulation of interleukin-4 production (GO:0032753),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,CEBPB
microtubule depolymerization (GO:0007019),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,STMN1
negative regulation of RNA metabolic process (GO:0051253),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,RPS13
positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,ADGRB1
toll-like receptor 4 signaling pathway (GO:0034142),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,NR1H4
regulation of T cell mediated cytotoxicity (GO:0001914),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,XCL1
regulation of fertilization (GO:0080154),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,LHFPL2
protein targeting to peroxisome (GO:0006625),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,PEX19
cytoplasmic sequestering of protein (GO:0051220),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,NFKBIA
base conversion or substitution editing (GO:0016553),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,APOBEC3B
cellular sodium ion homeostasis (GO:0006883),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,ATP4A
establishment of protein localization to endoplasmic reticulum (GO:0072599),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,SRPRA
nucleobase-containing small molecule catabolic process (GO:0034656),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,ENTPD6
protein targeting to ER (GO:0045047),5/97,0.5371052771771576,1,0,0,1.0309278350515463,0.6407846977351693,SRPRA;RPL24;RPL39;RPS21;RPS13
negative regulation of ubiquitin protein ligase activity (GO:1904667),4/77,0.541429111359833,1,0,0,1.0389610389610389,0.6374474106254083,PSMB6;PSMB3;ANAPC10;ANAPC11
response to ionizing radiation (GO:0010212),4/77,0.541429111359833,1,0,0,1.0389610389610389,0.6374474106254083,IFI16;HUS1;USP28;SPIDR
regulation of hematopoietic progenitor cell differentiation (GO:1901532),4/77,0.541429111359833,1,0,0,1.0389610389610389,0.6374474106254083,PSMB6;SPI1;KMT2A;PSMB3
regulation of smoothened signaling pathway (GO:0008589),2/36,0.5434764066615513,1,0,0,1.111111111111111,0.6775210926327332,OTX2;FUZ
organophosphate biosynthetic process (GO:0090407),2/36,0.5434764066615513,1,0,0,1.111111111111111,0.6775210926327332,IPPK;PCYT2
histone deacetylation (GO:0016575),2/36,0.5434764066615513,1,0,0,1.111111111111111,0.6775210926327332,HDAC4;PER2
regulation of blood circulation (GO:1903522),2/36,0.5434764066615513,1,0,0,1.111111111111111,0.6775210926327332,CYP2J2;PER2
vesicle-mediated transport in synapse (GO:0099003),2/36,0.5434764066615513,1,0,0,1.111111111111111,0.6775210926327332,SYT2;TMEM230
axonal transport (GO:0098930),2/36,0.5434764066615513,1,0,0,1.111111111111111,0.6775210926327332,FXR2;SOD1
regulation of ubiquitin protein ligase activity (GO:1904666),2/36,0.5434764066615513,1,0,0,1.111111111111111,0.6775210926327332,ANAPC10;ANAPC11
glutamate receptor signaling pathway (GO:0007215),2/36,0.5434764066615513,1,0,0,1.111111111111111,0.6775210926327332,GRM3;GRID2
secondary alcohol biosynthetic process (GO:1902653),2/36,0.5434764066615513,1,0,0,1.111111111111111,0.6775210926327332,HMGCS1;LSS
regulation of protein phosphorylation (GO:0001932),13/261,0.546078898833694,1,0,0,0.9961685823754788,0.6026738340336778,RALB;RARRES2;INHBA;BMP6;SOD1;PAK1;CCND2;BMPER;SESN2;SPDYE1;PAK6;PPIL4;PAK5
regulation of insulin secretion (GO:0050796),5/98,0.5463079186398003,1,0,0,1.0204081632653061,0.616910723108701,EPHA5;PER2;NR1H4;KCNA5;SLC25A5
positive regulation of cell death (GO:0010942),3/57,0.5477812798713707,1,0,0,1.0526315789473684,0.6335570484502631,HTRA2;CIDEB;POU4F2
regulation of neurogenesis (GO:0050767),3/57,0.5477812798713707,1,0,0,1.0526315789473684,0.6335570484502631,PER2;HOOK3;ASCL2
negative regulation of apoptotic process (GO:0043066),24/485,0.5511223976764702,1,0,0,0.9896907216494845,0.5896561060495205,EPHA5;TLE1;GSTP1;OSR1;STAT3;NR1H4;ALOX12;MIF;PIK3R1;YWHAZ;FOXO1;HSPD1;SOD1;NFKBIA;PRDX5;CCND2;DDRGK1;LAMP3;CASP3;BCL3;ZNF304;EPHB4;NAIP;AAMDC
positive regulation of translation (GO:0045727),4/78,0.5517212852986342,1,0,0,1.0256410256410255,0.6099613109295229,FXR2;BCL3;DAZ4;PYM1
negative regulation of inflammatory response (GO:0050728),4/78,0.5517212852986342,1,0,0,1.0256410256410255,0.6099613109295229,PTGIS;GSTP1;NR1H4;TNFAIP8L2
organonitrogen compound biosynthetic process (GO:1901566),9/181,0.555066973103549,1,0,0,0.9944751381215469,0.5854141991509727,ALDH3A2;GSTP1;GSTA1;ASL;PCTP;INHBA;ASPA;LPIN2;MFSD2A
steroid metabolic process (GO:0008202),5/99,0.5554224977737025,1,0,0,1.01010101010101,0.5939658561566864,UGT1A1;DHRS9;VDR;GBA2;LSS
protein monoubiquitination (GO:0006513),2/37,0.5584386214472209,1,0,0,1.0810810810810811,0.62984925993825025,TRIM25;KLHL22
base-excision repair (GO:0006284),2/37,0.5584386214472209,1,0,0,1.0810810810810811,0.62984925993825025,LIG1;POLK
regulation of regulated secretory pathway (GO:1903305),2/37,0.5584386214472209,1,0,0,1.0810810810810811,0.62984925993825025,SYT2;SYT9
regulation of dendrite development (GO:0050773),2/37,0.5584386214472209,1,0,0,1.0810810810810811,0.62984925993825025,CHRNA3;FXR2
negative regulation of G0 to G1 transition (GO:0070317),2/37,0.5584386214472209,1,0,0,1.0810810810810811,0.62984925993825025,APAF1;MGA
negative regulation of Ras protein signal transduction (GO:0046580),2/37,0.5584386214472209,1,0,0,1.0810810810810811,0.62984925993825025,STMN1;NF1
rRNA processing (GO:0006364),10/202,0.5586992801002776,1,0,0,0.9900990099009901,0.5763801099448563,EXOSC7;WDR37;ERI1;TEX10;SBDS;RPL24;RPL39;RPS21;RPS13;DIS3L2
DNA replication (GO:0006260),6/120,0.558921512029944,1,0,0,1,0.5817462235027698,HELB;RFC4;GRWD1;PNKP;HUS1;POLK
negative regulation of growth (GO:0045926),6/120,0.558921512029944,1,0,0,1,0.5817462235027698,NME6;SESN2;DACT3;INHBA;CRLF3;SIPA1
protein localization to microtubule organizing center (GO:1905508),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,HOOK3
positive regulation of epithelial cell apoptotic process (GO:1904037),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,ECSCR
regulation of actin nucleation (GO:0051125),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,WHAMM
negative regulation of NF-kappaB import into nucleus (GO:0042347),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,NFKBIA
postsynaptic membrane organization (GO:0001941),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,NRXN2
regulation of systemic arterial blood pressure by hormone (GO:0001990),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,EDN2
dendritic cell chemotaxis (GO:0002407),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,CCR6
positive regulation of secretion (GO:0051047),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,ALOX12B
fibrinolysis (GO:0042730),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,SERPINB2
glucose transmembrane transport (GO:1904659),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,SLC2A3
protein transport along microtubule (GO:0098840),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,RABL2B
embryonic digit morphogenesis (GO:0042733),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,OSR1
hyaluronan catabolic process (GO:0030214),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,LYVE1
regulation of cell cycle phase transition (GO:1901987),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,NEK11
activation of NF-kappaB-inducing kinase activity (GO:0007250),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,CARD10
cytoplasmic sequestering of transcription factor (GO:0042994),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,NFKBIA
sympathetic nervous system development (GO:0048485),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,NF1
negative regulation of striated muscle cell differentiation (GO:0051154),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,HDAC4
regulation of histone H3-K4 methylation (GO:0051569),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,KMT2A
regulation of energy homeostasis (GO:2000505),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,FOXO1
negative regulation of transcription regulatory region DNA binding (GO:2000678),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,PER2
negative regulation of translational initiation (GO:0045947),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,RBM4
positive regulation of immune system process (GO:0002684),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,TNFRSF18
glutamine family amino acid catabolic process (GO:0009065),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,GAD1
positive regulation of macrophage derived foam cell differentiation (GO:0010744),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,MSR1
hexose transport (GO:0008645),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,SLC45A3
positive regulation of myotube differentiation (GO:0010831),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,ADGRB1
positive regulation of cilium assembly (GO:0045724),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,FUZ
miRNA metabolic process (GO:0010586),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,DIS3L2
T cell migration (GO:0072678),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,CCR6
regulation of SMAD protein import into nucleus (GO:0060390),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,BMP6
positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,CDK4
positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,CCND2
artery development (GO:0060840),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,NF1
regulation of acrosome reaction (GO:0060046),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,ZP4
positive regulation of leukocyte activation (GO:0002696),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,HSPD1
endoplasmic reticulum to cytosol transport (GO:1903513),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,AUP1
myoblast differentiation (GO:0045445),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,EPAS1
inner dynein arm assembly (GO:0036159),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,CFAP100
positive regulation of response to endoplasmic reticulum stress (GO:1905898),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,PIK3R1
negative regulation of mitotic cell cycle phase transition (GO:1901991),4/79,0.561890006637219,1,0,0,1.0126582278481011,0.5837459908567373,PSMB6;RBL1;PSMB3;CUL1
anaphase-promoting complex-dependent catabolic process (GO:0031145),4/79,0.561890006637219,1,0,0,1.0126582278481011,0.5837459908567373,PSMB6;PSMB3;ANAPC10;ANAPC11
activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),4/79,0.561890006637219,1,0,0,1.0126582278481011,0.5837459908567373,APAF1;CASP3;CARD18;HSPD1
negative regulation of programmed cell death (GO:0043069),20/408,0.5692505073521742,1,0,0,0.9803921568627451,0.5523869438965053,EPHA5;CDSN;GSTP1;OSR1;STAT3;NR1H4;MIF;PIK3R1;YWHAZ;FOXO1;HSPD1;NFKBIA;PRDX5;CCND2;DDRGK1;CASP3;BCL3;EPHB4;NAIP;AAMDC
regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),3/59,0.5713815260202666,1,0,0,1.0169491525423728,0.5691845296161483,BMPER;INHBA;BMP6
keratinocyte differentiation (GO:0030216),3/59,0.5713815260202666,1,0,0,1.0169491525423728,0.5691845296161483,CDSN;CASP3;WNT16
cell morphogenesis (GO:0000902),3/59,0.5713815260202666,1,0,0,1.0169491525423728,0.5691845296161483,CAP1;VDR;CDH15
nucleic acid metabolic process (GO:0090304),4/80,0.5719316453053178,1,0,0,1,0.5587357959576575,HNRNPL;LSM8;ERI1;LSM1
NIK/NF-kappaB signaling (GO:0038061),4/80,0.5719316453053178,1,0,0,1,0.5587357959576575,PSMB6;CARD10;PSMB3;CUL1
regulation of protein serine/threonine kinase activity (GO:0071900),4/80,0.5719316453053178,1,0,0,1,0.5587357959576575,CCNT2;RALB;GTF2H1;CDKN3
negative regulation of MAPK cascade (GO:0043409),4/80,0.5719316453053178,1,0,0,1,0.5587357959576575,GSTP1;NF1;RANBP9;FOXO1
negative regulation of defense response (GO:0031348),4/80,0.5719316453053178,1,0,0,1,0.5587357959576575,PTGIS;IFI16;NR1H4;TNFAIP8L2
mitochondrion disassembly (GO:0061726),2/38,0.5730476768580657,1,0,0,1.0526315789473684,0.5860909053082317,FUNDC2;ATG9A
DNA damage checkpoint (GO:0000077),2/38,0.5730476768580657,1,0,0,1.0526315789473684,0.5860909053082317,HUS1;USP28
positive regulation of DNA repair (GO:0045739),2/38,0.5730476768580657,1,0,0,1.0526315789473684,0.5860909053082317,SLF1;SPIDR
regulation of kinase activity (GO:0043549),5/101,0.5733754172932677,1,0,0,0.9900990099009901,0.5507075230503586,EPHA5;RBL1;SPDYE1;EPHB4;SOD1
regulation of mitotic cell cycle phase transition (GO:1901990),9/184,0.5750649119113357,1,0,0,0.9782608695652174,0.5412446944002695,PSMB6;DCTN1;PSMB3;NDE1;CUL1;HAUS5;ANAPC10;ANAPC11;NEK11
glycerophospholipid biosynthetic process (GO:0046474),8/164,0.5794459572335974,1,0,0,0.975609756097561,0.5323735396380541,PCYT2;GPD1;PIK3C2G;PCTP;PIK3R1;LPIN2;MFSD2A;ETNPPL
positive regulation of protein targeting to mitochondrion (GO:1903955),4/81,0.5818428728182232,1,0,0,0.9876543209876543,0.5348689833845679,USP36;ELMOD1;ARIH2;HTRA2
protein catabolic process (GO:0030163),4/81,0.5818428728182232,1,0,0,0.9876543209876543,0.5348689833845679,PSMB6;PSMB3;HTRA2;UBE2G2
regulation of protein sumoylation (GO:0033233),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,HDAC4
positive regulation of cell cycle G2/M phase transition (GO:1902751),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,CDK4
DNA catabolic process (GO:0006308),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,ERI1
response to interferon-alpha (GO:0035455),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,LAMP3
regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,IGFBP6
positive regulation of lymphocyte migration (GO:2000403),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,XCL1
positive regulation of epidermal cell differentiation (GO:0045606),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,VDR
2-oxoglutarate metabolic process (GO:0006103),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,STAT5B
ureteric bud development (GO:0001657),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,OSR1
glycosphingolipid biosynthetic process (GO:0006688),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,B3GALT4
positive regulation of interleukin-6 secretion (GO:2000778),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,IFIH1
preassembly of GPI anchor in ER membrane (GO:0016254),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,PIGA
regulation of lipid catabolic process (GO:0050994),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,RARRES2
regulation of transposition (GO:0010528),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,APOBEC3B
histone H2A ubiquitination (GO:0033522),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,UBE2A
negative regulation of B cell activation (GO:0050869),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,INHBA
regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,SLC25A5
positive regulation of dendrite extension (GO:1903861),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,SYT2
negative regulation of cell development (GO:0010721),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,HOOK3
negative regulation of interleukin-8 production (GO:0032717),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,BCL3
positive regulation of hormone secretion (GO:0046887),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,SNX4
regulation of myelination (GO:0031641),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,NCMAP
N-glycan processing (GO:0006491),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,USF3
negative regulation of reactive oxygen species metabolic process (GO:2000378),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,PLIN5
spindle assembly checkpoint (GO:0071173),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,KLHL22
maturation of 5.8S rRNA (GO:0000460),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,WDR37
negative regulation of stress fiber assembly (GO:0051497),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,STMN1
DNA replication checkpoint (GO:0000076),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,HUS1
peptidyl-lysine trimethylation (GO:0018023),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,KMT2A
rRNA catabolic process (GO:0016075),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,EXOSC7
embryo development ending in birth or egg hatching (GO:0009792),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,RICTOR
response to purine-containing compound (GO:0014074),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,DUOX1
positive regulation of signal transduction by p53 class mediator (GO:1901798),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,HIC1
positive regulation of macrophage activation (GO:0043032),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,HSPD1
macrophage activation (GO:0042116),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,EDN2
neurotrophin signaling pathway (GO:0038179),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,CASP3
regulation of T cell migration (GO:2000404),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,CCR6
regulation of lamellipodium organization (GO:1902743),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,SSH2
synaptic vesicle transport (GO:0048489),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,TMEM230
purine-containing compound metabolic process (GO:0072521),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,TTR
mesonephric tubule development (GO:0072164),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,OSR1
positive regulation of cation transmembrane transport (GO:1904064),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,CTSS
mitotic spindle assembly checkpoint (GO:0007094),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,KLHL22
cellular monovalent inorganic cation homeostasis (GO:0030004),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,ATP4A
mitotic spindle checkpoint (GO:0071174),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,KLHL22
cell chemotaxis (GO:0060326),3/60,0.5828910435264506,1,0,0,1,0.5397549994176116,ELMO2;CCR6;DEFB4A
ncRNA processing (GO:0034470),11/227,0.5860450291204876,1,0,0,0.9691629955947136,0.5178806307843323,EXOSC7;ERI1;TEX10;INTS5;SBDS;RPL24;RPL39;RPS21;RPS13;MRPL44;DIS3L2
negative regulation of protein catabolic process (GO:0042177),2/39,0.5873014514915549,1,0,0,1.0256410256410255,0.5458636358886607,ADGRB1;MDM4
"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",2/39,0.5873014514915549,1,0,0,1.0256410256410255,0.5458636358886607,HNRNPL;RBM4
regulation of G0 to G1 transition (GO:0070316),2/39,0.5873014514915549,1,0,0,1.0256410256410255,0.5458636358886607,APAF1;MGA
inositol lipid-mediated signaling (GO:0048017),2/39,0.5873014514915549,1,0,0,1.0256410256410255,0.5458636358886607,PIK3C2G;PIK3R1
DNA replication-independent nucleosome assembly (GO:0006336),2/39,0.5873014514915549,1,0,0,1.0256410256410255,0.5458636358886607,CENPO;IPO4
mitotic DNA damage checkpoint (GO:0044773),2/39,0.5873014514915549,1,0,0,1.0256410256410255,0.5458636358886607,HUS1;NEK11
cellular response to amino acid starvation (GO:0034198),2/39,0.5873014514915549,1,0,0,1.0256410256410255,0.5458636358886607,SESN2;RNF152
C-terminal protein amino acid modification (GO:0018410),4/82,0.591620653904691,1,0,0,0.975609756097561,0.5120874505494942,NTM;LSAMP;ALPL;LYPD4
regulation of cellular ketone metabolic process (GO:0010565),3/61,0.5942021207725078,1,0,0,0.9836065573770492,0.5120023739386589,PSMB6;PSMB3;NR1H4
regulation of tumor necrosis factor production (GO:0032680),3/61,0.5942021207725078,1,0,0,0.9836065573770492,0.5120023739386589,GSTP1;CYBA;MIF
positive regulation of cellular amide metabolic process (GO:0034250),3/61,0.5942021207725078,1,0,0,0.9836065573770492,0.5120023739386589,FXR2;BCL3;PYM1
proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),14/291,0.5977003096216139,1,0,0,0.9621993127147767,0.4952110839741616,FBXW5;CUL1;RNF6;UBE2G2;AUP1;UBE2A;ANAPC10;ANAPC11;PSMB6;PCNP;NEMF;KCTD10;PSMB3;FBXO4
skeletal system development (GO:0001501),7/146,0.599384156291076,1,0,0,0.958904109589041,0.4908175204714428,POSTN;DLX6;ALPL;HAPLN3;ETS2;BMP6;HAPLN2
regulation of cellular localization (GO:0060341),2/40,0.60119891797304,1,0,0,1,0.5088294208836465,EPHA5;NR1H4
cognition (GO:0050890),2/40,0.60119891797304,1,0,0,1,0.5088294208836465,NF1;CTNS
autophagy of mitochondrion (GO:0000422),2/40,0.60119891797304,1,0,0,1,0.5088294208836465,FUNDC2;ATG9A
sterol biosynthetic process (GO:0016126),2/40,0.60119891797304,1,0,0,1,0.5088294208836465,HMGCS1;LSS
response to peptide hormone (GO:0043434),2/40,0.60119891797304,1,0,0,1,0.5088294208836465,REG1A;CRY1
negative regulation of ERK1 and ERK2 cascade (GO:0070373),2/40,0.60119891797304,1,0,0,1,0.5088294208836465,GSTP1;RANBP9
regulation of intracellular transport (GO:0032386),2/40,0.60119891797304,1,0,0,1,0.5088294208836465,RBM4;NDEL1
regulation of ATPase activity (GO:0043462),2/40,0.60119891797304,1,0,0,1,0.5088294208836465,VMA21;ALDOB
JAK-STAT cascade (GO:0007259),2/40,0.60119891797304,1,0,0,1,0.5088294208836465,STAT5B;STAT3
positive regulation of homeostatic process (GO:0032846),4/83,0.6012622374752512,1,0,0,0.963855421686747,0.4903364861494962,STAT5B;RTEL1;STAT3;INHBA
glucan catabolic process (GO:0009251),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,STBD1
regulation of adherens junction organization (GO:1903391),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,GPM6B
long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,ACSL6
"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,CACNG5
regulation of amyloid-beta formation (GO:1902003),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,TMED10
protein localization to centrosome (GO:0071539),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,HOOK3
receptor localization to synapse (GO:0097120),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,CACNG5
regulation of spindle organization (GO:0090224),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,DCTN1
regulation of keratinocyte proliferation (GO:0010837),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,VDR
negative regulation of osteoclast differentiation (GO:0045671),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,MAFB
release of cytochrome c from mitochondria (GO:0001836),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,GGCT
positive regulation of lipid catabolic process (GO:0050996),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,PLIN5
maintenance of protein localization in organelle (GO:0072595),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,BCL3
regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,BMP6
establishment or maintenance of apical/basal cell polarity (GO:0035088),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,CRB3
negative regulation of RNA splicing (GO:0033119),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,RPS13
positive regulation of metabolic process (GO:0009893),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,PIGA
ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,MVB12A
"retrograde protein transport, ER to cytosol (GO:0030970)",1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,AUP1
regulation of cardiac muscle cell membrane repolarization (GO:0099623),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,KCNA5
dolichol-linked oligosaccharide biosynthetic process (GO:0006488),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,ALG2
glycogen catabolic process (GO:0005980),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,STBD1
acute-phase response (GO:0006953),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,CEBPB
negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,HTRA2
DNA conformation change (GO:0071103),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,HHEX
blood vessel endothelial cell migration (GO:0043534),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,EPHB4
regulation of cellular response to growth factor stimulus (GO:0090287),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,OTX2
regulation of microtubule polymerization or depolymerization (GO:0031110),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,STMN1
regulation of peptidase activity (GO:0052547),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,ECM1
glyceraldehyde-3-phosphate metabolic process (GO:0019682),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,ALDOB
cell-substrate adherens junction assembly (GO:0007045),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,WHAMM
regulation of dendrite extension (GO:1903859),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,SYT2
snRNA metabolic process (GO:0016073),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,INTS5
response to organophosphorus (GO:0046683),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,DUOX1
DNA ligation (GO:0006266),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,LIG1
focal adhesion assembly (GO:0048041),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,WHAMM
negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),3/62,0.6053118695713461,1,0,0,0.9677419354838709,0.48581754858797044,PSMB6;PSMB3;CUL1
establishment of protein localization to organelle (GO:0072594),3/62,0.6053118695713461,1,0,0,0.9677419354838709,0.48581754858797044,PEX19;STAT3;TNPO3
G2/M transition of mitotic cell cycle (GO:0000086),6/126,0.6069214709956913,1,0,0,0.9523809523809523,0.47557701773519845,CCNA2;CCNH;DCTN1;NDE1;CUL1;HAUS5
DNA metabolic process (GO:0006259),15/314,0.6095726753677434,1,0,0,0.9554140127388535,0.4729271651141391,RTEL1;RFC4;LIG1;PNKP;HUS1;GTF2H1;UBE2A;HELB;ERI1;CBS;GRWD1;ERCC1;LONP1;POLK;POLH
cellular response to molecule of bacterial origin (GO:0071219),4/84,0.61076514771337,1,0,0,0.9523809523809523,0.4695645403132304,VDR;GSTP1;NR1H2;NR1H4
vesicle organization (GO:0016050),6/127,0.6146383855730021,1,0,0,0.9448818897637795,0.45989402366767695,SNX4;SYT2;STX19;HOOK3;SNX11;SYT9
positive regulation of protein kinase B signaling (GO:0051897),6/127,0.6146383855730021,1,0,0,0.9448818897637795,0.45989402366767695,FGF17;OSBPL8;RICTOR;PIK3R1;FGF3;FGF22
protein lipidation (GO:0006497),6/127,0.6146383855730021,1,0,0,0.9448818897637795,0.45989402366767695,NTM;PIGA;LSAMP;ALPL;ALOX12B;LYPD4
cell cycle G2/M phase transition (GO:0044839),6/127,0.6146383855730021,1,0,0,0.9448818897637795,0.45989402366767695,CCNA2;CCNH;DCTN1;NDE1;CUL1;HAUS5
odontogenesis (GO:0042476),2/41,0.6147400385913487,1,0,0,0.975609756097561,0.47468858733322344,OSR1;INHBA
peptide transport (GO:0015833),2/41,0.6147400385913487,1,0,0,0.975609756097561,0.47468858733322344,SNX4;IPO4
DNA duplex unwinding (GO:0032508),2/41,0.6147400385913487,1,0,0,0.975609756097561,0.47468858733322344,RTEL1;GTF2H1
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),2/41,0.6147400385913487,1,0,0,0.975609756097561,0.47468858733322344,CDH15;ATP2C1
synapse assembly (GO:0007416),3/63,0.6162178817161523,1,0,0,0.9523809523809523,0.4610996894309503,GRID2;DBNL;NRXN2
oligosaccharide metabolic process (GO:0009311),3/63,0.6162178817161523,1,0,0,0.9523809523809523,0.4610996894309503,GALNT14;GALNT2;GALNT10
carbohydrate homeostasis (GO:0033500),3/63,0.6162178817161523,1,0,0,0.9523809523809523,0.4610996894309503,GCGR;STAT3;CRY1
ribosomal large subunit biogenesis (GO:0042273),3/63,0.6162178817161523,1,0,0,0.9523809523809523,0.4610996894309503,WDR37;RPL24;SDAD1
mitochondrial ATP synthesis coupled electron transport (GO:0042775),4/85,0.6201271748700885,1,0,0,0.9411764705882353,0.4497230129121684,NDUFS8;SDHAF2;NDUFV2;COX6B1
regulation of type I interferon production (GO:0032479),4/85,0.6201271748700885,1,0,0,0.9411764705882353,0.4497230129121684,IFIH1;CRCP;IFI16;TRIM25
activation of protein kinase activity (GO:0032147),11/233,0.620807171924691,1,0,0,0.944206008583691,0.4501358225001974,MAP3K2;CARD10;OSBPL8;PAK1;CHRNA3;MLST8;PAK6;RICTOR;PAK5;CRKL;SOD1
regulation of G2/M transition of mitotic cell cycle (GO:0010389),7/149,0.6208672064504345,1,0,0,0.9395973154362416,0.44784783988129884,PSMB6;CDK4;DCTN1;PSMB3;NDE1;CUL1;HAUS5
regulation of mRNA stability (GO:0043488),6/128,0.6222697663749293,1,0,0,0.9375,0.4447327240020074,EXOSC7;PSMB6;FXR2;PSMB3;SERBP1;YWHAZ
positive regulation of NF-kappaB transcription factor activity (GO:0051092),6/128,0.6222697663749293,1,0,0,0.9375,0.4447327240020074,NFKBIA;TRIM52;DDRGK1;TRIM25;S100A12;TNFRSF11A
positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,HSP90AB1
positive regulation of chromosome organization (GO:2001252),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,RTEL1
protein import into mitochondrial matrix (GO:0030150),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,TOMM20L
regulation of protein kinase A signaling (GO:0010738),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,MIF
negative regulation of lymphocyte activation (GO:0051250),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,TNFAIP8L2
regulation of gluconeogenesis (GO:0006111),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,SOGA1
protein ADP-ribosylation (GO:0006471),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,TNKS2
regulation of sprouting angiogenesis (GO:1903670),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,EPN2
negative regulation of phosphate metabolic process (GO:0045936),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,INHBA
histone methylation (GO:0016571),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,FBLL1
negative regulation of protein localization to plasma membrane (GO:1903077),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,MRAP
positive regulation of heart contraction (GO:0045823),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,EDN2
cellular polysaccharide catabolic process (GO:0044247),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,STBD1
endoplasmic reticulum mannose trimming (GO:1904380),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,UGGT1
acetylcholine receptor signaling pathway (GO:0095500),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,CHRNA3
positive regulation of STAT cascade (GO:1904894),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,CRLF3
protein exit from endoplasmic reticulum (GO:0032527),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,AUP1
negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,LAMP3
production of small RNA involved in gene silencing by RNA (GO:0070918),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,MRPL44
negative regulation of transposition (GO:0010529),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,APOBEC3B
regulation of myotube differentiation (GO:0010830),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,HDAC4
cellular response to zinc ion (GO:0071294),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,ZNF658
positive regulation of toll-like receptor signaling pathway (GO:0034123),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,CYBA
negative regulation of lipid metabolic process (GO:0045833),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,UGT1A1
osteoclast differentiation (GO:0030316),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,TNFRSF11A
nucleosome disassembly (GO:0006337),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,GRWD1
chromatin disassembly (GO:0031498),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,GRWD1
leukotriene metabolic process (GO:0006691),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,ALOX12
extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,CASP3
gamma-aminobutyric acid signaling pathway (GO:0007214),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,GABBR2
cellular polysaccharide biosynthetic process (GO:0033692),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,B3GALT4
purine ribonucleotide catabolic process (GO:0009154),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,HINT1
positive regulation of immunoglobulin production (GO:0002639),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,XCL1
nucleotide-sugar biosynthetic process (GO:0009226),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,PGM3
DNA double-strand break processing (GO:0000729),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,RNF138
aspartate family amino acid catabolic process (GO:0009068),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,ASPA
hexose transmembrane transport (GO:0035428),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,SLC2A3
positive regulation of epithelial cell differentiation (GO:0030858),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,FOXN1
protein heterotetramerization (GO:0051290),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,RCC1
innate immune response in mucosa (GO:0002227),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,RPL39
regulation of cAMP biosynthetic process (GO:0030817),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,CAP1
positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,HSP90AB1
regulation of catenin import into nucleus (GO:0035412),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,DACT3
activin receptor signaling pathway (GO:0032924),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,INHBA
positive regulation of neuron apoptotic process (GO:0043525),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,NF1
positive regulation of axon extension (GO:0045773),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,POU4F2
regulation of canonical Wnt signaling pathway (GO:0060828),10/213,0.6262337285932289,1,0,0,0.9389671361502346,0.43946629972475976,PSMB6;SDHAF2;TNKS2;PSMB3;FUZ;KREMEN2;NOTUM;IGFBP6;MLLT3;NAIP
inorganic anion transmembrane transport (GO:0098661),3/64,0.6269182035693374,1,0,0,0.9375,0.4377555034562452,CLIC6;SLC20A1;CLCNKA
positive regulation of JAK-STAT cascade (GO:0046427),3/64,0.6269182035693374,1,0,0,0.9375,0.4377555034562452,TNFRSF18;STAT3;CRLF3
glucose metabolic process (GO:0006006),3/64,0.6269182035693374,1,0,0,0.9375,0.4377555034562452,PER2;CRY1;ALDOB
cellular response to decreased oxygen levels (GO:0036294),3/64,0.6269182035693374,1,0,0,0.9375,0.4377555034562452,PTGIS;EPAS1;MDM4
positive regulation of gene expression (GO:0010628),37/771,0.6272775219756392,1,0,0,0.959792477302205,0.4476147872196714,HDAC4;KDM3A;SPI1;KMT2A;RNF6;ALOX12B;PIK3R1;MRPL12;MLLT3;FOXO1;ETS2;CKS1B;SEC14L2;MED13;FXR2;DDRGK1;LAMP3;HIVEP3;OTX2;MAP3K2;TLE1;VDR;OSR1;NR1H2;STAT3;ESRRB;PYM1;MITF;INHBA;WNT16;SOX10;PIAS2;RUNX2;FUBP3;POLR1B;BCL3;CRLF3
cellular response to interleukin-1 (GO:0071347),7/150,0.6278858639339182,1,0,0,0.9333333333333333,0.4343704160691258,NFKBIA;PSMB6;PTGIS;PSMB3;CUL1;XCL1;ST18
regulation of interleukin-6 production (GO:0032675),2/42,0.6279256694973029,1,0,0,0.9523809523809523,0.4431747430401906,CYBA;HSPD1
positive regulation of protein localization to nucleus (GO:1900182),2/42,0.6279256694973029,1,0,0,0.9523809523809523,0.4431747430401906,CARD10;SESN2
regulation of telomerase activity (GO:0051972),2/42,0.6279256694973029,1,0,0,0.9523809523809523,0.4431747430401906,HSP90AB1;PNKP
"negative regulation of transcription, DNA-templated (GO:0045892)",39/813,0.6304898632199725,1,0,0,0.959409594095941,0.4425355434654634,HOMEZ;HDAC4;CEBPB;SPI1;ZNF350;NAB2;ASCL2;FOXO1;ETS2;HHEX;PRDX5;DACH1;ZNF608;IFI16;TBX22;BASP1;TCEAL1;HOXA7;TLE1;CDX2;VDR;OSR1;NR1H2;STAT3;SETDB2;NR1H4;MITF;BMP6;POU4F2;HIC1;RUNX2;PER2;ZNF417;BCL3;ZNF658;CRY1;XCL1;MDM4;MCPH1
RNA processing (GO:0006396),9/193,0.6324859877108375,1,0,0,0.9326424870466321,0.4272409235217067,DHX40;HNRNPL;RBM4;HELB;SNRNP40;DQX1;LSM1;SNRNP35;MRPL44
regulation of cytokine production (GO:0001817),5/108,0.6330463554564062,1,0,0,0.9259259259259258,0.4233441001393671,IFIH1;IFI16;BTN1A1;HSPD1;SOD1
positive regulation of protein kinase activity (GO:0045860),8/172,0.6333337048835047,1,0,0,0.9302325581395349,0.4248909914769504,MAP3K2;PAK1;RALB;NAB2;DOK7;PAK6;LAT;PAK5
negative regulation of nucleic acid-templated transcription (GO:1903507),21/444,0.6355838499109221,1,0,0,0.9459459459459459,0.4287133482316115,HDAC4;SPI1;ZNF350;TLE1;VDR;NR1H2;SETDB2;FOXO1;RUNX2;PER2;HHEX;DACH1;IFI16;BASP1;TBX22;ZNF417;BCL3;ZNF658;CRY1;XCL1;HOXA7
positive regulation of protein modification by small protein conjugation or removal (GO:1903322),3/65,0.6374113112791769,1,0,0,0.9230769230769231,0.41569858263660475,HDAC4;PHF23;FBXO4
regulation of myeloid cell differentiation (GO:0045637),3/65,0.6374113112791769,1,0,0,0.9230769230769231,0.41569858263660475,SPI1;KMT2A;DPY30
cellular response to reactive oxygen species (GO:0034614),3/65,0.6374113112791769,1,0,0,0.9230769230769231,0.41569858263660475,PRDX5;PXMP2;FOXO1
negative regulation of blood vessel morphogenesis (GO:2000181),3/65,0.6374113112791769,1,0,0,0.9230769230769231,0.41569858263660475,HHEX;ADGRB1;ECSCR
DNA synthesis involved in DNA repair (GO:0000731),3/65,0.6374113112791769,1,0,0,0.9230769230769231,0.41569858263660475,RFC4;TRIM25;POLH
fatty acid catabolic process (GO:0009062),3/65,0.6374113112791769,1,0,0,0.9230769230769231,0.41569858263660475,ALDH3A2;NUDT19;LPIN2
"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",11/236,0.6376285765709633,1,0,0,0.9322033898305084,0.4194909041541967,DHX40;HNRNPL;XAB2;LSM8;SNRNP40;FIP1L1;DQX1;GEMIN5;SNRNP35;ESS2;CCAR1
positive regulation of interferon-gamma production (GO:0032729),2/43,0.6407574714002146,1,0,0,0.9302325581395349,0.41405046828616976,EBI3;HSPD1
male gonad development (GO:0008584),2/43,0.6407574714002146,1,0,0,0.9302325581395349,0.41405046828616976,INHBA;RBMY1B
negative regulation of protein metabolic process (GO:0051248),2/43,0.6407574714002146,1,0,0,0.9302325581395349,0.41405046828616976,ADGRB1;MDM4
histone H3 acetylation (GO:0043966),2/43,0.6407574714002146,1,0,0,0.9302325581395349,0.41405046828616976,SPI1;TAF5L
digestive tract development (GO:0048565),2/43,0.6407574714002146,1,0,0,0.9302325581395349,0.41405046828616976,CDX2;RARRES2
regulation of interferon-gamma production (GO:0032649),2/43,0.6407574714002146,1,0,0,0.9302325581395349,0.41405046828616976,XCL1;HSPD1
negative regulation of innate immune response (GO:0045824),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,IFI16
proteoglycan metabolic process (GO:0006029),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,HS3ST4
negative regulation of intracellular protein transport (GO:0090317),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,INSIG1
negative regulation of macromolecule biosynthetic process (GO:0010558),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,GSTP1
regulation of regulatory T cell differentiation (GO:0045589),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,TNFRSF18
negative regulation of actin filament bundle assembly (GO:0032232),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,STMN1
viral budding via host ESCRT complex (GO:0039702),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,MVB12A
negative regulation of ion transport (GO:0043271),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,GPM6B
regulation of lipoprotein lipase activity (GO:0051004),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,NR1H2
embryonic digestive tract development (GO:0048566),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,RARRES2
response to progesterone (GO:0032570),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,CATSPERD
error-prone translesion synthesis (GO:0042276),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,RFC4
regulation of cholesterol transport (GO:0032374),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,NR1H2
neuromuscular junction development (GO:0007528),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,ZC4H2
mitochondrial respiratory chain complex IV assembly (GO:0033617),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,PET117
androgen metabolic process (GO:0008209),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,DHRS9
autophagy of nucleus (GO:0044804),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,ATG9A
positive regulation of gene silencing by miRNA (GO:2000637),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,STAT3
regulation of response to cytokine stimulus (GO:0060759),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,IFIH1
steroid hormone mediated signaling pathway (GO:0043401),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,MED13
positive regulation of T cell migration (GO:2000406),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,XCL1
telomere maintenance via telomerase (GO:0007004),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,HSP90AB1
inositol phosphate-mediated signaling (GO:0048016),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,EDN2
heparan sulfate proteoglycan metabolic process (GO:0030201),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,HS3ST4
regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,OTX2
cellular response to estradiol stimulus (GO:0071392),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,POU4F2
positive regulation of cAMP biosynthetic process (GO:0030819),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,NF1
mitochondrial RNA metabolic process (GO:0000959),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,MRPL12
peptide biosynthetic process (GO:0043043),8/174,0.6461933813797057,1,0,0,0.9195402298850575,0.40152318897970674,RPL24;MRPS2;RPL39;MRPL13;MRPL24;RPS21;RPS13;MRPS5
regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),4/88,0.6473496582204271,1,0,0,0.9090909090909091,0.39533518222257213,HSP90AB1;DDRGK1;RNF138;ARIH2
regulation of protein targeting to mitochondrion (GO:1903214),4/88,0.6473496582204271,1,0,0,0.9090909090909091,0.39533518222257213,USP36;ELMOD1;ARIH2;HTRA2
JNK cascade (GO:0007254),3/66,0.6476960862533626,1,0,0,0.9090909090909091,0.3948488139467768,MAP3K2;DBNL;CRKL
positive regulation of establishment of protein localization to mitochondrion (GO:1903749),5/110,0.6491253231277532,1,0,0,0.9090909090909091,0.3928449809345964,USP36;ELMOD1;ARIH2;HTRA2;YWHAZ
amide biosynthetic process (GO:0043604),2/44,0.6532378269725155,1,0,0,0.9090909090909091,0.38710364483347576,ALOX12B;ASL
regulation of dendrite morphogenesis (GO:0048814),2/44,0.6532378269725155,1,0,0,0.9090909090909091,0.38710364483347576,CHRNA3;FXR2
negative regulation of type I interferon production (GO:0032480),2/44,0.6532378269725155,1,0,0,0.9090909090909091,0.38710364483347576,IFIH1;TRIM25
positive regulation of actin filament bundle assembly (GO:0032233),2/44,0.6532378269725155,1,0,0,0.9090909090909091,0.38710364483347576,PAK1;SYNPO2
SRP-dependent cotranslational protein targeting to membrane (GO:0006614),4/89,0.6561310542796738,1,0,0,0.898876404494382,0.3787817816859613,RPL24;RPL39;RPS21;RPS13
peptidyl-threonine modification (GO:0018210),4/89,0.6561310542796738,1,0,0,0.898876404494382,0.3787817816859613,GALNT14;GALNT2;OSR1;GALNT10
epidermal cell differentiation (GO:0009913),3/67,0.657771791741192,1,0,0,0.8955223880597014,0.3751318467538853,CDSN;CASP3;WNT16
negative regulation of protein serine/threonine kinase activity (GO:0071901),3/67,0.657771791741192,1,0,0,0.8955223880597014,0.3751318467538853,HHEX;GSTP1;NF1
insulin receptor signaling pathway (GO:0008286),3/67,0.657771791741192,1,0,0,0.8955223880597014,0.3751318467538853,PIK3R1;SOGA1;FOXO1
"mRNA splicing, via spliceosome (GO:0000398)",12/261,0.6585582788214799,1,0,0,0.9195402298850575,0.38409403156639316,DHX40;HNRNPL;XAB2;LSM8;SNRNP40;FIP1L1;DQX1;GEMIN5;SNRNP35;LIME1;ESS2;CCAR1
hyaluronan metabolic process (GO:0030212),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,LYVE1
positive regulation of transcription from RNA polymerase I promoter (GO:0045943),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,IPPK
GTP metabolic process (GO:0046039),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,IMPDH2
RNA-dependent DNA biosynthetic process (GO:0006278),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,HSP90AB1
establishment of protein localization to vacuole (GO:0072666),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,CACNG5
positive regulation of leukocyte cell-cell adhesion (GO:1903039),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,HSPD1
regulation of ruffle assembly (GO:1900027),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,NDEL1
"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,COX6B1
energy reserve metabolic process (GO:0006112),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,GBE1
sterol transport (GO:0015918),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,MSR1
mesoderm development (GO:0007498),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,HES7
histone ubiquitination (GO:0016574),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,UBE2A
zinc II ion transport (GO:0006829),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,SLC39A3
positive regulation of translational initiation (GO:0045948),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,DAZ4
positive regulation of histone acetylation (GO:0035066),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,TADA2B
vesicle docking (GO:0048278),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,STX19
negative regulation of protein tyrosine kinase activity (GO:0061099),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,SOCS4
regulation of nuclear division (GO:0051783),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,RCC1
regulation of interleukin-2 production (GO:0032663),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,XCL1
response to nicotine (GO:0035094),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,CHRNA3
cellular response to misfolded protein (GO:0071218),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,UGGT1
protein-DNA complex disassembly (GO:0032986),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,GRWD1
mitochondrial respiratory chain complex IV biogenesis (GO:0097034),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,PET117
negative regulation of cyclin-dependent protein kinase activity (GO:1904030),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,HHEX
"synaptic transmission, glutamatergic (GO:0035249)",1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,GRID2
hepaticobiliary system development (GO:0061008),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,NF1
glutamate metabolic process (GO:0006536),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,GAD1
response to lipopolysaccharide (GO:0032496),7/155,0.6618579190514627,1,0,0,0.9032258064516128,0.37276523730143096,VDR;TNFRSF18;GSTP1;NR1H2;NR1H4;TNFRSF11A;CXCL3
mRNA processing (GO:0006397),13/283,0.6629473582844175,1,0,0,0.9187279151943463,0.37765201313307,CCNH;DQX1;GTF2H1;ESS2;CCAR1;DHX40;HNRNPL;XAB2;LSM8;SNRNP40;FIP1L1;GEMIN5;SNRNP35
negative regulation of signal transduction (GO:0009968),13/283,0.6629473582844175,1,0,0,0.9187279151943463,0.37765201313307,EPHA5;TLE1;HIC1;EPN2;HHEX;HMGXB4;GRB14;MMRN2;CRY1;DACT3;NOTUM;EPHB4;PLIN5
nucleus organization (GO:0006997),2/45,0.665369764985953,1,0,0,0.8888888888888888,0.3621443158089169,USP36;ATXN7
"regulation of synaptic transmission, glutamatergic (GO:0051966)",2/45,0.665369764985953,1,0,0,0.8888888888888888,0.3621443158089169,GRM3;CACNG5
mitochondrial gene expression (GO:0140053),2/45,0.665369764985953,1,0,0,0.8888888888888888,0.3621443158089169,MRPS2;MRPL12
negative regulation of ossification (GO:0030279),2/45,0.665369764985953,1,0,0,0.8888888888888888,0.3621443158089169,ECM1;KREMEN2
negative regulation of gene expression (GO:0010629),29/618,0.665881994486181,1,0,0,0.9385113268608414,0.38163888279342295,HDAC4;SPI1;ZNF350;FOXO1;RBM4;HHEX;DACH1;FXR2;IFI16;DDRGK1;BASP1;TBX22;HOXA7;RPS13;DIS3L2;MSR1;TLE1;VDR;NR1H2;SETDB2;MIF;RUNX2;PER2;RBL1;ZNF417;BCL3;ZNF658;CRY1;XCL1
vesicle-mediated transport (GO:0016192),19/410,0.6668787682352812,1,0,0,0.9268292682926829,0.3755021034509481,TMED10;SYT2;DCTN1;STX19;RAB39B;TVP23A;SNX11;HOOK3;SYT9;BET1L;MAPK8IP1;SNX4;HMGXB4;GOLGA5;TBC1D4;DPYSL2;TBC1D10A;CSNK1G1;MFSD2A
negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),3/68,0.6676380497864279,1,0,0,0.8823529411764706,0.3564786122927678,BCL2L12;LAMP3;NAIP
protein sumoylation (GO:0016925),3/68,0.6676380497864279,1,0,0,0.8823529411764706,0.3564786122927678,IFIH1;MITF;PIAS2
cellular protein localization (GO:0034613),15/327,0.6713830851285463,1,0,0,0.9174311926605505,0.36551870475904863,RIC3;GRID2;TMED10;STX19;COG3;ATG9A;RAB39B;RABL2B;HPS6;DNAJC27;HHEX;RAB31;PACS2;TBC1D4;TBC1D10A
viral transcription (GO:0019083),5/113,0.6723926318192525,1,0,0,0.8849557522123893,0.3512502969378424,CCNT2;RPL24;RPL39;RPS21;RPS13
regulation of protein catabolic process (GO:0042176),4/91,0.6732482464251353,1,0,0,0.8791208791208791,0.34781639730574376,ADGRB1;ASB9;MDM4;FOXO1
cellular response to acid chemical (GO:0071229),4/91,0.6732482464251353,1,0,0,0.8791208791208791,0.34781639730574376,SPAAR;SESN2;NR1H4;HTRA2
cellular response to lipopolysaccharide (GO:0071222),4/91,0.6732482464251353,1,0,0,0.8791208791208791,0.34781639730574376,VDR;GSTP1;NR1H2;NR1H4
rRNA metabolic process (GO:0016072),9/200,0.6741003093932334,1,0,0,0.8999999999999999,0.3549387169354863,EXOSC7;ERI1;TEX10;SBDS;RPL24;RPL39;RPS21;RPS13;DIS3L2
negative regulation of protein polymerization (GO:0032272),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,STMN1
NAD biosynthetic process (GO:0009435),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,PTGIS
positive regulation of protein targeting to membrane (GO:0090314),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,TCAF2
early endosome to late endosome transport (GO:0045022),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,HOOK3
activation of phospholipase C activity (GO:0007202),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,S1PR4
regulation of DNA biosynthetic process (GO:2000278),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,DACH1
negative regulation of cell cycle G1/S phase transition (GO:1902807),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,RBL1
"DNA catabolic process, endonucleolytic (GO:0000737)",1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,CASP3
negative regulation of myeloid cell differentiation (GO:0045638),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,MAFB
protein localization to cell surface (GO:0034394),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,RIC3
rRNA modification (GO:0000154),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,FBLL1
"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,GTF2H1
branched-chain amino acid metabolic process (GO:0009081),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,STAT5B
beta-catenin destruction complex disassembly (GO:1904886),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,FRAT1
urogenital system development (GO:0001655),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,OSR1
regulation of ERBB signaling pathway (GO:1901184),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,MVB12A
protein complex localization (GO:0031503),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,RABL2B
C21-steroid hormone metabolic process (GO:0008207),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,DHRS9
viral genome replication (GO:0019079),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,PIK3C2G
negative regulation of nervous system development (GO:0051961),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,HOOK3
maturation of LSU-rRNA (GO:0000470),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,WDR37
positive regulation of RNA splicing (GO:0033120),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,PIK3R1
regulation of bone resorption (GO:0045124),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,NF1
positive regulation of phosphatase activity (GO:0010922),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,HSP90AB1
NLS-bearing protein import into nucleus (GO:0006607),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,IPO4
glucose transport (GO:0015758),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,SLC2A3
protein complex disassembly (GO:0043241),2/46,0.677156889708468,1,0,0,0.8695652173913043,0.3390019916216445,FRAT1;PYM1
nucleocytoplasmic transport (GO:0006913),2/46,0.677156889708468,1,0,0,0.8695652173913043,0.3390019916216445,NEMF;GEMIN5
intraciliary transport (GO:0042073),2/46,0.677156889708468,1,0,0,0.8695652173913043,0.3390019916216445,RABL2B;HSPB11
regulation of G1/S transition of mitotic cell cycle (GO:2000045),2/46,0.677156889708468,1,0,0,0.8695652173913043,0.3390019916216445,CCND2;RBL1
cartilage development (GO:0051216),2/46,0.677156889708468,1,0,0,0.8695652173913043,0.3390019916216445,OSR1;RUNX2
pyruvate metabolic process (GO:0006090),2/46,0.677156889708468,1,0,0,0.8695652173913043,0.3390019916216445,PKM;ALDOB
"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",2/46,0.677156889708468,1,0,0,0.8695652173913043,0.3390019916216445,NDUFS8;NDUFV2
negative regulation of autophagy (GO:0010507),2/46,0.677156889708468,1,0,0,0.8695652173913043,0.3390019916216445,LZTS1;EIF4G2
regulation of endothelial cell migration (GO:0010594),3/69,0.6772948191670352,1,0,0,0.8695652173913043,0.338824888725687,BMPER;ADGRB1;NF1
negative regulation of cell cycle G2/M phase transition (GO:1902750),3/69,0.6772948191670352,1,0,0,0.8695652173913043,0.338824888725687,PSMB6;PSMB3;CUL1
regulation of Notch signaling pathway (GO:0008593),3/70,0.6867423738774998,1,0,0,0.8571428571428571,0.32211090747805676,LFNG;STAT3;EPN2
positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),3/70,0.6867423738774998,1,0,0,0.8571428571428571,0.32211090747805676,DDRGK1;RNF138;ARIH2
protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0042787),3/70,0.6867423738774998,1,0,0,0.8571428571428571,0.32211090747805676,ARIH2;CUL1;ANAPC11
snRNA transcription (GO:0009301),3/70,0.6867423738774998,1,0,0,0.8571428571428571,0.32211090747805676,CCNT2;SNAPC1;INTS5
snRNA transcription from RNA polymerase II promoter (GO:0042795),3/70,0.6867423738774998,1,0,0,0.8571428571428571,0.32211090747805676,CCNT2;SNAPC1;INTS5
positive regulation of cellular biosynthetic process (GO:0031328),7/159,0.6876338328576245,1,0,0,0.880503144654088,0.32974737319264463,SLC45A3;FXR2;HSP90AB1;NR1H2;BCL3;PYM1;PLIN5
polyol metabolic process (GO:0019751),2/47,0.6886033156551076,1,0,0,0.8510638297872339,0.3175233302317852,IPPK;IPMK
"positive regulation of gene expression, epigenetic (GO:0045815)",2/47,0.6886033156551076,1,0,0,0.8510638297872339,0.3175233302317852,POLR1B;PADI2
heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),2/47,0.6886033156551076,1,0,0,0.8510638297872339,0.3175233302317852,GRID2;CRB3
inositol phosphate metabolic process (GO:0043647),2/47,0.6886033156551076,1,0,0,0.8510638297872339,0.3175233302317852,IPPK;IPMK
cellular response to heat (GO:0034605),2/47,0.6886033156551076,1,0,0,0.8510638297872339,0.3175233302317852,CLPB;HTRA2
positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),2/47,0.6886033156551076,1,0,0,0.8510638297872339,0.3175233302317852,INHBA;BMP6
cellular transition metal ion homeostasis (GO:0046916),4/93,0.6897669196744971,1,0,0,0.8602150537634409,0.3194851922842808,FTMT;CUL1;BMP6;SOD1
mitotic G2/M transition checkpoint (GO:0044818),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,HUS1
chromosome condensation (GO:0030261),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,PHF23
microtubule polymerization or depolymerization (GO:0031109),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,STMN1
cell-cell adhesion mediated by cadherin (GO:0044331),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,CDH15
lamellipodium assembly (GO:0030032),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,WHAMM
zinc II ion transmembrane transport (GO:0071577),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,SLC39A3
vesicle-mediated transport between endosomal compartments (GO:0098927),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,HOOK3
membrane assembly (GO:0071709),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,NRXN2
peroxisome organization (GO:0007031),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,PEX19
phospholipid dephosphorylation (GO:0046839),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,PLPP5
cellular response to ammonium ion (GO:0071242),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,CASP3
apoptotic nuclear changes (GO:0030262),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,CASP3
rRNA methylation (GO:0031167),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,FBLL1
response to alkaloid (GO:0043279),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,CHRNA3
negative regulation of axonogenesis (GO:0050771),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,RNF6
regulation of monooxygenase activity (GO:0032768),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,VDR
regulation of microtubule cytoskeleton organization (GO:0070507),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,STMN1
viral budding (GO:0046755),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,MVB12A
negative regulation of axon extension (GO:0030517),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,RNF6
regulation of macroautophagy (GO:0016241),5/116,0.6946174064374339,1,0,0,0.8620689655172414,0.3141328270082842,CASP3;SESN2;MLST8;LZTS1;PAFAH1B2
cellular response to interferon-gamma (GO:0071346),5/116,0.6946174064374339,1,0,0,0.8620689655172414,0.3141328270082842,TRIM25;XCL1;HLA-DQA2;HLA-DRB1;OASL
Fc-epsilon receptor signaling pathway (GO:0038095),8/182,0.6949570991694919,1,0,0,0.8791208791208791,0.3199166269329807,NFKBIA;PSMB6;PAK1;PSMB3;GRAP2;CUL1;PIK3R1;LAT
phosphatidylcholine metabolic process (GO:0046470),3/71,0.6959812822212856,1,0,0,0.8450704225352113,0.30628099636865247,PCTP;LPIN2;MFSD2A
nuclear import (GO:0051170),3/71,0.6959812822212856,1,0,0,0.8450704225352113,0.30628099636865247,STAT3;GEMIN5;TNPO3
regulation of cation channel activity (GO:2001257),3/71,0.6959812822212856,1,0,0,0.8450704225352113,0.30628099636865247,NETO1;CTSS;CACNG5
organelle membrane fusion (GO:0090174),3/71,0.6959812822212856,1,0,0,0.8450704225352113,0.30628099636865247,SYT2;STX19;SYT9
respiratory electron transport chain (GO:0022904),4/94,0.6978008887433855,1,0,0,0.8510638297872339,0.3062310439097954,NDUFS8;SDHAF2;NDUFV2;COX6B1
negative regulation of transcription from RNA polymerase II promoter (GO:0000122),26/565,0.6979361780758137,1,0,0,0.9203539823008849,0.3309847083668817,HDAC4;HOMEZ;CEBPB;ZNF350;ASCL2;ETS2;HHEX;ZNF608;IFI16;TBX22;TCEAL1;HOXA7;CDX2;VDR;NR1H2;OSR1;STAT3;NR1H4;MITF;POU4F2;HIC1;BMP6;PER2;CRY1;MDM4;MCPH1
cytoplasmic microtubule organization (GO:0031122),2/48,0.6997136081858564,1,0,0,0.8333333333333333,0.29757013234898655,TUBGCP2;HOOK3
regulation of mitochondrion organization (GO:0010821),2/48,0.6997136081858564,1,0,0,0.8333333333333333,0.29757013234898655,USP36;HTRA2
amino acid transport (GO:0006865),2/48,0.6997136081858564,1,0,0,0.8333333333333333,0.29757013234898655,SLC16A10;SLC38A2
phosphate-containing compound metabolic process (GO:0006796),8/183,0.7007406269620085,1,0,0,0.8743169398907104,0.31092237355176994,IPPK;PLPP5;SLC20A1;PNKP;IPMK;STAT3;ALDOB;NADK
Fc receptor signaling pathway (GO:0038093),8/183,0.7007406269620085,1,0,0,0.8743169398907104,0.31092237355176994,NFKBIA;PSMB6;PAK1;PSMB3;GRAP2;CUL1;PIK3R1;LAT
lipid biosynthetic process (GO:0008610),3/72,0.7050123870135998,1,0,0,0.8333333333333333,0.2912832550768055,PCYT2;ACSM3;LSS
regulation of neuron death (GO:1901214),3/72,0.7050123870135998,1,0,0,0.8333333333333333,0.2912832550768055,GRID2;AKT1S1;HTRA2
regulation of epithelial cell proliferation (GO:0050678),3/72,0.7050123870135998,1,0,0,0.8333333333333333,0.2912832550768055,OSR1;ZNF304;BMP6
positive regulation of histone methylation (GO:0031062),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,KMT2A
ear morphogenesis (GO:0042471),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,OSR1
histone mRNA metabolic process (GO:0008334),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,LSM1
Golgi to plasma membrane protein transport (GO:0043001),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,RAB31
receptor clustering (GO:0043113),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,NRXN2
negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,RBL1
cellular modified amino acid biosynthetic process (GO:0042398),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,GGCT
negative regulation of developmental growth (GO:0048640),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,RNF6
negative regulation of sequestering of calcium ion (GO:0051283),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,XCL1
regulation of actin filament bundle assembly (GO:0032231),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,SYNPO2
camera-type eye development (GO:0043010),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,NF1
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,CEBPB
regulation of epidermal growth factor-activated receptor activity (GO:0007176),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,SOCS4
neuromuscular synaptic transmission (GO:0007274),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,CHRNA3
positive regulation of endopeptidase activity (GO:0010950),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,STAT3
eosinophil chemotaxis (GO:0048245),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,XCL1
DNA geometric change (GO:0032392),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,RTEL1
axoneme assembly (GO:0035082),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,MAPRE2
regulation of chemotaxis (GO:0050920),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,RARRES2
negative regulation of oxidative stress-induced cell death (GO:1903202),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,HTRA2
regulation of AMPA receptor activity (GO:2000311),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,CACNG5
eosinophil migration (GO:0072677),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,XCL1
cilium-dependent cell motility (GO:0060285),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,SPATA4
mucosal immune response (GO:0002385),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,RPL39
limb development (GO:0060173),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,KREMEN2
positive regulation of vascular endothelial growth factor production (GO:0010575),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,CCBE1
regulation of neuronal synaptic plasticity (GO:0048168),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,NETO1
fatty acid derivative biosynthetic process (GO:1901570),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,AWAT1
"protein alpha-1,2-demannosylation (GO:0036508)",1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,UGGT1
negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,HSP90AB1
negative regulation of T cell proliferation (GO:0042130),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,CEBPB
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,MIF
regulation of cell cycle G1/S phase transition (GO:1902806),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,DDRGK1
regulation of cellular senescence (GO:2000772),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,RBL1
organic hydroxy compound biosynthetic process (GO:1901617),2/49,0.7104927276749392,1,0,0,0.8163265306122448,0.2790176057147895,PER2;ALOX12
regulation of megakaryocyte differentiation (GO:0045652),2/49,0.7104927276749392,1,0,0,0.8163265306122448,0.2790176057147895,KMT2A;DPY30
cilium movement (GO:0003341),2/49,0.7104927276749392,1,0,0,0.8163265306122448,0.2790176057147895,CFAP61;CFAP100
establishment of protein localization to mitochondrion (GO:0072655),2/49,0.7104927276749392,1,0,0,0.8163265306122448,0.2790176057147895,TOMM20L;HSPD1
positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),7/163,0.7121164303112548,1,0,0,0.8588957055214724,0.29160699221433833,ECM1;DDRGK1;SLC20A1;CARD9;TRIM25;S100A12;ATP2C1
protein localization to nucleus (GO:0034504),4/96,0.7134178055156833,1,0,0,0.8333333333333333,0.28140670641508325,HHEX;STAT3;BCL3;TNPO3
regulation of cell death (GO:0010941),4/96,0.7134178055156833,1,0,0,0.8333333333333333,0.28140670641508325,HTRA2;CIDEB;WNT16;IER3
positive regulation of inflammatory response (GO:0050729),3/73,0.7138367865008747,1,0,0,0.821917808219178,0.2770692600889438,NFKBIA;SNX4;S100A12
B cell activation (GO:0042113),3/73,0.7138367865008747,1,0,0,0.821917808219178,0.2770692600889438,HDAC4;HHEX;HSPD1
lymphocyte differentiation (GO:0030098),3/73,0.7138367865008747,1,0,0,0.821917808219178,0.2770692600889438,LFNG;HDAC4;HHEX
regulation of peptide hormone secretion (GO:0090276),3/73,0.7138367865008747,1,0,0,0.821917808219178,0.2770692600889438,PER2;KCNA5;SLC25A5
regulation of protein complex assembly (GO:0043254),3/73,0.7138367865008747,1,0,0,0.821917808219178,0.2770692600889438,SLF1;RALB;SPIDR
cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),6/142,0.7194862015133059,1,0,0,0.8450704225352113,0.2782123358209349,CLDN20;GRID2;CLDN9;CDH15;ATP2C1;CRB3
fatty acid oxidation (GO:0019395),2/50,0.7209459791839935,1,0,0,0.7999999999999999,0.2617528554824198,ALDH3A2;ALOX12
myeloid leukocyte differentiation (GO:0002573),2/50,0.7209459791839935,1,0,0,0.7999999999999999,0.2617528554824198,IFI16;TNFRSF11A
wound healing (GO:0042060),2/50,0.7209459791839935,1,0,0,0.7999999999999999,0.2617528554824198,PAK1;NF1
negative regulation of viral genome replication (GO:0045071),2/50,0.7209459791839935,1,0,0,0.7999999999999999,0.2617528554824198,IFI16;OASL
heart morphogenesis (GO:0003007),2/50,0.7209459791839935,1,0,0,0.7999999999999999,0.2617528554824198,FLRT2;EPHB4
neurogenesis (GO:0022008),2/50,0.7209459791839935,1,0,0,0.7999999999999999,0.2617528554824198,NOM1;SALL4
receptor internalization (GO:0031623),2/50,0.7209459791839935,1,0,0,0.7999999999999999,0.2617528554824198,RAB31;CACNG5
double-strand break repair via nonhomologous end joining (GO:0006303),2/50,0.7209459791839935,1,0,0,0.7999999999999999,0.2617528554824198,ERCC1;POLK
mitochondrial respiratory chain complex assembly (GO:0033108),4/97,0.7210011321847114,1,0,0,0.8247422680412371,0.269785213526288,NDUFS8;SDHAF2;NDUFV2;PET117
positive regulation of cell proliferation (GO:0008284),19/424,0.7215154782884873,1,0,0,0.8962264150943395,0.29252959968450437,HDAC4;EDN2;OSR1;REG1A;TNFRSF11A;MIF;UBE2A;FGF3;BMP6;CCAR1;CRKL;FOSL1;PAK1;CCND2;FTMT;DDRGK1;CDK4;ZNF304;SLC25A5
positive regulation of defense response (GO:0031349),3/74,0.722455815470999,1,0,0,0.8108108108108109,0.2635937966943547,NFKBIA;S100A12;CYBA
regulation of centrosome duplication (GO:0010824),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,FBXW5
respiratory chain complex IV assembly (GO:0008535),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,PET117
lamellipodium organization (GO:0097581),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,WHAMM
"negative regulation of gene expression, epigenetic (GO:0045814)",1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,SPI1
potassium ion homeostasis (GO:0055075),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,ATP4A
positive regulation of interleukin-12 production (GO:0032735),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,HSPD1
in utero embryonic development (GO:0001701),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,RARRES2
positive regulation of leukocyte mediated cytotoxicity (GO:0001912),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,XCL1
response to alcohol (GO:0097305),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,SOD1
regulation of lamellipodium assembly (GO:0010591),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,SSH2
positive regulation of glucose transport (GO:0010828),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,PIK3R1
cellular response to epidermal growth factor stimulus (GO:0071364),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,STAT5B
female gamete generation (GO:0007292),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,CGB3
regulation of apoptotic signaling pathway (GO:2001233),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,DEPTOR
regulation of viral release from host cell (GO:1902186),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,TRIM25
regulation of potassium ion transmembrane transporter activity (GO:1901016),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,NETO1
long-chain fatty acid transport (GO:0015909),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,LCN1
negative regulation of insulin receptor signaling pathway (GO:0046627),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,GRB14
long-chain fatty-acyl-CoA metabolic process (GO:0035336),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,ACSL6
protein depolymerization (GO:0051261),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,STMN1
positive regulation of calcium ion transmembrane transport (GO:1904427),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,XCL1
positive regulation of nitric oxide biosynthetic process (GO:0045429),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,HSP90AB1
positive regulation of nitric oxide metabolic process (GO:1904407),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,HSP90AB1
response to UV (GO:0009411),4/98,0.7284348779278988,1,0,0,0.8163265306122448,0.25865881578997496,BCL3;UBE2A;USP28;POLH
translation (GO:0006412),10/232,0.7287862614859804,1,0,0,0.8620689655172414,0.2727368828310504,EEF2K;RPL24;MRPS2;GTPBP2;RPL39;MRPL13;MRPL24;RPS21;RPS13;MRPS5
regulation of inflammatory response (GO:0050727),7/166,0.7296137574922477,1,0,0,0.8433734939759036,0.2658650469053982,NFKBIA;PTGIS;NR1H4;CARD18;S100A12;XCL1;TNFAIP8L2
"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",3/75,0.7308710279969972,1,0,0,0.7999999999999999,0.2508146136696121,PSMB6;PSMB3;CYBA
cAMP-mediated signaling (GO:0019933),3/75,0.7308710279969972,1,0,0,0.7999999999999999,0.2508146136696121,EPHA5;PTGER2;GCGR
carboxylic acid transport (GO:0046942),2/51,0.7310789651903944,1,0,0,0.7843137254901961,0.24567356984329963,SLC16A10;SLC38A2
regulation of cellular amine metabolic process (GO:0033238),2/51,0.7310789651903944,1,0,0,0.7843137254901961,0.24567356984329963,PSMB6;PSMB3
telomere maintenance (GO:0000723),2/51,0.7310789651903944,1,0,0,0.7843137254901961,0.24567356984329963,RTEL1;SNRNP40
regulation of cellular amino acid metabolic process (GO:0006521),2/51,0.7310789651903944,1,0,0,0.7843137254901961,0.24567356984329963,PSMB6;PSMB3
positive regulation of developmental growth (GO:0048639),2/51,0.7310789651903944,1,0,0,0.7843137254901961,0.24567356984329963,SYT2;POU4F2
negative regulation of cellular macromolecule biosynthetic process (GO:2000113),23/512,0.7321018416119248,1,0,0,0.8984375,0.2801648389336166,HDAC4;SPI1;ZNF350;TLE1;VDR;NR1H2;SETDB2;FOXO1;RUNX2;PER2;RBM4;HHEX;DACH1;FXR2;IFI16;BASP1;TBX22;ZNF417;BCL3;ZNF658;CRY1;XCL1;HOXA7
neuron projection development (GO:0031175),7/167,0.7352803017726739,1,0,0,0.8383233532934131,0.25778735647850953,PAK1;DBNL;STMN1;TBC1D24;PPP1R9A;GPM6B;MANF
sulfur compound biosynthetic process (GO:0044272),5/122,0.735892322358741,1,0,0,0.8196721311475409,0.25137005909781296,GGCT;CBS;GSTP1;GSTA1;B4GALT5
sodium ion homeostasis (GO:0055078),1/26,0.7367044256304639,1,0,0,0.7692307692307693,0.2350527061077511,ATP4A
apoptotic cell clearance (GO:0043277),1/26,0.7367044256304639,1,0,0,0.7692307692307693,0.2350527061077511,ADGRB1
positive regulation of synapse assembly (GO:0051965),1/26,0.7367044256304639,1,0,0,0.7692307692307693,0.2350527061077511,GRID2
cytoskeleton-dependent intracellular transport (GO:0030705),1/26,0.7367044256304639,1,0,0,0.7692307692307693,0.2350527061077511,HOOK3
positive regulation of interferon-beta production (GO:0032728),1/26,0.7367044256304639,1,0,0,0.7692307692307693,0.2350527061077511,IFIH1
regulation of centrosome cycle (GO:0046605),1/26,0.7367044256304639,1,0,0,0.7692307692307693,0.2350527061077511,FBXW5
response to ketone (GO:1901654),1/26,0.7367044256304639,1,0,0,0.7692307692307693,0.2350527061077511,CATSPERD
regulation of supramolecular fiber organization (GO:1902903),1/26,0.7367044256304639,1,0,0,0.7692307692307693,0.2350527061077511,SSH2
regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),1/26,0.7367044256304639,1,0,0,0.7692307692307693,0.2350527061077511,ESRRB
negative regulation of cellular response to insulin stimulus (GO:1900077),1/26,0.7367044256304639,1,0,0,0.7692307692307693,0.2350527061077511,GRB14
regulation of muscle contraction (GO:0006937),1/26,0.7367044256304639,1,0,0,0.7692307692307693,0.2350527061077511,CHRNA3
regulation of viral entry into host cell (GO:0046596),1/26,0.7367044256304639,1,0,0,0.7692307692307693,0.2350527061077511,TRIM25
positive regulation of release of cytochrome c from mitochondria (GO:0090200),1/26,0.7367044256304639,1,0,0,0.7692307692307693,0.2350527061077511,CIDEB
strand displacement (GO:0000732),1/26,0.7367044256304639,1,0,0,0.7692307692307693,0.2350527061077511,RTEL1
endocrine system development (GO:0035270),1/26,0.7367044256304639,1,0,0,0.7692307692307693,0.2350527061077511,NF1
RNA biosynthetic process (GO:0032774),1/26,0.7367044256304639,1,0,0,0.7692307692307693,0.2350527061077511,HELB
negative regulation of telomere maintenance via telomere lengthening (GO:1904357),1/26,0.7367044256304639,1,0,0,0.7692307692307693,0.2350527061077511,TNKS2
positive regulation of apoptotic signaling pathway (GO:2001235),3/76,0.739084180089673,1,0,0,0.7894736842105262,0.2386922002972212,HTRA2;CIDEB;ST18
chemokine-mediated signaling pathway (GO:0070098),2/52,0.740897542993205,1,0,0,0.7692307692307693,0.23068687062400378,XCL1;CXCL3
plasma membrane bounded cell projection morphogenesis (GO:0120039),2/52,0.740897542993205,1,0,0,0.7692307692307693,0.23068687062400378,PAK1;DBNL
B cell differentiation (GO:0030183),2/52,0.740897542993205,1,0,0,0.7692307692307693,0.23068687062400378,HDAC4;HHEX
positive regulation of nervous system development (GO:0051962),2/52,0.740897542993205,1,0,0,0.7692307692307693,0.23068687062400378,GRID2;NCMAP
triglyceride metabolic process (GO:0006641),2/52,0.740897542993205,1,0,0,0.7692307692307693,0.23068687062400378,AGMO;LPIN2
regulation of lipid metabolic process (GO:0019216),4/100,0.7428559954663433,1,0,0,0.7999999999999999,0.23780245442692988,RBL1;HMGCS1;RARRES2;OPA3
mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),4/100,0.7428559954663433,1,0,0,0.7999999999999999,0.23780245442692988,UPF2;NXF1;HHEX;FIP1L1
antigen receptor-mediated signaling pathway (GO:0050851),11/257,0.7433475644492396,1,0,0,0.8560311284046692,0.2538916063956462,PSMB6;NFKBIA;PAK1;PSMB3;GRAP2;BTN1A1;CUL1;PIK3R1;HLA-DQA2;HLA-DRB1;LAT
regulation of transcription from RNA polymerase II promoter (GO:0006357),69/1478,0.7456590007874685,1,0,0,0.9336941813261164,0.2740269984858142,SPI1;CCNT2;AMHR2;CCNH;CITED4;CGB3;ETS2;HHEX;MED13;YY2;ZNF608;HOXA7;TCF19;OSR1;MITF;SOX10;HIC1;RUNX2;RBL1;CRY1;ZNF750;MCPH1;HOMEZ;HDAC4;CEBPB;ZNF350;KMT2A;SRCAP;EPAS1;TSHZ1;HOXD13;PIK3R1;ASCL2;FOXO1;HSPD1;BCL2L12;IFI16;TBX22;DDRGK1;TCEAL1;ZNF304;OTX2;AAMDC;STAT5B;CDX4;CDX2;VDR;NR1H2;STAT3;ESRRB;NR1H4;GTF2H1;GRHL3;INHBA;FOXN1;BMP6;ST18;POU4F2;TARBP1;POU4F3;PER2;FOSL1;TADA2B;NFKBIA;FUBP3;MDM4;CRLF3;PPIL4;LPIN2
negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),3/77,0.7470972136000291,1,0,0,0.7792207792207791,0.22718958204818146,SPART;BMPER;ASPN
water-soluble vitamin metabolic process (GO:0006767),3/77,0.7470972136000291,1,0,0,0.7792207792207791,0.22718958204818146,PDZD11;SLC19A3;SLC2A3
dephosphorylation (GO:0016311),5/124,0.7487088303457675,1,0,0,0.8064516129032258,0.23339122223979591,PLPP5;SDHAF2;PNKP;PTPN7;SSH2
protein processing (GO:0016485),4/101,0.7498448770134236,1,0,0,0.792079207920792,0.22803083128155077,HTRA2;PRSS12;CTSS;PCSK4
mRNA polyadenylation (GO:0006378),1/27,0.7498862689651448,1,0,0,0.7407407407407407,0.2132101669113366,FIP1L1
telomere maintenance via telomere lengthening (GO:0010833),1/27,0.7498862689651448,1,0,0,0.7407407407407407,0.2132101669113366,HSP90AB1
regulation of cilium assembly (GO:1902017),1/27,0.7498862689651448,1,0,0,0.7407407407407407,0.2132101669113366,FUZ
endocytic recycling (GO:0032456),1/27,0.7498862689651448,1,0,0,0.7407407407407407,0.2132101669113366,SNX4
negative regulation of microtubule polymerization or depolymerization (GO:0031111),1/27,0.7498862689651448,1,0,0,0.7407407407407407,0.2132101669113366,STMN1
negative regulation of small GTPase mediated signal transduction (GO:0051058),1/27,0.7498862689651448,1,0,0,0.7407407407407407,0.2132101669113366,NF1
release of sequestered calcium ion into cytosol (GO:0051209),1/27,0.7498862689651448,1,0,0,0.7407407407407407,0.2132101669113366,XCL1
negative regulation of cell-matrix adhesion (GO:0001953),1/27,0.7498862689651448,1,0,0,0.7407407407407407,0.2132101669113366,HOXA7
regulation of protein transport (GO:0051223),1/27,0.7498862689651448,1,0,0,0.7407407407407407,0.2132101669113366,NDEL1
purine ribonucleoside triphosphate biosynthetic process (GO:0009206),1/27,0.7498862689651448,1,0,0,0.7407407407407407,0.2132101669113366,IMPDH2
regulation of neurotransmitter secretion (GO:0046928),1/27,0.7498862689651448,1,0,0,0.7407407407407407,0.2132101669113366,CHRNA3
positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),1/27,0.7498862689651448,1,0,0,0.7407407407407407,0.2132101669113366,CRKL
regulation of protein targeting to membrane (GO:0090313),1/27,0.7498862689651448,1,0,0,0.7407407407407407,0.2132101669113366,TCAF2
regulation of vascular endothelial growth factor production (GO:0010574),1/27,0.7498862689651448,1,0,0,0.7407407407407407,0.2132101669113366,CCBE1
cargo loading into vesicle (GO:0035459),1/27,0.7498862689651448,1,0,0,0.7407407407407407,0.2132101669113366,TMED10
regulation of blood vessel diameter (GO:0097746),1/27,0.7498862689651448,1,0,0,0.7407407407407407,0.2132101669113366,PER2
regulation of calcium ion-dependent exocytosis (GO:0017158),2/53,0.7504077852742062,1,0,0,0.7547169811320754,0.21670830680118947,SYT2;SYT9
monocarboxylic acid transport (GO:0015718),2/53,0.7504077852742062,1,0,0,0.7547169811320754,0.21670830680118947,NR1H4;MFSD2A
positive regulation of protein import into nucleus (GO:0042307),2/53,0.7504077852742062,1,0,0,0.7547169811320754,0.21670830680118947,PIK3R1;BMP6
embryonic organ development (GO:0048568),2/53,0.7504077852742062,1,0,0,0.7547169811320754,0.21670830680118947,KMT2A;RARRES2
positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),2/53,0.7504077852742062,1,0,0,0.7547169811320754,0.21670830680118947,TNFRSF18;STAT3
regulation of apoptotic process (GO:0042981),37/815,0.7535633703129863,1,0,0,0.9079754601226994,0.2569045407959188,GSTP1;HTRA2;TNFRSF11A;PIK3R1;FOXO1;HSPD1;PAK1;PRDX5;CCND2;ADAMTSL4;DDRGK1;CASP3;PAK6;EPHB4;PAK5;AAMDC;EPHA5;MAP3K2;GRID2;PTGIS;APAF1;TNFRSF18;OSR1;STAT3;ARHGEF19;NR1H4;CIDEB;MIF;INHBA;YWHAZ;BMP6;SOD1;NFKBIA;BCL3;AKT1S1;NF1;NAIP
regulation of cellular response to heat (GO:1900034),3/78,0.7549122409335416,1,0,0,0.7692307692307693,0.2162721335871487,HSP90AB1;AKT1S1;MLST8
antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),3/78,0.7549122409335416,1,0,0,0.7692307692307693,0.2162721335871487,PSMB6;PSMB3;CYBA
regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),3/78,0.7549122409335416,1,0,0,0.7692307692307693,0.2162721335871487,PSMB6;EPAS1;PSMB3
negative regulation of multicellular organismal process (GO:0051241),5/125,0.7549416651407419,1,0,0,0.7999999999999999,0.2248918379459466,SDHAF2;FUZ;KREMEN2;HOXA7;USF3
cellular response to cytokine stimulus (GO:0071345),20/456,0.7586925684836013,1,0,0,0.8771929824561403,0.24224441381741096,STAT5B;EDN2;PTGIS;STAT3;HTRA2;PIK3R1;UBE2G2;YWHAZ;POU4F2;FOXO1;ASPN;CRKL;IL22RA1;DUOX1;IL1RL2;FLRT2;CASP3;XCL1;PTPN7;SOCS4
protein targeting to mitochondrion (GO:0006626),2/54,0.7596159436572443,1,0,0,0.7407407407407407,0.2036609709042825,TOMM20L;HSPD1
cellular response to tumor necrosis factor (GO:0071356),8/194,0.7596168702829397,1,0,0,0.8247422680412371,0.22675553885422534,PSMB6;NFKBIA;PSMB3;TNFRSF18;LTA;XCL1;TNFRSF11A;ST18
cytoskeleton organization (GO:0007010),5/126,0.7610581948279559,1,0,0,0.7936507936507936,0.21670274009732135,DPYSL2;KRT25;PAK6;PAK5;SIPA1
regulation of vasculature development (GO:1901342),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,NF1
negative regulation of endocytosis (GO:0045806),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,NR1H2
RNA polyadenylation (GO:0043631),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,FIP1L1
cellular response to ketone (GO:1901655),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,PTGER2
RNA phosphodiester bond hydrolysis (GO:0090501),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,MRPL44
acute inflammatory response (GO:0002526),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,CEBPB
cellular amino acid biosynthetic process (GO:0008652),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,ASPA
positive regulation of phosphate metabolic process (GO:0045937),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,MIF
positive regulation of protein tyrosine kinase activity (GO:0061098),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,DOK7
organelle fission (GO:0048285),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,PEX19
regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,BMPER
lytic vacuole organization (GO:0080171),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,HOOK3
negative regulation of JNK cascade (GO:0046329),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,GSTP1
cardiac muscle cell action potential involved in contraction (GO:0086002),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,KCNA5
production of miRNAs involved in gene silencing by miRNA (GO:0035196),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,MRPL44
triglyceride homeostasis (GO:0070328),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,NR1H4
regulation of defense response to virus by virus (GO:0050690),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,ELMO1
protein K63-linked deubiquitination (GO:0070536),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,ABRAXAS2
regulation of actin polymerization or depolymerization (GO:0008064),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,SSH2
bicellular tight junction assembly (GO:0070830),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,CRB3
protein import into nucleus (GO:0006606),4/103,0.7633839575456066,1,0,0,0.7766990291262135,0.20970419679401037,BCL3;STAT3;IPO4;TNPO3
regulation of axonogenesis (GO:0050770),2/55,0.7685284162153218,1,0,0,0.7272727272727272,0.1914747203489268,PAK1;SSH2
regulation of RNA splicing (GO:0043484),2/55,0.7685284162153218,1,0,0,0.7272727272727272,0.1914747203489268,PIK3R1;RPS13
DNA recombination (GO:0006310),2/55,0.7685284162153218,1,0,0,0.7272727272727272,0.1914747203489268,RTEL1;ERCC1
regulation of cellular response to stress (GO:0080135),4/104,0.7699363530876122,1,0,0,0.7692307692307693,0.20111340452197826,HSP90AB1;AKT1S1;MLST8;IER3
mRNA transport (GO:0051028),4/104,0.7699363530876122,1,0,0,0.7692307692307693,0.20111340452197826,UPF2;NXF1;HHEX;FIP1L1
cellular response to hormone stimulus (GO:0032870),3/80,0.7699574892635191,1,0,0,0.7499999999999999,0.1960649808053572,STAT5B;STAT3;CTSS
defense response to bacterium (GO:0042742),10/241,0.7702799299779656,1,0,0,0.8298755186721991,0.21659857657685055,GSDMC;CEBPB;RNASE8;RARRES2;ADGRB1;S100A12;DEFB124;DEFB4A;RPL39;LYZL4
ion transmembrane transport (GO:0034220),9/219,0.7718008106095379,1,0,0,0.821917808219178,0.21290036679018165,ATP4A;GABRR2;STOML3;CHRNA3;PDZD11;CLCNKA;LRRIQ4;ATP2C1;CALHM6
positive regulation of mitochondrion organization (GO:0010822),5/128,0.7729447333197296,1,0,0,0.78125,0.20120916351791152,USP36;ELMOD1;ARIH2;HTRA2;CIDEB
dicarboxylic acid transport (GO:0006835),1/29,0.7743049289744676,1,0,0,0.689655172413793,0.17640656406412805,SLC1A6
very long-chain fatty acid metabolic process (GO:0000038),1/29,0.7743049289744676,1,0,0,0.689655172413793,0.17640656406412805,ACOT4
collagen fibril organization (GO:0030199),1/29,0.7743049289744676,1,0,0,0.689655172413793,0.17640656406412805,NF1
synaptic vesicle endocytosis (GO:0048488),1/29,0.7743049289744676,1,0,0,0.689655172413793,0.17640656406412805,SYT2
keratan sulfate biosynthetic process (GO:0018146),1/29,0.7743049289744676,1,0,0,0.689655172413793,0.17640656406412805,B4GALT5
regulation of vasoconstriction (GO:0019229),1/29,0.7743049289744676,1,0,0,0.689655172413793,0.17640656406412805,PER2
positive regulation of histone modification (GO:0031058),1/29,0.7743049289744676,1,0,0,0.689655172413793,0.17640656406412805,TADA2B
negative regulation of Notch signaling pathway (GO:0045746),1/29,0.7743049289744676,1,0,0,0.689655172413793,0.17640656406412805,LFNG
negative regulation of lymphocyte proliferation (GO:0050672),1/29,0.7743049289744676,1,0,0,0.689655172413793,0.17640656406412805,CEBPB
B cell proliferation (GO:0042100),1/29,0.7743049289744676,1,0,0,0.689655172413793,0.17640656406412805,HSPD1
synaptic vesicle recycling (GO:0036465),1/29,0.7743049289744676,1,0,0,0.689655172413793,0.17640656406412805,SYT2
MyD88-dependent toll-like receptor signaling pathway (GO:0002755),1/29,0.7743049289744676,1,0,0,0.689655172413793,0.17640656406412805,HSPD1
amino acid transmembrane transport (GO:0003333),1/29,0.7743049289744676,1,0,0,0.689655172413793,0.17640656406412805,SLC38A2
respiratory system development (GO:0060541),1/29,0.7743049289744676,1,0,0,0.689655172413793,0.17640656406412805,BASP1
carbohydrate derivative biosynthetic process (GO:1901137),1/29,0.7743049289744676,1,0,0,0.689655172413793,0.17640656406412805,ALG2
positive regulation of cytokine production (GO:0001819),9/220,0.7763020553794393,1,0,0,0.8181818181818181,0.20717475374678998,CCBE1;CEBPB;CRCP;IFI16;XCL1;CYBA;MIF;HSPD1;SOD1
mRNA export from nucleus (GO:0006406),4/105,0.7763456159434972,1,0,0,0.761904761904762,0.192881886919067,UPF2;NXF1;HHEX;FIP1L1
ribosome assembly (GO:0042255),2/56,0.7771517166186133,1,0,0,0.7142857142857142,0.180085491565519,SBDS;RPL24
regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),2/56,0.7771517166186133,1,0,0,0.7142857142857142,0.180085491565519,GSTP1;CCDC3
regulation of BMP signaling pathway (GO:0030510),2/56,0.7771517166186133,1,0,0,0.7142857142857142,0.180085491565519,SPART;BMPER
protein import (GO:0017038),2/56,0.7771517166186133,1,0,0,0.7142857142857142,0.180085491565519,STAT3;TNPO3
negative regulation of cellular catabolic process (GO:0031330),2/56,0.7771517166186133,1,0,0,0.7142857142857142,0.180085491565519,EIF4G2;PLIN5
autophagosome organization (GO:1905037),2/56,0.7771517166186133,1,0,0,0.7142857142857142,0.180085491565519,PACS2;ATG9A
ATP metabolic process (GO:0046034),2/56,0.7771517166186133,1,0,0,0.7142857142857142,0.180085491565519,CTNS;NADK
BMP signaling pathway (GO:0030509),3/81,0.7771926567464108,1,0,0,0.7407407407407407,0.18671630360614933,AMHR2;RUNX2;BMP6
"DNA-templated transcription, termination (GO:0006353)",4/106,0.7826130830889017,1,0,0,0.7547169811320754,0.1849938504751301,FIP1L1;CCNH;POLR1B;GTF2H1
spermatogenesis (GO:0007283),6/153,0.7826524992964198,1,0,0,0.7843137254901961,0.19220901041264157,MYCBP;CATSPERD;TESMIN;TNP2;RBMY1B;SOD1
regulation of anatomical structure morphogenesis (GO:0022603),3/82,0.7842396846897038,1,0,0,0.7317073170731706,0.17783457445402553,LFNG;CDX2;NF1
"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",3/82,0.7842396846897038,1,0,0,0.7317073170731706,0.17783457445402553,SESN2;BCL3;MDM4
mitotic sister chromatid segregation (GO:0000070),3/82,0.7842396846897038,1,0,0,0.7317073170731706,0.17783457445402553,PHF23;KLHL22;DIS3L2
"retrograde transport, endosome to Golgi (GO:0042147)",3/82,0.7842396846897038,1,0,0,0.7317073170731706,0.17783457445402553,DCTN1;TBC1D10A;BET1L
positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),3/82,0.7842396846897038,1,0,0,0.7317073170731706,0.17783457445402553,HSP90AB1;INHBA;BMP6
chloride transmembrane transport (GO:1902476),2/57,0.7854924470082494,1,0,0,0.7017543859649122,0.16943469252891025,CLIC6;CLCNKA
I-kappaB kinase/NF-kappaB signaling (GO:0007249),2/57,0.7854924470082494,1,0,0,0.7017543859649122,0.16943469252891025,NFKBIA;BCL3
ribosomal large subunit assembly (GO:0000027),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,RPL24
regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,YWHAZ
negative regulation of endothelial cell proliferation (GO:0001937),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,NF1
beta-catenin-TCF complex assembly (GO:1904837),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,TLE1
hippo signaling (GO:0035329),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,CASP3
replication fork processing (GO:0031297),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,RTEL1
bile acid and bile salt transport (GO:0015721),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,NR1H4
negative regulation of DNA biosynthetic process (GO:2000279),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,DACH1
fatty-acyl-CoA biosynthetic process (GO:0046949),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,ACSL6
'de novo' posttranslational protein folding (GO:0051084),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,UGGT1
positive regulation of cation channel activity (GO:2001259),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,CTSS
protein localization to lysosome (GO:0061462),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,CACNG5
positive regulation of phospholipase C activity (GO:0010863),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,S1PR4
artery morphogenesis (GO:0048844),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,NF1
positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,YWHAZ
positive regulation of B cell proliferation (GO:0030890),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,MIF
nuclear envelope organization (GO:0006998),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,DCTN1
CENP-A containing nucleosome assembly (GO:0034080),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,CENPO
CENP-A containing chromatin organization (GO:0061641),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,CENPO
bile acid metabolic process (GO:0008206),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,GBA2
regulation of angiogenesis (GO:0045765),7/177,0.7873883393387747,1,0,0,0.7909604519774012,0.18906621102380866,ECM1;HHEX;PTGIS;ADGRB1;ECSCR;NF1;ZNF304
male gamete generation (GO:0048232),6/154,0.7878188191943859,1,0,0,0.7792207792207791,0.1858341354087713,MYCBP;CATSPERD;TESMIN;TNP2;RBMY1B;SOD1
positive regulation of epithelial cell proliferation (GO:0050679),4/107,0.7887401751709202,1,0,0,0.747663551401869,0.1774342589951246,ECM1;OSR1;ZNF304;BMP6
negative regulation of response to external stimulus (GO:0032102),4/107,0.7887401751709202,1,0,0,0.747663551401869,0.1774342589951246,GRID2;PTGIS;NR1H4;TNFAIP8L2
regulation of protein secretion (GO:0050708),4/107,0.7887401751709202,1,0,0,0.747663551401869,0.1774342589951246,PER2;KCNA5;SLC25A5;BMP6
negative regulation of neuron death (GO:1901215),3/83,0.7911013287526669,1,0,0,0.7228915662650601,0.1693946149369998,HTRA2;NAIP;SOD1
protein maturation (GO:0051604),3/83,0.7911013287526669,1,0,0,0.7228915662650601,0.1693946149369998,CTSS;PCSK4;HSPD1
cellular response to lipid (GO:0071396),7/178,0.7921477736375266,1,0,0,0.7865168539325842,0.1832641856039621,VDR;INSIG1;GSTP1;NR1H2;NR1H4;HTRA2;POU4F2
negative regulation of protein phosphorylation (GO:0001933),7/178,0.7921477736375266,1,0,0,0.7865168539325842,0.1832641856039621,DEPTOR;FLRT2;GSTP1;AKT1S1;NF1;SOCS4;ASPN
response to light stimulus (GO:0009416),2/58,0.7935572729047958,1,0,0,0.689655172413793,0.15946866485970154,PER2;UBE2A
ubiquitin-dependent ERAD pathway (GO:0030433),2/58,0.7935572729047958,1,0,0,0.689655172413793,0.15946866485970154,AUP1;UBE2G2
tRNA modification (GO:0006400),2/58,0.7935572729047958,1,0,0,0.689655172413793,0.15946866485970154,MTO1;TARBP1
autophagosome assembly (GO:0000045),2/58,0.7935572729047958,1,0,0,0.689655172413793,0.15946866485970154,PACS2;ATG9A
integrin-mediated signaling pathway (GO:0007229),2/58,0.7935572729047958,1,0,0,0.689655172413793,0.15946866485970154,ZNF304;LAT
negative regulation of hydrolase activity (GO:0051346),4/108,0.7947283904475327,1,0,0,0.7407407407407407,0.1701887925469081,ECM1;PCDH11X;ZFYVE1;PLIN5
cellular response to hypoxia (GO:0071456),5/132,0.7953524382434503,1,0,0,0.7575757575757576,0.17346207880243836,PSMB6;PTGIS;EPAS1;PSMB3;MDM4
regulation of dendritic spine development (GO:0060998),1/31,0.7963417210162199,1,0,0,0.6451612903225806,0.1469205725810339,FXR2
positive regulation of ubiquitin-protein transferase activity (GO:0051443),1/31,0.7963417210162199,1,0,0,0.6451612903225806,0.1469205725810339,ANAPC10
negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),1/31,0.7963417210162199,1,0,0,0.6451612903225806,0.1469205725810339,GSTP1
positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),1/31,0.7963417210162199,1,0,0,0.6451612903225806,0.1469205725810339,XCL1
regulation of glucose import (GO:0046324),1/31,0.7963417210162199,1,0,0,0.6451612903225806,0.1469205725810339,PIK3R1
positive regulation of protein dephosphorylation (GO:0035307),1/31,0.7963417210162199,1,0,0,0.6451612903225806,0.1469205725810339,HSP90AB1
regulation of protein tyrosine kinase activity (GO:0061097),1/31,0.7963417210162199,1,0,0,0.6451612903225806,0.1469205725810339,DOK7
skeletal system morphogenesis (GO:0048705),1/31,0.7963417210162199,1,0,0,0.6451612903225806,0.1469205725810339,FUZ
positive regulation of interleukin-1 beta production (GO:0032731),1/31,0.7963417210162199,1,0,0,0.6451612903225806,0.1469205725810339,IFI16
lysosome organization (GO:0007040),1/31,0.7963417210162199,1,0,0,0.6451612903225806,0.1469205725810339,HOOK3
regulation of cytokine secretion (GO:0050707),1/31,0.7963417210162199,1,0,0,0.6451612903225806,0.1469205725810339,MIF
positive regulation of cell motility (GO:2000147),7/179,0.7968264892762255,1,0,0,0.7821229050279329,0.17763444702070694,TCAF2;PAK1;DDRGK1;TACR2;ZNF304;ELP5;CCAR1
positive regulation of multicellular organismal process (GO:0051240),8/202,0.7969426233488249,1,0,0,0.792079207920792,0.17978027212892997,SNX4;IFI16;VDR;ESRRB;ALOX12B;OTX2;INHBA;SOD1
positive regulation of supramolecular fiber organization (GO:1902905),3/84,0.7977804363560652,1,0,0,0.7142857142857142,0.16137275842992269,PAK1;DCTN1;SYNPO2
regulation of cell cycle G2/M phase transition (GO:1902749),3/84,0.7977804363560652,1,0,0,0.7142857142857142,0.16137275842992269,DCTN1;NDE1;HAUS5
regulation of neuron differentiation (GO:0045664),3/84,0.7977804363560652,1,0,0,0.7142857142857142,0.16137275842992269,ZC4H2;NCS1;NDEL1
Wnt signaling pathway (GO:0016055),4/109,0.8005792983505415,1,0,0,0.7339449541284404,0.1632438094873767,TNKS2;CUL1;WNT16;CSNK1G1
regulation of extrinsic apoptotic signaling pathway (GO:2001236),2/59,0.8013529002820844,1,0,0,0.6779661016949152,0.15013820630777816,DEPTOR;GSTP1
dicarboxylic acid metabolic process (GO:0043648),2/59,0.8013529002820844,1,0,0,0.6779661016949152,0.15013820630777816,STAT5B;ACOT4
viral gene expression (GO:0019080),4/110,0.8062945339593786,1,0,0,0.7272727272727272,0.1565863101665403,RPL24;RPL39;RPS21;RPS13
protein deacetylation (GO:0006476),1/32,0.806540365201665,1,0,0,0.625,0.13437583301390715,HDAC4
positive regulation of calcium ion transport into cytosol (GO:0010524),1/32,0.806540365201665,1,0,0,0.625,0.13437583301390715,XCL1
response to zinc ion (GO:0010043),1/32,0.806540365201665,1,0,0,0.625,0.13437583301390715,ZNF658
cellular response to glucagon stimulus (GO:0071377),1/32,0.806540365201665,1,0,0,0.625,0.13437583301390715,GCGR
sister chromatid segregation (GO:0000819),1/32,0.806540365201665,1,0,0,0.625,0.13437583301390715,KLHL22
chromatin remodeling at centromere (GO:0031055),1/32,0.806540365201665,1,0,0,0.625,0.13437583301390715,CENPO
microtubule bundle formation (GO:0001578),1/32,0.806540365201665,1,0,0,0.625,0.13437583301390715,MAPRE2
cyclic-nucleotide-mediated signaling (GO:0019935),1/32,0.806540365201665,1,0,0,0.625,0.13437583301390715,EPHA5
negative regulation of receptor activity (GO:2000272),1/32,0.806540365201665,1,0,0,0.625,0.13437583301390715,SOCS4
phagosome maturation (GO:0090382),1/32,0.806540365201665,1,0,0,0.625,0.13437583301390715,RAB31
activation of adenylate cyclase activity (GO:0007190),1/32,0.806540365201665,1,0,0,0.625,0.13437583301390715,CAP1
endodermal cell differentiation (GO:0035987),1/32,0.806540365201665,1,0,0,0.625,0.13437583301390715,INHBA
positive regulation of transcription factor import into nucleus (GO:0042993),1/32,0.806540365201665,1,0,0,0.625,0.13437583301390715,PIK3R1
mismatch repair (GO:0006298),1/32,0.806540365201665,1,0,0,0.625,0.13437583301390715,LIG1
positive regulation of myeloid leukocyte differentiation (GO:0002763),1/32,0.806540365201665,1,0,0,0.625,0.13437583301390715,POU4F2
axon guidance (GO:0007411),6/158,0.8075497749747111,1,0,0,0.7594936708860759,0.1623422164173327,EPHA5;ANOS1;RANBP9;OTX2;PIK3R1;POU4F2
"regulation of mRNA splicing, via spliceosome (GO:0048024)",2/60,0.8088860547790443,1,0,0,0.6666666666666666,0.14139814589399213,HNRNPL;RBM4
nucleosome assembly (GO:0006334),2/60,0.8088860547790443,1,0,0,0.6666666666666666,0.14139814589399213,GRWD1;IPO4
regulation of stress fiber assembly (GO:0051492),2/60,0.8088860547790443,1,0,0,0.6666666666666666,0.14139814589399213,PAK1;STMN1
toll-like receptor signaling pathway (GO:0002224),3/86,0.8106028254070419,1,0,0,0.6976744186046511,0.14649563666446674,NR1H4;CTSS;HSPD1
ubiquitin-dependent protein catabolic process (GO:0006511),14/341,0.8113919799604691,1,0,0,0.8211143695014662,0.17161619791289887,FBXW5;CUL1;RNF6;UBE2G2;UBE2A;ANAPC10;ANAPC11;PSMB6;PCNP;KCTD10;PSMB3;ARIH2;MVB12A;TRIM25
cellular response to oxygen-containing compound (GO:1901701),11/274,0.8122111565206551,1,0,0,0.802919708029197,0.16700322658038597,PRDX5;SPAAR;VDR;GSTP1;NR1H2;INSIG1;SESN2;PXMP2;NR1H4;HTRA2;POU4F2
potassium ion transport (GO:0006813),2/61,0.8161634632362453,1,0,0,0.6557377049180327,0.1332069649091696,KCNA5;KCNK1
regulation of tyrosine phosphorylation of STAT protein (GO:0042509),2/61,0.8161634632362453,1,0,0,0.6557377049180327,0.1332069649091696,TNFRSF18;STAT3
regulation of vesicle fusion (GO:0031338),2/61,0.8161634632362453,1,0,0,0.6557377049180327,0.1332069649091696,TBC1D4;TBC1D10A
positive regulation of T cell proliferation (GO:0042102),2/61,0.8161634632362453,1,0,0,0.6557377049180327,0.1332069649091696,EBI3;ZP4
negative regulation of viral life cycle (GO:1903901),2/61,0.8161634632362453,1,0,0,0.6557377049180327,0.1332069649091696,IFI16;OASL
protein targeting to membrane (GO:0006612),2/61,0.8161634632362453,1,0,0,0.6557377049180327,0.1332069649091696,PEX19;SRPRA
negative regulation of MAP kinase activity (GO:0043407),2/61,0.8161634632362453,1,0,0,0.6557377049180327,0.1332069649091696,GSTP1;NF1
axonemal dynein complex assembly (GO:0070286),1/33,0.8162287694193023,1,0,0,0.6060606060606061,0.12306703553305594,CFAP100
activation of MAPKK activity (GO:0000186),1/33,0.8162287694193023,1,0,0,0.6060606060606061,0.12306703553305594,CRKL
protein acetylation (GO:0006473),1/33,0.8162287694193023,1,0,0,0.6060606060606061,0.12306703553305594,FOXO1
stem cell differentiation (GO:0048863),1/33,0.8162287694193023,1,0,0,0.6060606060606061,0.12306703553305594,OSR1
regulation of cell-substrate adhesion (GO:0010810),1/33,0.8162287694193023,1,0,0,0.6060606060606061,0.12306703553305594,NF1
positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),1/33,0.8162287694193023,1,0,0,0.6060606060606061,0.12306703553305594,SOD1
embryonic organ morphogenesis (GO:0048562),1/33,0.8162287694193023,1,0,0,0.6060606060606061,0.12306703553305594,FUZ
regulation of phosphatidylinositol 3-kinase activity (GO:0043551),1/33,0.8162287694193023,1,0,0,0.6060606060606061,0.12306703553305594,PIK3R1
positive regulation of locomotion (GO:0040017),1/33,0.8162287694193023,1,0,0,0.6060606060606061,0.12306703553305594,RARRES2
regulation of intracellular protein transport (GO:0033157),1/33,0.8162287694193023,1,0,0,0.6060606060606061,0.12306703553305594,NDEL1
regulation of interleukin-12 production (GO:0032655),1/33,0.8162287694193023,1,0,0,0.6060606060606061,0.12306703553305594,HSPD1
cellular response to BMP stimulus (GO:0071773),3/87,0.8167521653641692,1,0,0,0.689655172413793,0.13959970848873965,AMHR2;RUNX2;BMP6
regulation of MAP kinase activity (GO:0043405),3/87,0.8167521653641692,1,0,0,0.689655172413793,0.13959970848873965,GSTP1;NF1;S100A12
protein localization to membrane (GO:0072657),6/160,0.8168643739779579,1,0,0,0.7499999999999999,0.15171165211906248,MRAP;PACS2;PDZD11;NRXN2;HPS6;CRB3
positive regulation of cellular process (GO:0048522),22/519,0.8169268383145423,1,0,0,0.8477842003853564,0.17142682932590336,HDAC4;HSP90AB1;EDN2;KMT2A;REG1A;CIDEB;HTRA2;TNFRSF11A;UBE2A;NCMAP;POU4F2;FGF3;CCAR1;CRKL;FOSL1;PAK1;CCND2;FTMT;DDRGK1;CDK4;SLC25A5;EIF4G2
positive regulation of macromolecule metabolic process (GO:0010604),11/276,0.8193212421558144,1,0,0,0.7971014492753622,0.1588456075843277,TLE1;FUBP3;DDRGK1;VDR;LAMP3;OSR1;STAT3;ALOX12B;MITF;INHBA;WNT16
positive regulation of transferase activity (GO:0051347),5/137,0.8208780761188903,1,0,0,0.72992700729927,0.14407349424250715,EPHA5;HSP90AB1;RFC4;PNKP;EPHB4
negative regulation of intracellular signal transduction (GO:1902532),6/161,0.8213866488058535,1,0,0,0.7453416149068323,0.14665440878370145,DEPTOR;TLE1;GSTP1;AKT1S1;NF1;NR1H4
positive regulation of developmental process (GO:0051094),4/113,0.8226434279131911,1,0,0,0.7079646017699115,0.13821765033879096,HSP90AB1;ESRRB;OTX2;POU4F2
positive regulation of canonical Wnt signaling pathway (GO:0090263),4/113,0.8226434279131911,1,0,0,0.7079646017699115,0.13821765033879096,PSMB6;TNKS2;PSMB3;NAIP
T cell activation (GO:0042110),3/88,0.8227310669841436,1,0,0,0.6818181818181818,0.1330403886090264,LFNG;LAT;HSPD1
"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",3/88,0.8227310669841436,1,0,0,0.6818181818181818,0.1330403886090264,PSMB6;PSMB3;ARHGEF19
positive regulation of catabolic process (GO:0009896),2/62,0.8231918367006723,1,0,0,0.6451612903225806,0.12552645874570276,ASB9;FOXO1
cellular amide metabolic process (GO:0043603),2/62,0.8231918367006723,1,0,0,0.6451612903225806,0.12552645874570276,STAT5B;PDZD11
stress-activated MAPK cascade (GO:0051403),2/62,0.8231918367006723,1,0,0,0.6451612903225806,0.12552645874570276,CUL1;CRKL
negative regulation of peptidase activity (GO:0010466),2/62,0.8231918367006723,1,0,0,0.6451612903225806,0.12552645874570276,ECM1;SERPINB2
regulation of T cell proliferation (GO:0042129),2/62,0.8231918367006723,1,0,0,0.6451612903225806,0.12552645874570276,CEBPB;ZP4
epithelial tube morphogenesis (GO:0060562),1/34,0.8254324369271197,1,0,0,0.588235294117647,0.11285168470716885,PAK1
embryonic limb morphogenesis (GO:0030326),1/34,0.8254324369271197,1,0,0,0.588235294117647,0.11285168470716885,OSR1
negative regulation of cellular metabolic process (GO:0031324),1/34,0.8254324369271197,1,0,0,0.588235294117647,0.11285168470716885,PLIN5
keratan sulfate metabolic process (GO:0042339),1/34,0.8254324369271197,1,0,0,0.588235294117647,0.11285168470716885,B4GALT5
regulation of wound healing (GO:0061041),1/34,0.8254324369271197,1,0,0,0.588235294117647,0.11285168470716885,SPAAR
response to peptide (GO:1901652),1/34,0.8254324369271197,1,0,0,0.588235294117647,0.11285168470716885,REG1A
positive regulation of DNA binding (GO:0043388),1/34,0.8254324369271197,1,0,0,0.588235294117647,0.11285168470716885,POU4F2
bone development (GO:0060348),1/34,0.8254324369271197,1,0,0,0.588235294117647,0.11285168470716885,SBDS
regulation of insulin receptor signaling pathway (GO:0046626),1/34,0.8254324369271197,1,0,0,0.588235294117647,0.11285168470716885,GRB14
negative regulation of endothelial cell migration (GO:0010596),1/34,0.8254324369271197,1,0,0,0.588235294117647,0.11285168470716885,ADGRB1
regulation of interleukin-1 beta secretion (GO:0050706),1/34,0.8254324369271197,1,0,0,0.588235294117647,0.11285168470716885,CARD18
regulation of interferon-beta production (GO:0032648),1/34,0.8254324369271197,1,0,0,0.588235294117647,0.11285168470716885,IFIH1
cellular macromolecular complex assembly (GO:0034622),1/34,0.8254324369271197,1,0,0,0.588235294117647,0.11285168470716885,TMED10
positive regulation of intracellular signal transduction (GO:1902533),20/479,0.8269016708800515,1,0,0,0.8350730688935282,0.15872191198374538,EPHA5;OSBPL8;ECM1;SLC20A1;CARD9;ALOX12B;TNFRSF11A;MIF;PIK3R1;WNT16;ATP2C1;FGF3;FGF17;HTR6;MLST8;S100A12;TRIM25;RICTOR;EPHB4;FGF22
regulation of establishment of planar polarity (GO:0090175),3/89,0.8285426848935676,1,0,0,0.6741573033707865,0.1268001726406977,PSMB6;PSMB3;ARHGEF19
regulation of signal transduction (GO:0009966),9/233,0.8290606001734251,1,0,0,0.7725321888412018,0.1448204494161753,EPHA5;LFNG;DACT3;OTX2;FUZ;IGFBP6;EPHB4;NAIP;RGS6
kidney development (GO:0001822),2/63,0.8299778549215587,1,0,0,0.6349206349206349,0.1183214345173536,OSR1;NF1
regulation of viral genome replication (GO:0045069),2/63,0.8299778549215587,1,0,0,0.6349206349206349,0.1183214345173536,IFI16;OASL
regulation of proteolysis (GO:0030162),2/63,0.8299778549215587,1,0,0,0.6349206349206349,0.1183214345173536,IST1;TBC1D10A
negative regulation of dephosphorylation (GO:0035305),2/63,0.8299778549215587,1,0,0,0.6349206349206349,0.1183214345173536,PCDH11X;ZFYVE1
negative regulation of neuron apoptotic process (GO:0043524),2/63,0.8299778549215587,1,0,0,0.6349206349206349,0.1183214345173536,NAIP;SOD1
"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",2/63,0.8299778549215587,1,0,0,0.6349206349206349,0.1183214345173536,EXOSC7;LSM1
regulation of protein kinase B signaling (GO:0051896),6/163,0.8301653781445008,1,0,0,0.7361963190184049,0.13702847651248054,FGF17;OSBPL8;RICTOR;PIK3R1;FGF3;FGF22
cellular response to growth factor stimulus (GO:0071363),5/139,0.8303434515247903,1,0,0,0.7194244604316546,0.13375242213240954,STAT5B;HTRA2;XCL1;RUNX2;BMP6
peptidyl-lysine modification (GO:0018205),4/115,0.832896768257819,1,0,0,0.6956521739130435,0.12719691976114322,IFIH1;HDAC4;MITF;PIAS2
positive regulation of RNA metabolic process (GO:0051254),1/35,0.8341755971925006,1,0,0,0.5714285714285714,0.103606486053202,PIK3R1
regulation of heart rate by cardiac conduction (GO:0086091),1/35,0.8341755971925006,1,0,0,0.5714285714285714,0.103606486053202,KCNA5
positive regulation of NIK/NF-kappaB signaling (GO:1901224),1/35,0.8341755971925006,1,0,0,0.5714285714285714,0.103606486053202,CARD10
antibacterial humoral response (GO:0019731),1/35,0.8341755971925006,1,0,0,0.5714285714285714,0.103606486053202,RPL39
negative regulation of cell-substrate adhesion (GO:0010812),1/35,0.8341755971925006,1,0,0,0.5714285714285714,0.103606486053202,HOXA7
positive regulation of peptide secretion (GO:0002793),1/35,0.8341755971925006,1,0,0,0.5714285714285714,0.103606486053202,BMP6
regulation of endothelial cell apoptotic process (GO:2000351),1/35,0.8341755971925006,1,0,0,0.5714285714285714,0.103606486053202,ECSCR
anatomical structure homeostasis (GO:0060249),1/35,0.8341755971925006,1,0,0,0.5714285714285714,0.103606486053202,RTEL1
positive regulation of DNA replication (GO:0045740),1/35,0.8341755971925006,1,0,0,0.5714285714285714,0.103606486053202,BMP6
negative regulation of epithelial cell migration (GO:0010633),1/35,0.8341755971925006,1,0,0,0.5714285714285714,0.103606486053202,ADGRB1
apical junction assembly (GO:0043297),1/35,0.8341755971925006,1,0,0,0.5714285714285714,0.103606486053202,CRB3
regulation of mitotic spindle organization (GO:0060236),1/35,0.8341755971925006,1,0,0,0.5714285714285714,0.103606486053202,DCTN1
"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",1/35,0.8341755971925006,1,0,0,0.5714285714285714,0.103606486053202,RPS21
tRNA transport (GO:0051031),1/35,0.8341755971925006,1,0,0,0.5714285714285714,0.103606486053202,TOMM20L
regulation of synapse assembly (GO:0051963),1/35,0.8341755971925006,1,0,0,0.5714285714285714,0.103606486053202,GRID2
positive regulation of ATPase activity (GO:0032781),1/35,0.8341755971925006,1,0,0,0.5714285714285714,0.103606486053202,ALDOB
regulation of phosphoprotein phosphatase activity (GO:0043666),1/35,0.8341755971925006,1,0,0,0.5714285714285714,0.103606486053202,HSP90AB1
carboxylic acid transmembrane transport (GO:1905039),1/35,0.8341755971925006,1,0,0,0.5714285714285714,0.103606486053202,SLC38A2
flagellated sperm motility (GO:0030317),1/35,0.8341755971925006,1,0,0,0.5714285714285714,0.103606486053202,CATSPERD
actin filament bundle organization (GO:0061572),1/35,0.8341755971925006,1,0,0,0.5714285714285714,0.103606486053202,RND1
DNA-dependent DNA replication maintenance of fidelity (GO:0045005),1/35,0.8341755971925006,1,0,0,0.5714285714285714,0.103606486053202,RTEL1
cell-matrix adhesion (GO:0007160),3/90,0.8341902087803339,1,0,0,0.6666666666666666,0.120862556363351,WHAMM;LYVE1;THBS3
regulation of JNK cascade (GO:0046328),3/90,0.8341902087803339,1,0,0,0.6666666666666666,0.120862556363351,CARD9;WNT16;MAPK8IP1
negative regulation of sequence-specific DNA binding transcription factor activity (GO:0043433),5/140,0.8349213737401235,1,0,0,0.7142857142857142,0.12886980125028102,NFKBIA;HDAC4;PTGIS;XCL1;POU4F2
positive regulation of Wnt signaling pathway (GO:0030177),5/140,0.8349213737401235,1,0,0,0.7142857142857142,0.12886980125028102,PSMB6;HHEX;TNKS2;PSMB3;NAIP
positive regulation of protein polymerization (GO:0032273),2/64,0.8365281531009908,1,0,0,0.625,0.11155943955785279,PAK1;DCTN1
NADH dehydrogenase complex assembly (GO:0010257),2/64,0.8365281531009908,1,0,0,0.625,0.11155943955785279,NDUFS8;NDUFV2
mitochondrial respiratory chain complex I biogenesis (GO:0097031),2/64,0.8365281531009908,1,0,0,0.625,0.11155943955785279,NDUFS8;NDUFV2
mitochondrial respiratory chain complex I assembly (GO:0032981),2/64,0.8365281531009908,1,0,0,0.625,0.11155943955785279,NDUFS8;NDUFV2
glycerophospholipid metabolic process (GO:0006650),2/64,0.8365281531009908,1,0,0,0.625,0.11155943955785279,PIGA;PLA1A
positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),4/116,0.8378353080759515,1,0,0,0.689655172413793,0.1220232603840384,TNFRSF18;DOK7;STAT3;MIF
double-strand break repair (GO:0006302),5/141,0.8393978374467967,1,0,0,0.7092198581560284,0.12416347829381887,RNF138;ERCC1;HUS1;POLK;SPIDR
protein-DNA complex assembly (GO:0065004),3/91,0.8396768561291149,1,0,0,0.6593406593406593,0.11521197114942941,CCNH;GRWD1;GTF2H1
regulation of translation (GO:0006417),8/213,0.84093849241393,1,0,0,0.7511737089201878,0.13013089797826166,RBM4;FXR2;NEMF;BCL3;PYM1;GEMIN5;EIF4G2;EIF1
regulation of potassium ion transport (GO:0043266),1/36,0.8424812699182175,1,0,0,0.5555555555555555,0.09522436030767889,KCNA5
protein acylation (GO:0043543),1/36,0.8424812699182175,1,0,0,0.5555555555555555,0.09522436030767889,FOXO1
actin polymerization or depolymerization (GO:0008154),1/36,0.8424812699182175,1,0,0,0.5555555555555555,0.09522436030767889,CAP1
histone exchange (GO:0043486),1/36,0.8424812699182175,1,0,0,0.5555555555555555,0.09522436030767889,CENPO
organic hydroxy compound transport (GO:0015850),1/36,0.8424812699182175,1,0,0,0.5555555555555555,0.09522436030767889,NR1H4
lymphocyte proliferation (GO:0046651),1/36,0.8424812699182175,1,0,0,0.5555555555555555,0.09522436030767889,HSPD1
endoderm formation (GO:0001706),1/36,0.8424812699182175,1,0,0,0.5555555555555555,0.09522436030767889,INHBA
sodium ion transmembrane transport (GO:0035725),1/36,0.8424812699182175,1,0,0,0.5555555555555555,0.09522436030767889,KCNK1
mRNA catabolic process (GO:0006402),1/36,0.8424812699182175,1,0,0,0.5555555555555555,0.09522436030767889,DIS3L2
calcium ion transmembrane import into cytosol (GO:0097553),1/36,0.8424812699182175,1,0,0,0.5555555555555555,0.09522436030767889,XCL1
heart looping (GO:0001947),1/36,0.8424812699182175,1,0,0,0.5555555555555555,0.09522436030767889,SETDB2
plasma membrane organization (GO:0007009),1/36,0.8424812699182175,1,0,0,0.5555555555555555,0.09522436030767889,WHAMM
endosome organization (GO:0007032),1/36,0.8424812699182175,1,0,0,0.5555555555555555,0.09522436030767889,HOOK3
centromere complex assembly (GO:0034508),1/36,0.8424812699182175,1,0,0,0.5555555555555555,0.09522436030767889,CENPO
acylglycerol metabolic process (GO:0006639),1/36,0.8424812699182175,1,0,0,0.5555555555555555,0.09522436030767889,DGKZ
negative regulation of blood coagulation (GO:0030195),1/36,0.8424812699182175,1,0,0,0.5555555555555555,0.09522436030767889,SERPINB2
cardiac muscle tissue development (GO:0048738),1/36,0.8424812699182175,1,0,0,0.5555555555555555,0.09522436030767889,NDUFV2
regulation of cysteine-type endopeptidase activity (GO:2000116),1/36,0.8424812699182175,1,0,0,0.5555555555555555,0.09522436030767889,IFI16
protein localization to cell periphery (GO:1990778),4/117,0.8426510176169044,1,0,0,0.6837606837606838,0.1170614587500545,MRAP;PACS2;PDZD11;CRB3
negative regulation of apoptotic signaling pathway (GO:2001234),2/65,0.8428493095437481,1,0,0,0.6153846153846154,0.10521051812214251,GSTP1;SLC25A5
negative regulation of cell adhesion (GO:0007162),2/65,0.8428493095437481,1,0,0,0.6153846153846154,0.10521051812214251,SIPA1;RND1
positive regulation of cellular metabolic process (GO:0031325),3/92,0.845005864491722,1,0,0,0.6521739130434782,0.10983372484053684,NFKBIA;NR1H2;INHBA
cytosolic transport (GO:0016482),4/118,0.8473458741803346,1,0,0,0.6779661016949152,0.11230258687470465,DCTN1;HOOK3;TBC1D10A;BET1L
positive regulation of sequence-specific DNA binding transcription factor activity (GO:0051091),8/215,0.8480666942392859,1,0,0,0.7441860465116279,0.12263888179781321,EPHA5;NFKBIA;HDAC4;TRIM52;DDRGK1;TRIM25;S100A12;TNFRSF11A
organelle assembly (GO:0070925),15/376,0.8487592565433657,1,0,0,0.7978723404255319,0.13083486229732733,ACTR2;DBNL;IST1;DNAH14;ATG9A;NCF1B;RABL2B;FUZ;HAUS5;GOLGA8O;GOLGA2P5;GOLGA8CP;PACS2;MVB12A;RCC1
negative regulation of epithelial cell proliferation (GO:0050680),2/66,0.8489478345965421,1,0,0,0.6060606060606061,0.09924699267132996,VDR;NF1
sphingolipid biosynthetic process (GO:0030148),2/66,0.8489478345965421,1,0,0,0.6060606060606061,0.09924699267132996,ALDH3A2;ALOX12B
regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),3/93,0.8501804853980194,1,0,0,0.6451612903225806,0.10471394598415903,LAMP3;HTRA2;NAIP
regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),3/93,0.8501804853980194,1,0,0,0.6451612903225806,0.10471394598415903,PSMB6;EPAS1;PSMB3
spliceosomal snRNP assembly (GO:0000387),1/37,0.8503713249208762,1,0,0,0.5405405405405406,0.08761198488762709,GEMIN5
protein peptidyl-prolyl isomerization (GO:0000413),1/37,0.8503713249208762,1,0,0,0.5405405405405406,0.08761198488762709,PPIL4
regulation of DNA repair (GO:0006282),1/37,0.8503713249208762,1,0,0,0.5405405405405406,0.08761198488762709,POLH
positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),1/37,0.8503713249208762,1,0,0,0.5405405405405406,0.08761198488762709,YWHAZ
positive regulation of receptor activity (GO:2000273),1/37,0.8503713249208762,1,0,0,0.5405405405405406,0.08761198488762709,ALG10B
phospholipid biosynthetic process (GO:0008654),1/37,0.8503713249208762,1,0,0,0.5405405405405406,0.08761198488762709,PCYT2
positive regulation of axonogenesis (GO:0050772),1/37,0.8503713249208762,1,0,0,0.5405405405405406,0.08761198488762709,POU4F2
positive regulation of stress fiber assembly (GO:0051496),1/37,0.8503713249208762,1,0,0,0.5405405405405406,0.08761198488762709,PAK1
actin filament bundle assembly (GO:0051017),1/37,0.8503713249208762,1,0,0,0.5405405405405406,0.08761198488762709,RND1
regulation of metal ion transport (GO:0010959),1/37,0.8503713249208762,1,0,0,0.5405405405405406,0.08761198488762709,KCNA5
response to steroid hormone (GO:0048545),1/37,0.8503713249208762,1,0,0,0.5405405405405406,0.08761198488762709,CATSPERD
organic cyclic compound biosynthetic process (GO:1901362),1/37,0.8503713249208762,1,0,0,0.5405405405405406,0.08761198488762709,LSS
regulation of neuron projection development (GO:0010975),4/119,0.851921877903696,1,0,0,0.6722689075630252,0.10773811694664917,PAK1;NCS1;SSH2;NDEL1
regulation of phosphorylation (GO:0042325),4/119,0.851921877903696,1,0,0,0.6722689075630252,0.10773811694664917,SESN2;RICTOR;MIF;INHBA
RNA export from nucleus (GO:0006405),4/119,0.851921877903696,1,0,0,0.6722689075630252,0.10773811694664917,UPF2;NXF1;HHEX;FIP1L1
brain development (GO:0007420),4/119,0.851921877903696,1,0,0,0.6722689075630252,0.10773811694664917,VCX3B;NF1;CTNS;PAFAH1B2
negative regulation of cellular process (GO:0048523),22/534,0.8533275613847973,1,0,0,0.8239700374531834,0.13069136600889572,VDR;CUL1;HTRA2;FUZ;MIF;INHBA;WNT16;ST18;POU4F2;RND1;NME6;SESN2;ADGRB1;DACT3;MDM4;IGFBP6;CRLF3;SIPA1;CDKN3;DIS3L2;APOBEC3B;ZP4
negative regulation of protein binding (GO:0032091),2/67,0.8548301611907013,1,0,0,0.5970149253731343,0.0936432666623936,RALB;CARD18
extrinsic apoptotic signaling pathway (GO:0097191),2/67,0.8548301611907013,1,0,0,0.5970149253731343,0.0936432666623936,CASP3;INHBA
cellular response to UV (GO:0034644),2/67,0.8548301611907013,1,0,0,0.5970149253731343,0.0936432666623936,ERCC1;USP28
regulation of protein localization to plasma membrane (GO:1903076),2/67,0.8548301611907013,1,0,0,0.5970149253731343,0.0936432666623936,MRAP;PIK3R1
vesicle fusion (GO:0006906),3/94,0.855203978006065,1,0,0,0.6382978723404255,0.09983953259459333,SYT2;STX19;SYT9
actin filament organization (GO:0007015),4/120,0.8563810483662649,1,0,0,0.6666666666666666,0.10335990128643677,CAP1;WHAMM;PPP1R9A;RND1
sensory perception of smell (GO:0007608),9/241,0.8564176317450342,1,0,0,0.7468879668049792,0.11576549447269525,OR2W5;OR13J1;OR2AG1;OR2B11;OR5B12;OR10G8;OR5D16;OR2T8;OR5AK2
DNA repair (GO:0006281),11/288,0.8577848610413262,1,0,0,0.763888888888889,0.11718204944948626,ALKBH2;RFC4;LIG1;ASCC1;PNKP;ERCC1;HUS1;GTF2H1;UBE2A;POLK;POLH
potassium ion import (GO:0010107),1/38,0.8578665401729517,1,0,0,0.5263157894736842,0.08068775746154062,ATP4A
T cell differentiation (GO:0030217),1/38,0.8578665401729517,1,0,0,0.5263157894736842,0.08068775746154062,LFNG
positive regulation of neuron death (GO:1901216),1/38,0.8578665401729517,1,0,0,0.5263157894736842,0.08068775746154062,NF1
muscle filament sliding (GO:0030049),1/38,0.8578665401729517,1,0,0,0.5263157894736842,0.08068775746154062,MYL6
actin-myosin filament sliding (GO:0033275),1/38,0.8578665401729517,1,0,0,0.5263157894736842,0.08068775746154062,MYL6
regulation of ossification (GO:0030278),1/38,0.8578665401729517,1,0,0,0.5263157894736842,0.08068775746154062,KREMEN2
peptidyl-serine modification (GO:0018209),6/170,0.8581972449758943,1,0,0,0.7058823529411764,0.10794445882261061,GALNT14;GALNT2;RICTOR;STK32A;GALNT10;CSNK1G1
positive regulation of protein localization to membrane (GO:1905477),3/95,0.86007960317269,1,0,0,0.631578947368421,0.09519810454070905,TCAF2;PIK3R1;YWHAZ
regulation of epithelial to mesenchymal transition (GO:0010717),2/68,0.860502636162266,1,0,0,0.588235294117647,0.08837564694787858,SDHAF2;USF3
negative regulation of phosphatase activity (GO:0010923),2/68,0.860502636162266,1,0,0,0.588235294117647,0.08837564694787858,PCDH11X;ZFYVE1
monocarboxylic acid biosynthetic process (GO:0072330),2/68,0.860502636162266,1,0,0,0.588235294117647,0.08837564694787858,PER2;ACSM3
cholesterol metabolic process (GO:0008203),2/68,0.860502636162266,1,0,0,0.588235294117647,0.08837564694787858,HMGCS1;LSS
positive regulation of T cell activation (GO:0050870),2/68,0.860502636162266,1,0,0,0.588235294117647,0.08837564694787858,ZP4;HSPD1
ion transport (GO:0006811),11/289,0.8606759332603792,1,0,0,0.7612456747404844,0.11421519203659355,ATP4A;GABRR2;STOML3;CHRNA3;SLC20A1;PDZD11;CLCNKA;CTNS;SLC1A6;ATP2C1;CALHM6
negative regulation of cell migration (GO:0030336),4/121,0.8607254206096335,1,0,0,0.6611570247933884,0.09916015401943896,DACH1;NF1;FUZ;HOXA7
viral process (GO:0016032),8/220,0.8647752462940217,1,0,0,0.7272727272727272,0.10566228122626253,IST1;ELMO1;MVB12A;RCC1;RPL24;RPL39;RPS21;RPS13
ciliary basal body-plasma membrane docking (GO:0097711),3/96,0.8648106182658194,1,0,0,0.625,0.09077795902611915,DCTN1;NDE1;HAUS5
cellular metal ion homeostasis (GO:0006875),3/96,0.8648106182658194,1,0,0,0.625,0.09077795902611915,ATP4A;TESMIN;ATP2C1
skeletal muscle tissue development (GO:0007519),1/39,0.8649866555134298,1,0,0,0.5128205128205128,0.07438010221608295,MYL6
regulation of type I interferon-mediated signaling pathway (GO:0060338),1/39,0.8649866555134298,1,0,0,0.5128205128205128,0.07438010221608295,HSP90AB1
clathrin-dependent endocytosis (GO:0072583),1/39,0.8649866555134298,1,0,0,0.5128205128205128,0.07438010221608295,SYT2
purine ribonucleoside monophosphate biosynthetic process (GO:0009168),1/39,0.8649866555134298,1,0,0,0.5128205128205128,0.07438010221608295,IMPDH2
positive regulation of phagocytosis (GO:0050766),1/39,0.8649866555134298,1,0,0,0.5128205128205128,0.07438010221608295,CYBA
ERBB2 signaling pathway (GO:0038128),1/39,0.8649866555134298,1,0,0,0.5128205128205128,0.07438010221608295,PIK3R1
regulation of plasma membrane bounded cell projection assembly (GO:0120032),1/39,0.8649866555134298,1,0,0,0.5128205128205128,0.07438010221608295,SSH2
Golgi to plasma membrane transport (GO:0006893),1/39,0.8649866555134298,1,0,0,0.5128205128205128,0.07438010221608295,RAB31
alpha-amino acid catabolic process (GO:1901606),1/39,0.8649866555134298,1,0,0,0.5128205128205128,0.07438010221608295,CBS
DNA biosynthetic process (GO:0071897),1/39,0.8649866555134298,1,0,0,0.5128205128205128,0.07438010221608295,POLH
positive regulation of hydrolase activity (GO:0051345),6/172,0.8654695388328904,1,0,0,0.6976744186046511,0.10080216269543664,NF1;XCL1;ALDOB;RGS6;NDEL1;PLIN5
regulation of innate immune response (GO:0045088),2/69,0.8659715129706728,1,0,0,0.5797101449275363,0.08342218313842696,HSP90AB1;IFI16
regulation of osteoblast differentiation (GO:0045667),2/69,0.8659715129706728,1,0,0,0.5797101449275363,0.08342218313842696,RUNX2;BMP6
positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),2/69,0.8659715129706728,1,0,0,0.5797101449275363,0.08342218313842696,FUZ;NDEL1
proteolysis (GO:0006508),11/291,0.8663185674215276,1,0,0,0.7560137457044672,0.10848992098281442,RNF123;TPSD1;CAPN8;CASP3;LONP1;HTRA2;LCN1;CTSW;PRSS33;CTSS;PCSK4
response to tumor necrosis factor (GO:0034612),3/97,0.8694002721574682,1,0,0,0.6185567010309279,0.08656802931150201,CASP3;XCL1;TNFRSF11A
cellular response to organonitrogen compound (GO:0071417),3/97,0.8694002721574682,1,0,0,0.6185567010309279,0.08656802931150201,SPAAR;SESN2;NR1H4
negative regulation of cell motility (GO:2000146),3/97,0.8694002721574682,1,0,0,0.6185567010309279,0.08656802931150201,DACH1;NF1;FUZ
cytoskeleton-dependent cytokinesis (GO:0061640),2/70,0.8712429450339811,1,0,0,0.5714285714285714,0.0787625225498065,IST1;STMN1
phospholipid metabolic process (GO:0006644),2/70,0.8712429450339811,1,0,0,0.5714285714285714,0.0787625225498065,PLPP5;PCYT2
heart development (GO:0007507),5/149,0.871720550894918,1,0,0,0.6711409395973154,0.09213850710843985,FLRT2;OSR1;NF1;NDUFV2;EPHB4
negative regulation of transport (GO:0051051),1/40,0.8717504251826977,1,0,0,0.5,0.06862605284591321,NR1H2
embryonic heart tube morphogenesis (GO:0003143),1/40,0.8717504251826977,1,0,0,0.5,0.06862605284591321,SETDB2
intraciliary transport involved in cilium assembly (GO:0035735),1/40,0.8717504251826977,1,0,0,0.5,0.06862605284591321,HSPB11
negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),1/40,0.8717504251826977,1,0,0,0.5,0.06862605284591321,SOCS4
sensory organ development (GO:0007423),1/40,0.8717504251826977,1,0,0,0.5,0.06862605284591321,MAFB
positive regulation of mitotic nuclear division (GO:0045840),1/40,0.8717504251826977,1,0,0,0.5,0.06862605284591321,SLF1
response to cAMP (GO:0051591),1/40,0.8717504251826977,1,0,0,0.5,0.06862605284591321,DUOX1
negative regulation of cytokine secretion (GO:0050710),1/40,0.8717504251826977,1,0,0,0.5,0.06862605284591321,NR1H4
peptidyl-proline modification (GO:0018208),1/40,0.8717504251826977,1,0,0,0.5,0.06862605284591321,PPIL4
phosphatidic acid biosynthetic process (GO:0006654),1/40,0.8717504251826977,1,0,0,0.5,0.06862605284591321,GPD1
regulation of release of cytochrome c from mitochondria (GO:0090199),1/40,0.8717504251826977,1,0,0,0.5,0.06862605284591321,CIDEB
positive regulation of cytokine biosynthetic process (GO:0042108),1/40,0.8717504251826977,1,0,0,0.5,0.06862605284591321,EBI3
determination of heart left/right asymmetry (GO:0061371),1/40,0.8717504251826977,1,0,0,0.5,0.06862605284591321,SETDB2
negative regulation of macromolecule metabolic process (GO:0010605),4/124,0.8730902649815165,1,0,0,0.6451612903225806,0.08755892398339275,MSR1;RBL1;DDRGK1;MIF
phosphatidylinositol biosynthetic process (GO:0006661),3/98,0.8738518002871013,1,0,0,0.6122448979591836,0.08255784648566498,PIGA;PIK3C2G;PIK3R1
positive regulation of cell growth (GO:0030307),3/98,0.8738518002871013,1,0,0,0.6122448979591836,0.08255784648566498,SYT2;EIF4G2;POU4F2
response to molecule of bacterial origin (GO:0002237),3/98,0.8738518002871013,1,0,0,0.6122448979591836,0.08255784648566498,TNFRSF18;TNFRSF11A;CXCL3
regulation of cell communication (GO:0010646),2/71,0.8763229800185758,1,0,0,0.5633802816901409,0.07437777878706983,GRID2;NAIP
positive regulation of lymphocyte proliferation (GO:0050671),2/71,0.8763229800185758,1,0,0,0.5633802816901409,0.07437777878706983,MIF;ZP4
histone acetylation (GO:0016573),2/71,0.8763229800185758,1,0,0,0.5633802816901409,0.07437777878706983,SPI1;TAF5L
"G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",4/125,0.8769959948339774,1,0,0,0.64,0.08400182624919345,HTR6;OR10H3;GCGR;GPR1
regulation of phagocytosis (GO:0050764),1/41,0.878175666331951,1,0,0,0.4878048780487805,0.0633700633222169,CYBA
phosphatidic acid metabolic process (GO:0046473),1/41,0.878175666331951,1,0,0,0.4878048780487805,0.0633700633222169,GPD1
telomere organization (GO:0032200),1/41,0.878175666331951,1,0,0,0.4878048780487805,0.0633700633222169,RTEL1
regulation of substrate adhesion-dependent cell spreading (GO:1900024),1/41,0.878175666331951,1,0,0,0.4878048780487805,0.0633700633222169,CRKL
negative regulation of proteolysis (GO:0045861),1/41,0.878175666331951,1,0,0,0.4878048780487805,0.0633700633222169,ECM1
regulation of cell growth (GO:0001558),7/201,0.8805619416668193,1,0,0,0.6965174129353233,0.08859353598323239,NME6;SESN2;DACT3;INHBA;CRLF3;SIPA1;EIF4G2
lysosomal transport (GO:0007041),2/72,0.8812175551168138,1,0,0,0.5555555555555555,0.07025041245674381,HMGXB4;HOOK3
response to metal ion (GO:0010038),2/72,0.8812175551168138,1,0,0,0.5555555555555555,0.07025041245674381,ALG2;TESMIN
regulation of phosphatase activity (GO:0010921),2/72,0.8812175551168138,1,0,0,0.5555555555555555,0.07025041245674381,PCDH11X;ZFYVE1
positive regulation of MAP kinase activity (GO:0043406),6/177,0.8823041654912956,1,0,0,0.6779661016949152,0.08489384650292695,MAP3K2;PAK1;S100A12;TNFRSF11A;CRKL;SOD1
positive regulation of intracellular protein transport (GO:0090316),5/152,0.8823360987788662,1,0,0,0.6578947368421052,0.08235673104394964,TCAF2;USP36;ELMOD1;ARIH2;HTRA2
regulation of protein modification process (GO:0031399),1/42,0.8842793063304941,1,0,0,0.47619047619047616,0.05856300421956226,SESN2
glycolipid biosynthetic process (GO:0009247),1/42,0.8842793063304941,1,0,0,0.47619047619047616,0.05856300421956226,PIGA
regulation of ion transmembrane transporter activity (GO:0032412),1/42,0.8842793063304941,1,0,0,0.47619047619047616,0.05856300421956226,TCAF2
ceramide metabolic process (GO:0006672),1/42,0.8842793063304941,1,0,0,0.47619047619047616,0.05856300421956226,ALOX12B
cellular response to retinoic acid (GO:0071300),1/42,0.8842793063304941,1,0,0,0.47619047619047616,0.05856300421956226,HTRA2
positive regulation of cytokine secretion (GO:0050715),2/73,0.8859324931436037,1,0,0,0.547945205479452,0.06636412280550928,IFIH1;MIF
chloride transport (GO:0006821),2/73,0.8859324931436037,1,0,0,0.547945205479452,0.06636412280550928,CLIC6;CLCNKA
intracellular protein transport (GO:0006886),13/347,0.8899297776255123,1,0,0,0.7492795389048991,0.08737552575629592,TMED10;STX19;STAT3;RAB39B;RABL2B;DNAJC27;AP4B1;IPO4;RAB31;TBC1D4;BCL3;TBC1D10A;TNPO3
regulation of B cell proliferation (GO:0030888),1/43,0.8900774268754144,1,0,0,0.46511627906976744,0.05416131327939396,MIF
response to hydrogen peroxide (GO:0042542),1/43,0.8900774268754144,1,0,0,0.46511627906976744,0.05416131327939396,SOD1
positive regulation of protein localization to plasma membrane (GO:1903078),1/43,0.8900774268754144,1,0,0,0.46511627906976744,0.05416131327939396,PIK3R1
branching morphogenesis of an epithelial tube (GO:0048754),1/43,0.8900774268754144,1,0,0,0.46511627906976744,0.05416131327939396,PAK1
regulation of multicellular organismal development (GO:2000026),1/43,0.8900774268754144,1,0,0,0.46511627906976744,0.05416131327939396,SPAAR
regulation of G-protein coupled receptor protein signaling pathway (GO:0008277),2/74,0.8904734986911036,1,0,0,0.5405405405405406,0.06270374958254536,CRY1;RGS6
nitrogen compound transport (GO:0071705),2/74,0.8904734986911036,1,0,0,0.5405405405405406,0.06270374958254536,SLC16A10;SLC38A2
endosomal transport (GO:0016197),8/229,0.8910725229567775,1,0,0,0.6986899563318777,0.08057953523877992,SNX4;HMGXB4;DCTN1;MVB12A;DPY30;HOOK3;TBC1D10A;BET1L
extracellular matrix organization (GO:0030198),8/229,0.8910725229567775,1,0,0,0.6986899563318777,0.08057953523877992,FAM234B;POSTN;TTR;FLRT2;ICAM2;NF1;GPM6B;CTSS
MAPK cascade (GO:0000165),10/278,0.8935099822519456,1,0,0,0.7194244604316546,0.08100559163077616,PSMB6;FGF17;PSMB3;CUL1;NF1;RANBP9;POU4F2;FGF3;FGF22;LAT
positive regulation of angiogenesis (GO:0045766),3/103,0.8941493670111881,1,0,0,0.5825242718446602,0.06517423722567385,ECM1;PTGIS;ZNF304
negative regulation of phosphorylation (GO:0042326),2/75,0.8948461559431564,1,0,0,0.5333333333333333,0.0592551830845253,HDAC4;INHBA
negative regulation of cellular amide metabolic process (GO:0034249),2/75,0.8948461559431564,1,0,0,0.5333333333333333,0.0592551830845253,RBM4;FXR2
regulation of defense response (GO:0031347),2/75,0.8948461559431564,1,0,0,0.5333333333333333,0.0592551830845253,XCL1;CARD18
gland development (GO:0048732),2/75,0.8948461559431564,1,0,0,0.5333333333333333,0.0592551830845253,NF1;SOD1
positive regulation of signal transduction (GO:0009967),7/206,0.8949466944667533,1,0,0,0.6796116504854368,0.07543085943225253,CCBE1;HHEX;PTGIS;STAT3;PIK3R1;BMP6;EPN2
protein localization to plasma membrane (GO:0072659),4/130,0.8949983560248933,1,0,0,0.6153846153846154,0.06826670618625434,MRAP;RAB31;PACS2;CRB3
ribosomal small subunit biogenesis (GO:0042274),1/44,0.8955853061573006,1,0,0,0.45454545454545453,0.05012627322480098,NOM1
regulation of focal adhesion assembly (GO:0051893),1/44,0.8955853061573006,1,0,0,0.45454545454545453,0.05012627322480098,GPM6B
cholesterol transport (GO:0030301),1/44,0.8955853061573006,1,0,0,0.45454545454545453,0.05012627322480098,MSR1
adherens junction organization (GO:0034332),1/44,0.8955853061573006,1,0,0,0.45454545454545453,0.05012627322480098,CDH15
lymphocyte chemotaxis (GO:0048247),1/44,0.8955853061573006,1,0,0,0.45454545454545453,0.05012627322480098,XCL1
negative regulation of immune system process (GO:0002683),1/44,0.8955853061573006,1,0,0,0.45454545454545453,0.05012627322480098,HOXA7
positive regulation of transport (GO:0051050),1/44,0.8955853061573006,1,0,0,0.45454545454545453,0.05012627322480098,KMT2A
heart contraction (GO:0060047),1/44,0.8955853061573006,1,0,0,0.45454545454545453,0.05012627322480098,SOD1
carboxylic acid biosynthetic process (GO:0046394),1/44,0.8955853061573006,1,0,0,0.45454545454545453,0.05012627322480098,ASPA
posttranscriptional regulation of gene expression (GO:0010608),1/44,0.8955853061573006,1,0,0,0.45454545454545453,0.05012627322480098,GEMIN5
negative regulation of immune response (GO:0050777),1/44,0.8955853061573006,1,0,0,0.45454545454545453,0.05012627322480098,IFI16
positive regulation of viral process (GO:0048524),1/44,0.8955853061573006,1,0,0,0.45454545454545453,0.05012627322480098,MVB12A
positive regulation of vasculature development (GO:1904018),3/104,0.8978388517991447,1,0,0,0.5769230769230769,0.0621719302632217,ECM1;PTGIS;ZNF304
"phagocytosis, engulfment (GO:0006911)",3/104,0.8978388517991447,1,0,0,0.5769230769230769,0.0621719302632217,MSR1;ADGRB1;ELMO1
positive regulation of phosphorylation (GO:0042327),7/208,0.9002765100737999,1,0,0,0.673076923076923,0.07070897173106723,EPHA5;PAK1;CCND2;RALB;RARRES2;MIF;EPHB4
positive regulation of programmed cell death (GO:0043068),9/257,0.9005996114817824,1,0,0,0.7003891050583657,0.07332688892035875,APAF1;ADAMTSL4;NF1;ARHGEF19;HTRA2;POU4F2;FOXO1;HSPD1;SOD1
hexose metabolic process (GO:0019318),1/45,0.9008174591944802,1,0,0,0.4444444444444444,0.046423395514619575,ALDOB
protein complex subunit organization (GO:0071822),1/45,0.9008174591944802,1,0,0,0.4444444444444444,0.046423395514619575,NF1
metal ion homeostasis (GO:0055065),1/45,0.9008174591944802,1,0,0,0.4444444444444444,0.046423395514619575,TESMIN
peptidyl-tyrosine autophosphorylation (GO:0038083),1/45,0.9008174591944802,1,0,0,0.4444444444444444,0.046423395514619575,GRAP2
positive regulation of cellular catabolic process (GO:0031331),3/106,0.9048723287754362,1,0,0,0.5660377358490566,0.05658193494921566,RNF152;FOXO1;PLIN5
positive regulation of cellular component organization (GO:0051130),3/106,0.9048723287754362,1,0,0,0.5660377358490566,0.05658193494921566,GRID2;SLF1;SPIDR
RNA splicing (GO:0008380),3/106,0.9048723287754362,1,0,0,0.5660377358490566,0.05658193494921566,SNRNP40;LSM1;SNRNP35
transmembrane transport (GO:0055085),14/378,0.9057200244760695,1,0,0,0.7407407407407407,0.07335188478069316,MRS2;STOML3;CHRNA3;PEX19;CLCNKA;CTNS;ATP2C1;CALHM6;PSMB6;ATP4A;GABRR2;PDZD11;PSMB3;SLC19A3
positive regulation of protein localization to cell periphery (GO:1904377),1/46,0.9057876758651223,1,0,0,0.43478260869565216,0.04302189293649987,PIK3R1
nuclear envelope disassembly (GO:0051081),1/46,0.9057876758651223,1,0,0,0.43478260869565216,0.04302189293649987,DCTN1
tRNA aminoacylation for protein translation (GO:0006418),1/46,0.9057876758651223,1,0,0,0.43478260869565216,0.04302189293649987,CARS2
RNA secondary structure unwinding (GO:0010501),1/46,0.9057876758651223,1,0,0,0.43478260869565216,0.04302189293649987,DDX31
regulation of generation of precursor metabolites and energy (GO:0043467),1/46,0.9057876758651223,1,0,0,0.43478260869565216,0.04302189293649987,GCGR
positive regulation of ion transport (GO:0043270),1/46,0.9057876758651223,1,0,0,0.43478260869565216,0.04302189293649987,SNX4
aminoglycan biosynthetic process (GO:0006023),1/46,0.9057876758651223,1,0,0,0.43478260869565216,0.04302189293649987,B3GALT4
regulation of DNA metabolic process (GO:0051052),1/46,0.9057876758651223,1,0,0,0.43478260869565216,0.04302189293649987,POLH
adenylate cyclase-activating G-protein coupled receptor signaling pathway (GO:0007189),2/78,0.9070080241695482,1,0,0,0.5128205128205128,0.0500533240880421,PTGER2;GCGR
negative regulation of cell communication (GO:0010648),2/78,0.9070080241695482,1,0,0,0.5128205128205128,0.0500533240880421,EPHA5;EPHB4
viral life cycle (GO:0019058),3/107,0.9082222841413132,1,0,0,0.5607476635514018,0.053981004122237344,HSP90AB1;IST1;MVB12A
regulation of response to external stimulus (GO:0032101),3/107,0.9082222841413132,1,0,0,0.5607476635514018,0.053981004122237344,SPAAR;CARD18;XCL1
post-translational protein modification (GO:0043687),13/357,0.9103630252850958,1,0,0,0.7282913165266106,0.06839517040825754,FBXW5;EPAS1;LRR1;FBXO17;CUL1;KLHL22;SUMF1;PSMB6;PSMB3;ASB9;FBXO4;NOTUM;ARSD
regulation of organelle assembly (GO:1902115),1/47,0.9105090567783704,1,0,0,0.42553191489361697,0.03989422673431822,CEP295
fatty acid biosynthetic process (GO:0006633),1/47,0.9105090567783704,1,0,0,0.42553191489361697,0.03989422673431822,ACSM3
histone H4 acetylation (GO:0043967),1/47,0.9105090567783704,1,0,0,0.42553191489361697,0.03989422673431822,KMT2A
cellular response to organic cyclic compound (GO:0071407),4/135,0.9106439683988242,1,0,0,0.5925925925925926,0.055468605725438686,INSIG1;CASP3;SPIDR;POU4F2
mitochondrial transport (GO:0006839),4/135,0.9106439683988242,1,0,0,0.5925925925925926,0.055468605725438686,MRS2;TOMM20L;SLC25A5;HSPD1
regulation of endothelial cell proliferation (GO:0001936),2/79,0.9107606472852537,1,0,0,0.5063291139240506,0.047329191130890166,ECM1;NF1
cell-cell junction assembly (GO:0007043),2/79,0.9107606472852537,1,0,0,0.5063291139240506,0.047329191130890166,CDH15;CRB3
regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),2/79,0.9107606472852537,1,0,0,0.5063291139240506,0.047329191130890166,HSP90AB1;ASPN
regulation of GTPase activity (GO:0043087),6/188,0.9131597476168598,1,0,0,0.6382978723404255,0.0579858151181627,EPHA5;NF1;XCL1;RGS6;NDEL1;SOD1
regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),2/80,0.9143709716133156,1,0,0,0.5,0.04475945641757651,WNT16;IER3
positive regulation of stress-activated MAPK cascade (GO:0032874),2/80,0.9143709716133156,1,0,0,0.5,0.04475945641757651,CARD9;WNT16
regulation of epithelial cell migration (GO:0010632),1/48,0.914994048233663,1,0,0,0.41666666666666663,0.03701571599601437,BMPER
glycoprotein metabolic process (GO:0009100),1/48,0.914994048233663,1,0,0,0.41666666666666663,0.03701571599601437,USF3
interstrand cross-link repair (GO:0036297),1/48,0.914994048233663,1,0,0,0.41666666666666663,0.03701571599601437,ERCC1
pattern recognition receptor signaling pathway (GO:0002221),1/48,0.914994048233663,1,0,0,0.41666666666666663,0.03701571599601437,CTSS
cellular response to mechanical stimulus (GO:0071260),1/48,0.914994048233663,1,0,0,0.41666666666666663,0.03701571599601437,MAP3K2
positive regulation of protein modification process (GO:0031401),5/163,0.9150605393003802,1,0,0,0.6134969325153374,0.05445708756164863,PAK1;CCND2;RALB;RARRES2;ALG10B
macroautophagy (GO:0016236),3/110,0.9176399007049346,1,0,0,0.5454545454545454,0.04688194382454664,MVB12A;ZFYVE1;UBXN6
negative regulation of cytokine production (GO:0001818),3/110,0.9176399007049346,1,0,0,0.5454545454545454,0.04688194382454664,IFIH1;TRIM25;XCL1
negative regulation of cell death (GO:0060548),2/81,0.9178438273168302,1,0,0,0.49382716049382713,0.042334827448253703,HTRA2;WNT16
positive regulation of binding (GO:0051099),2/81,0.9178438273168302,1,0,0,0.49382716049382713,0.042334827448253703,RALB;STMN1
positive regulation of protein catabolic process (GO:0045732),2/81,0.9178438273168302,1,0,0,0.49382716049382713,0.042334827448253703,ASB9;FOXO1
regulation of signal transduction by p53 class mediator (GO:1901796),4/138,0.9190038309457114,1,0,0,0.5797101449275363,0.0489652104536948,RFC4;HUS1;MDM4;POU4F2
non-recombinational repair (GO:0000726),1/49,0.919254474341766,1,0,0,0.4081632653061224,0.034364200583535946,ERCC1
protein heterooligomerization (GO:0051291),1/49,0.919254474341766,1,0,0,0.4081632653061224,0.034364200583535946,RCC1
regulation of reactive oxygen species metabolic process (GO:2000377),1/49,0.919254474341766,1,0,0,0.4081632653061224,0.034364200583535946,PLIN5
protein autoubiquitination (GO:0051865),1/49,0.919254474341766,1,0,0,0.4081632653061224,0.034364200583535946,UBE2A
positive regulation of response to DNA damage stimulus (GO:2001022),1/49,0.919254474341766,1,0,0,0.4081632653061224,0.034364200583535946,HIC1
regulation of release of sequestered calcium ion into cytosol (GO:0051279),1/49,0.919254474341766,1,0,0,0.4081632653061224,0.034364200583535946,XCL1
regulation of protein binding (GO:0043393),3/111,0.9205777821657344,1,0,0,0.5405405405405406,0.04473177403808864,HDAC4;RALB;CARD18
negative regulation of cell proliferation (GO:0008285),13/363,0.9210371440620816,1,0,0,0.7162534435261708,0.0589153649673029,VDR;GSTP1;CUL1;FUZ;INHBA;ST18;PER2;ADGRB1;NF1;MDM4;IGFBP6;CDKN3;DIS3L2
modulation of chemical synaptic transmission (GO:0050804),2/82,0.9211839178855769,1,0,0,0.4878048780487805,0.04004661901274316,GRM3;GRID2
negative regulation of NF-kappaB transcription factor activity (GO:0032088),2/82,0.9211839178855769,1,0,0,0.4878048780487805,0.04004661901274316,NFKBIA;PTGIS
positive regulation of protein secretion (GO:0050714),2/82,0.9211839178855769,1,0,0,0.4878048780487805,0.04004661901274316,MIF;BMP6
positive regulation of DNA metabolic process (GO:0051054),2/82,0.9211839178855769,1,0,0,0.4878048780487805,0.04004661901274316,RTEL1;ZNF304
positive regulation of cell cycle arrest (GO:0071158),2/82,0.9211839178855769,1,0,0,0.4878048780487805,0.04004661901274316,MDM4;CRLF3
regulation of primary metabolic process (GO:0080090),4/139,0.9216307962341534,1,0,0,0.5755395683453237,0.04697011427115409,PSMB6;HMGCS1;PSMB3;OPA3
cilium organization (GO:0044782),6/192,0.9224978058129646,1,0,0,0.625,0.050418925995509435,CFAP61;ACTR2;DNAH14;RABL2B;FUZ;MNS1
positive regulation of GTPase activity (GO:0043547),6/192,0.9224978058129646,1,0,0,0.625,0.050418925995509435,TBC1D4;NF1;XCL1;TBC1D10A;RGS6;NDEL1
regulation of ion transport (GO:0043269),1/50,0.9233015685863551,1,0,0,0.39999999999999997,0.03191974852547144,CHRNA3
blood circulation (GO:0008015),1/50,0.9233015685863551,1,0,0,0.39999999999999997,0.03191974852547144,SOD1
regulation of blood vessel endothelial cell migration (GO:0043535),1/50,0.9233015685863551,1,0,0,0.39999999999999997,0.03191974852547144,NF1
fatty acid beta-oxidation (GO:0006635),1/50,0.9233015685863551,1,0,0,0.39999999999999997,0.03191974852547144,ACOXL
phosphatidylinositol metabolic process (GO:0046488),3/112,0.9234195962447295,1,0,0,0.5357142857142857,0.04268118605193645,PGAP1;PIK3C2G;PIK3R1
positive regulation of protein phosphorylation (GO:0001934),15/412,0.9238430149500843,1,0,0,0.7281553398058251,0.05767945559329548,EPHA5;CCNT2;RALB;CCNH;RARRES2;ALOX12B;TNFRSF11A;MIF;INHBA;BMP6;PAK1;CCND2;DDRGK1;LAT;EPHB4
negative regulation of signaling (GO:0023057),2/83,0.9243958207118659,1,0,0,0.4819277108433735,0.03788670924051055,EPHA5;EPHB4
positive regulation of protein ubiquitination (GO:0031398),2/83,0.9243958207118659,1,0,0,0.4819277108433735,0.03788670924051055,PHF23;FBXO4
negative regulation of endopeptidase activity (GO:0010951),2/83,0.9243958207118659,1,0,0,0.4819277108433735,0.03788670924051055,SERPINB2;IFI16
positive regulation of peptidyl-serine phosphorylation (GO:0033138),2/83,0.9243958207118659,1,0,0,0.4819277108433735,0.03788670924051055,PAK1;MIF
regulation of organelle organization (GO:0033043),3/113,0.9261680268010687,1,0,0,0.5309734513274336,0.04072545470868394,TBC1D4;STMN1;TBC1D10A
positive regulation of kinase activity (GO:0033674),3/113,0.9261680268010687,1,0,0,0.5309734513274336,0.04072545470868394,EPHA5;EPHB4;LAT
regulation of exocytosis (GO:0017157),1/51,0.9271460027962314,1,0,0,0.39215686274509803,0.029664402156312095,RALB
positive regulation of actin filament polymerization (GO:0030838),1/51,0.9271460027962314,1,0,0,0.39215686274509803,0.029664402156312095,WHAMM
activation of GTPase activity (GO:0090630),2/84,0.9274839879498789,1,0,0,0.47619047619047616,0.035847499197840214,TBC1D4;TBC1D10A
regulation of mitotic nuclear division (GO:0007088),2/84,0.9274839879498789,1,0,0,0.47619047619047616,0.035847499197840214,NME6;RCC1
positive regulation of cell migration (GO:0030335),7/221,0.9295999202145803,1,0,0,0.6334841628959276,0.04624496389007068,TCAF2;PAK1;DDRGK1;TNFRSF18;ZNF304;ELP5;CCAR1
positive regulation of cell-substrate adhesion (GO:0010811),1/52,0.9307979155856723,1,0,0,0.38461538461538464,0.027581956513803345,CRKL
positive regulation of secretion by cell (GO:1903532),1/52,0.9307979155856723,1,0,0,0.38461538461538464,0.027581956513803345,BMP6
regulation of peptidyl-serine phosphorylation (GO:0033135),2/86,0.9333063042418757,1,0,0,0.46511627906976744,0.032103177510297835,PAK1;MIF
axonogenesis (GO:0007409),7/223,0.9333684881308107,1,0,0,0.6278026905829596,0.043290264071117746,EPHA5;ADGRB1;ANOS1;RANBP9;OTX2;PIK3R1;POU4F2
transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),4/144,0.9336516399151867,1,0,0,0.5555555555555555,0.03813993714585849,AMHR2;INHBA;RUNX2;BMP6
positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),1/53,0.9342669389173686,1,0,0,0.3773584905660377,0.02565776594269266,WNT16
negative regulation of cellular response to transforming growth factor beta stimulus (GO:1903845),1/53,0.9342669389173686,1,0,0,0.3773584905660377,0.02565776594269266,ASPN
activation of MAPK activity (GO:0000187),3/117,0.9362798325982584,1,0,0,0.5128205128205128,0.033764554223065825,MAP3K2;DBNL;SOD1
RNA modification (GO:0009451),1/54,0.9375622230779963,1,0,0,0.37037037037037035,0.02387857483587084,TARBP1
intracellular transport of virus (GO:0075733),1/54,0.9375622230779963,1,0,0,0.37037037037037035,0.02387857483587084,MVB12A
positive regulation of immune response (GO:0050778),1/54,0.9375622230779963,1,0,0,0.37037037037037035,0.02387857483587084,ZP4
positive regulation of response to stimulus (GO:0048584),1/54,0.9375622230779963,1,0,0,0.37037037037037035,0.02387857483587084,IFIH1
transport of virus (GO:0046794),1/54,0.9375622230779963,1,0,0,0.37037037037037035,0.02387857483587084,MVB12A
negative regulation of supramolecular fiber organization (GO:1902904),1/54,0.9375622230779963,1,0,0,0.37037037037037035,0.02387857483587084,STMN1
protein transport (GO:0015031),11/326,0.9385898400456552,1,0,0,0.6748466257668712,0.042769552325530716,SNX4;PEX19;RAB31;TMED10;TBC1D4;STX19;RAB39B;RABL2B;DNAJC27;TBC1D10A;IPO4
divalent metal ion transport (GO:0070838),2/88,0.9386840239616273,1,0,0,0.45454545454545453,0.028761981412220677,MRS2;ATP2C1
negative regulation of translation (GO:0017148),2/88,0.9386840239616273,1,0,0,0.45454545454545453,0.028761981412220677,RBM4;FXR2
sensory perception of chemical stimulus (GO:0007606),11/327,0.9400254060317073,1,0,0,0.6727828746177369,0.04161052845811971,OR2W5;OR6K3;OR13J1;OR2AG1;OR2B11;OR5B12;OR10G8;OR5D16;OR2T8;OR5AK2;OR4C46
positive regulation of ERK1 and ERK2 cascade (GO:0070374),6/201,0.9403516571166085,1,0,0,0.5970149253731343,0.03671723603686233,EPHA5;BMPER;XCL1;MIF;TNFRSF11A;EPHB4
negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),1/55,0.9406924613791231,1,0,0,0.3636363636363636,0.022232368682920493,ASPN
negative regulation of cellular protein metabolic process (GO:0032269),2/89,0.9412159961600209,1,0,0,0.449438202247191,0.02722814686661418,RBM4;FXR2
chromosome organization (GO:0051276),1/56,0.9436659121708673,1,0,0,0.3571428571428571,0.020708243598219184,HHEX
anion transport (GO:0006820),1/56,0.9436659121708673,1,0,0,0.3571428571428571,0.020708243598219184,LRRIQ4
chordate embryonic development (GO:0043009),1/56,0.9436659121708673,1,0,0,0.3571428571428571,0.020708243598219184,RARRES2
positive regulation of protein transport (GO:0051222),1/56,0.9436659121708673,1,0,0,0.3571428571428571,0.020708243598219184,BMP6
glycosaminoglycan catabolic process (GO:0006027),1/56,0.9436659121708673,1,0,0,0.3571428571428571,0.020708243598219184,LYVE1
regulation of cell differentiation (GO:0045595),3/121,0.9450990402667404,1,0,0,0.49586776859504134,0.027999447503273347,HSP90AB1;RUNX2;POU4F2
regulation of glycolytic process (GO:0006110),1/57,0.9464904210788941,1,0,0,0.3508771929824561,0.01929629078749377,HDAC4
regulation of Rho protein signal transduction (GO:0035023),1/57,0.9464904210788941,1,0,0,0.3508771929824561,0.01929629078749377,STMN1
epidermal growth factor receptor signaling pathway (GO:0007173),1/57,0.9464904210788941,1,0,0,0.3508771929824561,0.01929629078749377,PIK3R1
cellular respiration (GO:0045333),1/57,0.9464904210788941,1,0,0,0.3508771929824561,0.01929629078749377,NDUFV2
response to retinoic acid (GO:0032526),1/57,0.9464904210788941,1,0,0,0.3508771929824561,0.01929629078749377,HTRA2
nuclear export (GO:0051168),2/92,0.9482287784921883,1,0,0,0.43478260869565216,0.02311281666022285,NXF1;NEMF
receptor metabolic process (GO:0043112),1/58,0.9491734416512021,1,0,0,0.3448275862068965,0.017987494665677846,RAB31
regulation of epidermal growth factor receptor signaling pathway (GO:0042058),1/58,0.9491734416512021,1,0,0,0.3448275862068965,0.017987494665677846,MVB12A
positive regulation of cell morphogenesis involved in differentiation (GO:0010770),1/58,0.9491734416512021,1,0,0,0.3448275862068965,0.017987494665677846,CRKL
sodium ion transport (GO:0006814),1/58,0.9491734416512021,1,0,0,0.3448275862068965,0.017987494665677846,KCNK1
post-Golgi vesicle-mediated transport (GO:0006892),1/58,0.9491734416512021,1,0,0,0.3448275862068965,0.017987494665677846,NUDT19
organic anion transport (GO:0015711),3/124,0.9509542388487732,1,0,0,0.48387096774193544,0.024333549956038612,PRELID2;OSBPL8;PCTP
mitotic cytokinesis (GO:0000281),1/59,0.95172205472190885,1,0,0,0.3389830508474576,0.01677364276098951,STMN1
cell junction assembly (GO:0034329),1/59,0.95172205472190885,1,0,0,0.3389830508474576,0.01677364276098951,CDH15
protein dephosphorylation (GO:0006470),3/125,0.9527728742359944,1,0,0,0.48,0.023221790818524435,SDHAF2;PTPN7;SSH2
regulation of cell proliferation (GO:0042127),28/740,0.9534486978554825,1,0,0,0.7567567567567568,0.03607433685925466,HDAC4;REG1A;CUL1;TNFRSF11A;CXCL3;FGF3;CCAR1;CRKL;PAK1;CCND2;FTMT;DDRGK1;GRAP2;IGFBP6;DIS3L2;EDN2;VDR;TNFRSF18;FUZ;UBE2A;INHBA;ST18;FOSL1;CDK4;ADGRB1;MDM4;SLC25A5;CDKN3
positive regulation of protein binding (GO:0032092),1/60,0.95414298697788,1,0,0,0.3333333333333333,0.015647245745596144,RALB
membrane lipid biosynthetic process (GO:0046467),1/60,0.95414298697788,1,0,0,0.3333333333333333,0.015647245745596144,ALDH3A2
cilium assembly (GO:0060271),9/288,0.9543281898247749,1,0,0,0.625,0.029217282626181253,ACTR2;DCTN1;NDE1;DNAH14;RABL2B;FUZ;HAUS5;MAPRE2;HSPB11
positive regulation of MAPK cascade (GO:0043410),9/289,0.9555180876272084,1,0,0,0.6228373702422144,0.028340087834866808,EPHA5;BMPER;CARD9;S100A12;XCL1;ALOX12B;MIF;TNFRSF11A;EPHB4
ribonucleoprotein complex assembly (GO:0022618),4/156,0.9559767338038594,1,0,0,0.5128205128205128,0.02308805294981418,XAB2;HSP90AB1;RPL24;GEMIN5
negative regulation of response to stimulus (GO:0048585),3/127,0.9562226890751985,1,0,0,0.47244094488188976,0.021148561272512884,EPHA5;RBL1;EPHB4
non-canonical Wnt signaling pathway (GO:0035567),3/127,0.9562226890751985,1,0,0,0.47244094488188976,0.021148561272512884,PSMB6;PSMB3;ARHGEF19
RNA 3'-end processing (GO:0031123),1/61,0.956442628953957,1,0,0,0.32786885245901637,0.014601466257298934,FIP1L1
regulation of cell migration (GO:0030334),10/316,0.9573784698045901,1,0,0,0.6329113924050633,0.027567399031011415,TCAF2;PAK1;DACH1;DDRGK1;NF1;ZNF304;FUZ;ELP5;CCAR1;RND1
regulation of protein processing (GO:0070613),3/128,0.9578577572454201,1,0,0,0.46875,0.02018249573547579,CCBE1;CFH;TNP2
protein localization to organelle (GO:0033365),2/97,0.9581767039032599,1,0,0,0.41237113402061853,0.017617759662583495,HHEX;COG3
negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),1/62,0.9586270516234485,1,0,0,0.3225806451612903,0.013630055718159003,HTRA2
"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",1/62,0.9586270516234485,1,0,0,0.3225806451612903,0.013630055718159003,MDM4
vesicle coating (GO:0006901),1/63,0.9607020222041087,1,0,0,0.31746031746031744,0.012727297981234762,TMED10
COPII vesicle coating (GO:0048208),1/63,0.9607020222041087,1,0,0,0.31746031746031744,0.012727297981234762,TMED10
"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",1/63,0.9607020222041087,1,0,0,0.31746031746031744,0.012727297981234762,TMED10
signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431),1/63,0.9607020222041087,1,0,0,0.31746031746031744,0.012727297981234762,MDM4
homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),1/64,0.9626730196391721,1,0,0,0.3125,0.011887958847229707,CDH15
positive regulation of endocytosis (GO:0045807),1/64,0.9626730196391721,1,0,0,0.3125,0.011887958847229707,CYBA
negative regulation of neuron differentiation (GO:0045665),1/64,0.9626730196391721,1,0,0,0.3125,0.011887958847229707,POU4F2
positive regulation of cell adhesion (GO:0045785),1/64,0.9626730196391721,1,0,0,0.3125,0.011887958847229707,TNFRSF18
cellular response to metal ion (GO:0071248),2/100,0.9632369873558141,1,0,0,0.39999999999999997,0.014982321868347009,ZNF658;BMP6
cellular response to type I interferon (GO:0071357),1/65,0.9645452489317999,1,0,0,0.3076923076923077,0.011107241028940524,OASL
chromatin assembly (GO:0031497),1/65,0.9645452489317999,1,0,0,0.3076923076923077,0.011107241028940524,GRWD1
regulation of cell division (GO:0051302),1/65,0.9645452489317999,1,0,0,0.3076923076923077,0.011107241028940524,ESRRB
type I interferon signaling pathway (GO:0060337),1/65,0.9645452489317999,1,0,0,0.3076923076923077,0.011107241028940524,OASL
metal ion transport (GO:0030001),2/101,0.9647890418591292,1,0,0,0.396039603960396,0.014196360797659355,KCNA5;KCNK1
protein targeting (GO:0006605),3/133,0.9652081031256262,1,0,0,0.45112781954887216,0.015975135331615462,PEX19;SRPRA;AP4B1
positive regulation of cytosolic calcium ion concentration (GO:0007204),3/133,0.9652081031256262,1,0,0,0.45112781954887216,0.015975135331615462,EDN2;PTGER2;S1PR4
detection of chemical stimulus involved in sensory perception (GO:0050907),2/102,0.9662779974899206,1,0,0,0.39215686274509803,0.013452432976578837,OR6K3;OR4C46
cellular response to light stimulus (GO:0071482),1/66,0.9663236546235302,1,0,0,0.30303030303030304,0.010380743845736572,USP28
regulation of ERK1 and ERK2 cascade (GO:0070372),7/247,0.9665054408516541,1,0,0,0.5668016194331984,0.019309996468212867,EPHA5;BMPER;GSTP1;RANBP9;XCL1;MIF;EPHB4
plasma membrane invagination (GO:0099024),2/103,0.9677062755799263,1,0,0,0.38834951456310673,0.01274822216284486,MSR1;ELMO1
phagocytosis (GO:0006909),3/135,0.9677952919812572,1,0,0,0.4444444444444444,0.014548750798032252,MSR1;ADGRB1;ELMO1
regulation of gene silencing by miRNA (GO:0060964),1/67,0.9680129340715097,1,0,0,0.29850746268656714,0.00970442691065804,STAT3
positive regulation of synaptic transmission (GO:0050806),1/67,0.9680129340715097,1,0,0,0.29850746268656714,0.00970442691065804,CACNG5
positive regulation of endothelial cell proliferation (GO:0001938),1/67,0.9680129340715097,1,0,0,0.29850746268656714,0.00970442691065804,ECM1
monovalent inorganic cation transport (GO:0015672),2/104,0.9690762134019278,1,0,0,0.38461538461538464,0.0120815456087189,KCNA5;KCNK1
response to interferon-gamma (GO:0034341),1/68,0.9696175495526317,1,0,0,0.2941176470588235,0.009074577660222398,XCL1
regulation of endopeptidase activity (GO:0052548),1/68,0.9696175495526317,1,0,0,0.2941176470588235,0.009074577660222398,SERPINB2
COPII-coated vesicle budding (GO:0090114),1/68,0.9696175495526317,1,0,0,0.2941176470588235,0.009074577660222398,TMED10
termination of RNA polymerase II transcription (GO:0006369),1/68,0.9696175495526317,1,0,0,0.2941176470588235,0.009074577660222398,FIP1L1
peptidyl-threonine phosphorylation (GO:0018107),1/68,0.9696175495526317,1,0,0,0.2941176470588235,0.009074577660222398,OSR1
muscle contraction (GO:0006936),3/137,0.9702000312158441,1,0,0,0.43795620437956206,0.013249493867024583,CKMT2;MYL6;TACR2
regulation of cytosolic calcium ion concentration (GO:0051480),3/137,0.9702000312158441,1,0,0,0.43795620437956206,0.013249493867024583,EDN2;PTGER2;S1PR4
positive regulation of neurogenesis (GO:0050769),1/69,0.9711417402987961,1,0,0,0.2898550724637681,0.00848778197469868,ZC4H2
regulation of vesicle-mediated transport (GO:0060627),3/138,0.9713377151896119,1,0,0,0.43478260869565216,0.012643943360258838,TBC1D4;TBC1D10A;BET1L
neuropeptide signaling pathway (GO:0007218),1/70,0.972589533427257,1,0,0,0.2857142857142857,0.007940897858985217,GPR1
positive regulation of apoptotic process (GO:0043065),9/307,0.9726950675837398,1,0,0,0.5863192182410423,0.01623203646454053,PTGIS;APAF1;ADAMTSL4;NF1;ARHGEF19;HTRA2;FOXO1;HSPD1;SOD1
inorganic cation transmembrane transport (GO:0098662),3/140,0.9734908104308518,1,0,0,0.42857142857142855,0.011514383115519571,ATP2C1;KCNK1;SLC39A3
positive regulation of growth (GO:0045927),1/71,0.9739647545480367,1,0,0,0.28169014084507044,0.00743103163098366,EIF4G2
circulatory system development (GO:0072359),2/109,0.9751270159817813,1,0,0,0.3669724770642202,0.009243135290725672,OSR1;NF1
cell-cell junction organization (GO:0045216),1/72,0.9752710378445755,1,0,0,0.27777777777777773,0.006955516411879717,CDH15
positive regulation of macromolecule biosynthetic process (GO:0010557),3/142,0.9754898668704344,1,0,0,0.4225352112676056,0.010485425323662952,FXR2;BCL3;PYM1
canonical Wnt signaling pathway (GO:0060070),1/73,0.9765118358730951,1,0,0,0.273972602739726,0.0065118926107079,FRAT1
protein autophosphorylation (GO:0046777),4/175,0.9776183591008238,1,0,0,0.45714285714285713,0.010347845016468711,PAK1;EEF2K;GRAP2;EPHB4
mRNA 3'-end processing (GO:0031124),1/74,0.9776904281936729,1,0,0,0.2702702702702703,0.00609789044447976,FIP1L1
peptidyl-serine phosphorylation (GO:0018105),3/145,0.9782218699760653,1,0,0,0.41379310344827586,0.009111216728335437,RICTOR;STK32A;CSNK1G1
purine ribonucleotide biosynthetic process (GO:0009152),1/75,0.9788099305759348,1,0,0,0.26666666666666666,0.005711413813620137,IMPDH2
regulation of humoral immune response (GO:0002920),2/113,0.9791273621981581,1,0,0,0.35398230088495575,0.007466743623819164,CFH;ZP4
negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),1/76,0.9798733026216075,1,0,0,0.2631578947368421,0.005350525977491548,GSTP1
regulation of intracellular signal transduction (GO:1902531),13/422,0.9800778904618177,1,0,0,0.6161137440758293,0.012398198832538827,ARHGAP11B;RFC4;ARHGEF19;HUS1;INHBA;POU4F2;BMP6;PAK1;PAK6;RICTOR;MDM4;PAK5;IER3
positive regulation of cytoskeleton organization (GO:0051495),1/77,0.9808833558575986,1,0,0,0.2597402597402597,0.00501343630948899,SYNPO2
sensory perception of mechanical stimulus (GO:0050954),1/78,0.9818427613794292,1,0,0,0.2564102564102564,0.004698488267500739,SOD1
extracellular matrix disassembly (GO:0022617),1/78,0.9818427613794292,1,0,0,0.2564102564102564,0.004698488267500739,CTSS
nucleosome organization (GO:0034728),1/79,0.982754056231908,1,0,0,0.2531645569620253,0.004404148673065393,GRWD1
peptidyl-tyrosine phosphorylation (GO:0018108),1/79,0.982754056231908,1,0,0,0.2531645569620253,0.004404148673065393,GRAP2
steroid biosynthetic process (GO:0006694),1/79,0.982754056231908,1,0,0,0.2531645569620253,0.004404148673065393,LSS
response to calcium ion (GO:0051592),1/79,0.982754056231908,1,0,0,0.2531645569620253,0.004404148673065393,ALG2
plasma membrane bounded cell projection assembly (GO:0120031),6/241,0.9829119112920234,1,0,0,0.49792531120331945,0.00858212861292399,ACTR2;DNAH14;PMP22;RABL2B;FUZ;WHAMM
calcium ion transport (GO:0006816),2/118,0.9832579796031666,1,0,0,0.3389830508474576,0.005723305818546954,ORAI2;ATP2C1
RNA transport (GO:0050658),1/80,0.9836196507462239,1,0,0,0.25,0.004128997611953673,NXF1
ERBB signaling pathway (GO:0038127),1/80,0.9836196507462239,1,0,0,0.25,0.004128997611953673,PIK3R1
sensory perception of sound (GO:0007605),1/81,0.9844418345091214,1,0,0,0.24691358024691357,0.003871719481130927,SOD1
enzyme linked receptor protein signaling pathway (GO:0007167),2/120,0.9846775335112893,1,0,0,0.3333333333333333,0.005147022851847904,GRAP2;PILRA
regulation of acute inflammatory response (GO:0002673),2/121,0.9853427079965097,1,0,0,0.3305785123966942,0.004881246751261704,CFH;GSTP1
establishment of protein localization to membrane (GO:0090150),1/83,0.9859645609779344,1,0,0,0.24096385542168675,0.0034059921056594548,RAB31
protein complex assembly (GO:0006461),4/189,0.986650135078189,1,0,0,0.42328042328042326,0.00568879384585356,TLE1;TMED10;DBNL;NCF1B
protein homooligomerization (GO:0051260),4/190,0.9871407452940422,1,0,0,0.42105263157894735,0.005449537108559381,LONP1;HTRA2;MIF;POLK
regulation of peptidyl-tyrosine phosphorylation (GO:0050730),1/85,0.987338361755133,1,0,0,0.23529411764705882,0.0029982305654579823,MIF
calcium ion transmembrane transport (GO:0070588),1/86,0.9879740196694372,1,0,0,0.23255813953488372,0.0028136924328252115,ATP2C1
calcium ion homeostasis (GO:0055074),1/87,0.9885777887454201,1,0,0,0.22988505747126436,0.002640907067682,ATP2C1
organic substance transport (GO:0071702),1/87,0.9885777887454201,1,0,0,0.22988505747126436,0.002640907067682,PCTP
neuron projection morphogenesis (GO:0048812),3/163,0.989424215322232,1,0,0,0.36809815950920244,0.00391365855217165,PAK1;DBNL;ADGRB1
regulation of cell cycle process (GO:0010564),1/90,0.9902133488804308,1,0,0,0.2222222222222222,0.002185523367001884,RCC1
regulation of cytokine-mediated signaling pathway (GO:0001959),1/90,0.9902133488804308,1,0,0,0.2222222222222222,0.002185523367001884,HSP90AB1
protein tetramerization (GO:0051262),1/90,0.9902133488804308,1,0,0,0.2222222222222222,0.002185523367001884,RCC1
regulation of Ras protein signal transduction (GO:0046578),1/90,0.9902133488804308,1,0,0,0.2222222222222222,0.002185523367001884,NF1
phospholipase C-activating G-protein coupled receptor signaling pathway (GO:0007200),1/91,0.9907047643496917,1,0,0,0.21978021978021978,0.002052462844095697,GRPR
adenylate cyclase-modulating G-protein coupled receptor signaling pathway (GO:0007188),2/134,0.9918061738095247,1,0,0,0.29850746268656714,0.002455994057658477,PTGER2;GCGR
axon development (GO:0061564),1/94,0.9920359395529106,1,0,0,0.21276595744680848,0.001701264460748507,ADGRB1
regulation of heart contraction (GO:0008016),1/95,0.9924358915832194,1,0,0,0.21052631578947367,0.0015984971305800805,CYP2J2
mRNA metabolic process (GO:0016071),1/97,0.993176581718741,1,0,0,0.20618556701030927,0.001411712214835502,DIS3L2
cell morphogenesis involved in neuron differentiation (GO:0048667),1/97,0.993176581718741,1,0,0,0.20618556701030927,0.001411712214835502,ADGRB1
positive regulation of neuron projection development (GO:0010976),1/97,0.993176581718741,1,0,0,0.20618556701030927,0.001411712214835502,SYT2
positive regulation of neuron differentiation (GO:0045666),1/98,0.9935192823457568,1,0,0,0.2040816326530612,0.0013268997301213528,ZC4H2
regulation of small GTPase mediated signal transduction (GO:0051056),2/140,0.9937514842124622,1,0,0,0.2857142857142857,0.0017908912764511386,ARHGAP11B;ARHGEF19
glycosaminoglycan biosynthetic process (GO:0006024),1/99,0.9938447802854349,1,0,0,0.20202020202020202,0.0012473214492474535,B4GALT5
cellular response to transforming growth factor beta stimulus (GO:0071560),1/100,0.9941539382186212,1,0,0,0.19999999999999998,0.0011726433786248553,XCL1
protein phosphorylation (GO:0006468),13/470,0.9944184991534595,1,0,0,0.553191489361702,0.0030962877934140594,MAP3K2;OSR1;GTF2H1;CCNA2;PAK1;EEF2K;CDK4;CRY1;RICTOR;STK32A;EPHB4;CSNK1G1;NEK11
cellular divalent inorganic cation homeostasis (GO:0072503),1/101,0.9944475754934881,1,0,0,0.198019801980198,0.0011025537650444187,ATP2C1
positive regulation of lymphocyte activation (GO:0051251),1/104,0.9952429552680097,1,0,0,0.19230769230769232,9.169991309490005e-4,HSPD1
positive regulation of cell cycle process (GO:0090068),1/107,0.9959244354269028,1,0,0,0.18691588785046725,7.633443590547408e-4,CRLF3
regulation of protein activation cascade (GO:2000257),1/108,0.9961291716353845,1,0,0,0.18518518518518517,7.182110017849846e-4,CFH
cellular protein metabolic process (GO:0044267),13/484,0.9962329136876205,1,0,0,0.5371900826446281,0.0020274626229846646,MRPS2;HTRA2;UBE2G2;MRPL13;MRPL24;MRPS5;TTR;RPL24;NOTUM;IGFBP6;RPL39;RPS21;RPS13
regulation of cell motility (GO:2000145),1/109,0.9963236252556655,1,0,0,0.1834862385321101,6.758071960977404e-4,RND1
regulation of complement activation (GO:0030449),1/109,0.9963236252556655,1,0,0,0.1834862385321101,6.758071960977404e-4,CFH
regulation of immune effector process (GO:0002697),1/114,0.9971588332597501,1,0,0,0.17543859649122806,4.991597395875789e-4,CFH
endocytosis (GO:0006897),5/263,0.9972955132956056,1,0,0,0.38022813688212925,0.0010297149945732022,SNX4;MSR1;DPYSL2;SNX11;CSNK1G1
phosphorylation (GO:0016310),9/386,0.997490134369023,1,0,0,0.46632124352331605,0.0011718749023356674,MAP3K2;PAK1;CDK4;PNKP;STAT3;IDNK;DGKZ;NADK;NEK11
positive regulation of B cell activation (GO:0050871),1/119,0.9978042883455355,1,0,0,0.1680672268907563,3.694329014686676e-4,MIF
mitochondrion organization (GO:0007005),2/167,0.9981852391273138,1,0,0,0.23952095808383234,4.350681547623163e-4,LONP1;HSPD1
cellular calcium ion homeostasis (GO:0006874),1/123,0.9982133248787647,1,0,0,0.16260162601626016,2.907761185247364e-4,ATP2C1
regulation of macromolecule metabolic process (GO:0060255),1/129,0.9986884703691545,1,0,0,0.15503875968992248,2.0347138582387002e-4,CDK4
receptor-mediated endocytosis (GO:0006898),2/188,0.9993161305762219,1,0,0,0.21276595744680848,1.4555390832707665e-4,MSR1;RAB31
regulation of immune response (GO:0050776),3/251,0.9997523439170474,1,0,0,0.2390438247011952,5.920798919151151e-5,BTN1A1;ICAM2;PILRA
protein oligomerization (GO:0051259),2/217,0.9998237277194254,1,0,0,0.18433179723502302,3.24954503887545e-5,LONP1;POLK
cellular protein modification process (GO:0006464),28/1001,0.9998460938690573,1,0,0,0.5594405594405594,8.610795843725326e-5,PGAP1;EPAS1;GPAA1;LRR1;CUL1;GLRX;ALOX12B;PSMB6;SERP2;PAK1;PSMB3;FBXO4;ARSD;MAP3K2;FBXW5;FBXO17;COG3;B3GALT4;KLHL22;SSH2;SUMF1;SDHAF2;CDK4;ASB9;PTPN7;NOTUM;ALG10B;NEK11
